var title_f32_39_33392="Flunisolide: Drug information";
var content_f32_39_33392=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Flunisolide: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <div class=\"block inc\" id=\"F12624509\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <p>",
"     Information for this drug is presented separately based upon the following methods of administration:",
"    </p>",
"   </div>",
"   <div class=\"sec_xr rmolist\" id=\"F12624510\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <ul xmlns=\"\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?29/62/30691?source=see_link\">",
"       Flunisolide (nasal): Drug information",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?9/34/9766?source=see_link\">",
"       Flunisolide (oral inhalation): Drug information",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8457 Version 30.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-D40D2B0C78-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_39_33392=[""].join("\n");
var outline_f32_39_33392=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   DRUG INFORMATION",
"   <br/>",
"   [by method of administration]",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?29/62/30691?source=related_link\">",
"      Flunisolide (nasal): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?9/34/9766?source=related_link\">",
"      Flunisolide (oral inhalation): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_39_33393="CXR - pulmonary involvement of CLM";
var content_f32_39_33393=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F81742&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F81742&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    CXR - pulmonary involvement of CLM",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 407px; height: 432px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior chest x-ray showing bilaterial reticulonodular infiltrates.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Mackowiak PA. A rash and cough in a traveler. Clin Infect Dis 2011; 53:167, by permission of Oxford University Press. Copyright &copy; 2011.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_39_33393=[""].join("\n");
var outline_f32_39_33393=null;
var title_f32_39_33394="Trapezoid fractures";
var content_f32_39_33394=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Trapezoid fractures",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/39/33394/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/39/33394/contributors\">",
"     Patrice Eiff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/39/33394/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/39/33394/contributors\">",
"     Karl B Fields, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/39/33394/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/39/33394/contributors\">",
"     Jonathan Grayzel, MD, FAAEM",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/39/33394/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 25, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Upper extremity fractures are among the most common of the extremity injuries with carpal fractures accounting for 18 percent of hand fractures and 6 percent of all fractures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33394/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Of these, fractures to bones of the distal row are less frequent than fractures of the bones of the proximal row (ie, scaphoid, lunate, triquetrum, and pisiform). Trapezoid fractures are the least common carpal fracture of the wrist, involving less than 1 percent of all carpal fractures. Its shape and location afford protection, and dislocation is probably more common than fracture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33394/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic reviews fractures of the trapezoid in adults. An overview of carpal fractures in adults is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?4/49/4886?source=see_link\">",
"     \"Overview of carpal fractures\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PERTINENT ANATOMY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The trapezoid is in the distal carpal row and articulates distally with the index metacarpal base, radially with the trapezium, ulnar with the capitate and proximally with the scaphoid (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef70211 \" href=\"mobipreview.htm?37/16/38146\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef69097 \" href=\"mobipreview.htm?1/31/1527\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef78359 \" href=\"mobipreview.htm?26/34/27172\">",
"     figure 2",
"    </a>",
"    ). A detailed discussion of wrist anatomy is provided separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/45/14039?source=see_link\">",
"     \"Anatomy and basic biomechanics of the wrist\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     MECHANISM OF INJURY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fractures of the trapezoid generally occur with axial loading of the 2nd (index) metacarpal, or may rarely occur secondary to direct dorsal trauma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33394/abstract/5\">",
"     5",
"    </a>",
"    ]. Wrist hyperflexion with dorsal loading of the index metacarpal and index finger hyperextension with wrist hyperextension have been suggested as mechanisms and likened to the effect of a nutcracker [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33394/abstract/4\">",
"     4",
"    </a>",
"    ]. More typically, with a dorsally applied force to the distal aspect of the index metacarpal a dislocation will occur with the proximal aspect of the metacarpal slipping volar (palmar) to the trapezoid.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     SYMPTOMS AND EXAMINATION FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients usually have some degree of swelling on the dorsum of the hand, and point tenderness dorsally just proximal to the 2nd metacarpal base. Resisted wrist dorsiflexion may cause pain as the extensor carpi radialis inserts on the proximal aspect of the index metacarpal, which is closely fixed to the trapezoid by firm intercarpal ligamentous attachments.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     RADIOGRAPHIC FINDINGS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Trapezoid fractures are hard to detect on standard AP, lateral, and oblique views of the wrist. With several structures often overlapping on these views, CT scan is the best imaging modality if index of suspicion is high for fracture based upon the history and clinical examination. An AP view plain x-ray can show fracture-dislocation as evidenced by a loss of the normal linear relationship and loss of congruence of the proximal joint surface of the index metacarpal. Magnetic resonance imaging is an alternative approach to imaging. (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef51063 graphicRef59798 graphicRef72554 \" href=\"mobipreview.htm?16/36/16966\">",
"     image 2A-C",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR SURGICAL REFERRAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Comminuted fractures, dislocations or fracture-dislocations should be referred for hand surgery evaluation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     INITIAL TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;If patient is to be referred the wrist can be immobilized in a volar splint (",
"    <a class=\"graphic graphic_figure graphicRef65696 \" href=\"mobipreview.htm?42/15/43263\">",
"     figure 3",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/54/15208?source=see_link\">",
"     \"Splinting of musculoskeletal injuries\"",
"    </a>",
"    .) Ice and elevation are used to minimize swelling. The splint can be used for three to five days if swelling prevents immediate application of a cast to a non-displaced fracture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     FOLLOW-UP CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Follow-up again in three to five days for appropriate casting is appropriate. Immobilization of the index and middle fingers MCPs in flexion in the cast is sometimes employed to decrease loading on the trapezoid. Non-displaced fractures typically heal well with four to six weeks of short arm casting.",
"   </p>",
"   <p>",
"    Similar tenants to standard care for other non-displaced carpal fractures can be followed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     RECOMMENDATIONS FOR RETURN TO SPORT OR WORK",
"    </span>",
"    &nbsp;&mdash;&nbsp;As with other carpal fractures treated with casting, if the patient can return functionally to their work or sport, no restrictions are needed while casted. Removable wrist support can be utilized after radiographic healing until the patient has returned to full functional capability.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Isolated fractures of the trapezoid are rare. Fractures generally occur with axial loading of the 2nd (index) metacarpal, or may occur secondary to direct dorsal trauma. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Mechanism of injury'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with a trapezoid fracture usually have some degree of swelling on the dorsum of the hand, and point tenderness dorsally just proximal to the 2nd metacarpal base. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Symptoms and examination findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Standard radiographic views of the wrist may not be sufficient for diagnosis. Oblique projections or CT scan may be necessary for identification of the fracture. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Radiographic findings'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Non-displaced fractures can be treated adequately with a short arm cast for four to six weeks, followed by removable splinting while range of motion and strength return. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Initial treatment'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Follow-up care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Late arthrosis has been reported.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15768479\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The author and editors would like to acknowledge Kevin E Burroughs, MD, who contributed to earlier versions of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Dobyns JH, Beckenbaugh RD, Bryan RS, et al. Fractures of the hand and wrist. In: Hand Surgery, 3rd, Flynn JE (Ed), Williams &amp; Wilkins, Philadelphia 1982.",
"    </li>",
"    <li>",
"     Eiff MP, Hatch RL, Calmbach WL. Carpal fractures. In: Fracture Management for Primary Care, 2nd, Saunders, Philadelphia 2003.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33394/abstract/3\">",
"      Jeong GK, Kram D, Lester B. Isolated fracture of the trapezoid. Am J Orthop (Belle Mead NJ) 2001; 30:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33394/abstract/4\">",
"      Miyawaki T, Kobayashi M, Matsuura S, et al. Trapezoid bone fracture. Ann Plast Surg 2000; 44:444.",
"     </a>",
"    </li>",
"    <li>",
"     Seitz WH, Papandrea RF. Fractures and dislocations of the wrist. In: Rockwood and Green's Fractures in Adults, 5th, Bucholz RW, Heckman JD (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2002.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 202 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-221.179.173.170-82E6EA8F2F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_39_33394=[""].join("\n");
var outline_f32_39_33394=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PERTINENT ANATOMY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      MECHANISM OF INJURY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      SYMPTOMS AND EXAMINATION FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      RADIOGRAPHIC FINDINGS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      INDICATIONS FOR SURGICAL REFERRAL",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      INITIAL TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      FOLLOW-UP CARE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      RECOMMENDATIONS FOR RETURN TO SPORT OR WORK",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15768479\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/202\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/202|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?37/16/38146\" title=\"diagnostic image 1\">",
"      Normal adult wrist AP xray",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?26/41/27295\" title=\"diagnostic image 2A\">",
"      Trapezoid edema T1 MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?42/12/43214\" title=\"diagnostic image 2B\">",
"      Trapezoid edema T2 axial MRI",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?43/15/44287\" title=\"diagnostic image 2C\">",
"      Trapezoid edema T2 coronal MRI",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/202|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?1/31/1527\" title=\"figure 1\">",
"      Anatomy of the volar aspect of the wrist",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?26/34/27172\" title=\"figure 2\">",
"      Anatomy wrist dorsal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?42/15/43263\" title=\"figure 3\">",
"      Volar forearm splint",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/45/14039?source=related_link\">",
"      Anatomy and basic biomechanics of the wrist",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/49/4886?source=related_link\">",
"      Overview of carpal fractures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/54/15208?source=related_link\">",
"      Splinting of musculoskeletal injuries",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_39_33395="Patient information: Avoiding infections in pregnancy (The Basics)";
var content_f32_39_33395=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15831\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_table\" href=\"mobipreview.htm?0/34/557\">",
"         Tips for safe food handling",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?27/32/28161\">",
"         Patient information: Animal bites (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?22/52/23362\">",
"         Patient information: Chlamydia and gonorrhea (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?10/22/10595\">",
"         Patient information: Food poisoning (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?14/51/15155\">",
"         Patient information: Insect bites and stings (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?27/29/28114\">",
"         Patient information: Listeria (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?3/47/3826\">",
"         Patient information: Malaria (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?26/42/27298\">",
"         Patient information: Staying healthy when you travel (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?7/52/8003\">",
"         Patient information: Vaccines and pregnancy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?27/22/28003\">",
"         Patient information: Vaccines for babies and children age 0 to 6 years (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?22/15/22770\">",
"         Patient information: Animal bites (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?24/14/24802\">",
"         Patient information: Chlamydia (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?28/30/29156\">",
"         Patient information: Food poisoning (food-borne illness) (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?16/2/16421\">",
"         Patient information: General travel advice (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?1/44/1730\">",
"         Patient information: Gonorrhea (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?10/63/11248\">",
"         Patient information: Group B streptococcus and pregnancy (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?17/7/17522\">",
"         Patient information: Vaccination during pregnancy (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?16/19/16690\">",
"         Patient information: West Nile virus infection (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Avoiding infections in pregnancy (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/avoiding-infections-in-pregnancy-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H28792387\">",
"      <span class=\"h1\">",
"       Why should pregnant women avoid getting infections?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Pregnant women should try to avoid getting infections because certain infections can:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Be worse in pregnant women than in people who are not pregnant",
"       </li>",
"       <li>",
"        Be passed from a woman to her unborn baby",
"       </li>",
"       <li>",
"        Cause problems for a baby after its birth",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H28792394\">",
"      <span class=\"h1\">",
"       How might a pregnant woman get an infection?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Pregnant women can get infections from different sources, just like everyone else. People can get infections from other people, animals, mosquitoes, and certain foods.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H28792401\">",
"      <span class=\"h1\">",
"       Which infections can cause problems for a mother and her baby?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Infections that can cause health problems for a mother and her baby include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Parvovirus, also called &ldquo;fifth disease&rdquo; &mdash; Parvovirus is spread from person to person. It can cause a rash on the face, chest, back, arms, and legs. It can also cause joint pain and body aches. If you have been around someone who has parvovirus, tell your doctor or nurse. He or she might do a blood test to check for the infection.",
"       </li>",
"       <li>",
"        Cytomegalovirus, also called &ldquo;CMV&rdquo; &mdash; CMV can be spread by sex and through saliva, urine, and other body fluids. It can cause a fever, sore throat, or body aches. Tell your doctor or nurse if you have these symptoms. He or she might do a blood test to check for CMV.",
"       </li>",
"       <li>",
"        Toxoplasmosis &mdash; People can get toxoplasmosis from eating uncooked meat or by touching cat waste when changing a cat&rsquo;s litter box. Toxoplasmosis does not usually cause symptoms in adults.",
"       </li>",
"       <li>",
"        Listeria &mdash; Listeria can cause a fever, chills, and back pain. People can get it from eating spoiled food. Sometimes, it can be hard to tell if food is spoiled. Because of this, most doctors recommend that pregnant women avoid certain foods, such as raw milk, soft cheeses, and deli meats. Ask your doctor or nurse which foods to avoid.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H28792408\">",
"      <span class=\"h1\">",
"       What should I know about vaccines and pregnancy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Vaccines are treatments that can prevent certain serious or deadly infections. Some vaccines are safe to get during pregnancy. These include vaccines to prevent:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Influenza (flu) &mdash; The flu can cause a fever, chills, muscle aches, cough, or sore throat. All adults should get the flu vaccine each year.",
"       </li>",
"       <li>",
"        Tetanus and diphtheria &mdash; Tetanus causes the muscles to work abnormally. Diphtheria can cause a thick covering in the back of the throat that can lead to breathing problems. All adults need 1 dose of a tetanus and diphtheria vaccine every 10 years.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H28792415\">",
"      <span class=\"h1\">",
"       What can I do to avoid getting an infection?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can reduce your chance of getting an infection in different ways. You can:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Wash your hands often, especially after preparing food. Also, wash your hands after using the bathroom, changing diapers, gardening, or touching garbage or animals.",
"       </li>",
"       <li>",
"        Avoid sharing foods, drinks, or eating utensils with other people",
"       </li>",
"       <li>",
"        Pay attention to food safety and follow the food safety tips in the table (",
"        <a class=\"graphic graphic_table graphicRef60529 \" href=\"mobipreview.htm?0/34/557\">",
"         table 1",
"        </a>",
"        )",
"       </li>",
"       <li>",
"        Avoid getting mosquito bites by using bug spray, wearing pants and long-sleeved shirts, and staying inside at dusk",
"       </li>",
"       <li>",
"        Use a condom when you have sex, if there is a chance that your sex partner has an infection you could catch during sex",
"       </li>",
"       <li>",
"        Avoid traveling to countries where you could catch serious infections",
"       </li>",
"       <li>",
"        Avoid touching rats or mice",
"       </li>",
"       <li>",
"        Avoid changing a cat&rsquo;s litter box &ndash; If you need to change a cat&rsquo;s litter box, use gloves and wash your hands afterward.",
"       </li>",
"       <li>",
"        Make sure that your family members are up to date on their vaccines so they stay healthy, too",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H28792422\">",
"      <span class=\"h1\">",
"       What&rsquo;s the best way to wash hands?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The best way to wash hands is:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Wet your hands and put soap on them",
"       </li>",
"       <li>",
"        Rub your hands together for 15 to 30 seconds. Make sure to clean your wrists, fingernails, and in between your fingers.",
"       </li>",
"       <li>",
"        Rinse your hands",
"       </li>",
"       <li>",
"        Dry your hands with a paper towel that you can throw away",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If there is no sink, you can use a hand gel to clean your hands. The gels that clean hands the best are those with alcohol in them.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H28792429\">",
"      <span class=\"h1\">",
"       How are infections in pregnancy treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment depends on the:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Type of infection",
"       </li>",
"       <li>",
"        Chance that the infection will harm the mother",
"       </li>",
"       <li>",
"        Chance that the infection will harm the unborn baby",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      If you have an infection, talk to your doctor or nurse about the treatment that is right for you.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H28792436\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?7/52/8003?source=see_link\">",
"       Patient information: Vaccines and pregnancy (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?10/22/10595?source=see_link\">",
"       Patient information: Food poisoning (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?22/52/23362?source=see_link\">",
"       Patient information: Chlamydia and gonorrhea (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/32/28161?source=see_link\">",
"       Patient information: Animal bites (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?14/51/15155?source=see_link\">",
"       Patient information: Insect bites and stings (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?26/42/27298?source=see_link\">",
"       Patient information: Staying healthy when you travel (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/22/28003?source=see_link\">",
"       Patient information: Vaccines for babies and children age 0 to 6 years (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/47/3826?source=see_link\">",
"       Patient information: Malaria (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/29/28114?source=see_link\">",
"       Patient information: Listeria (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/7/17522?source=see_link\">",
"       Patient information: Vaccination during pregnancy (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/44/1730?source=see_link\">",
"       Patient information: Gonorrhea (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?24/14/24802?source=see_link\">",
"       Patient information: Chlamydia (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?10/63/11248?source=see_link\">",
"       Patient information: Group B streptococcus and pregnancy (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?16/19/16690?source=see_link\">",
"       Patient information: West Nile virus infection (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?28/30/29156?source=see_link\">",
"       Patient information: Food poisoning (food-borne illness) (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?16/2/16421?source=see_link\">",
"       Patient information: General travel advice (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?22/15/22770?source=see_link\">",
"       Patient information: Animal bites (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?32/39/33395?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15831 Version 5.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-C9BE2142DC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_39_33395=[""].join("\n");
var outline_f32_39_33395=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28792387\">",
"      Why should pregnant women avoid getting infections?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28792394\">",
"      How might a pregnant woman get an infection?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28792401\">",
"      Which infections can cause problems for a mother and her baby?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28792408\">",
"      What should I know about vaccines and pregnancy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28792415\">",
"      What can I do to avoid getting an infection?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28792422\">",
"      What&rsquo;s the best way to wash hands?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28792429\">",
"      How are infections in pregnancy treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H28792436\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15831\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?0/34/557\">",
"      Tips for safe food handling",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?22/15/22770?source=related_link\">",
"      Patient information: Animal bites (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/32/28161?source=related_link\">",
"      Patient information: Animal bites (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?24/14/24802?source=related_link\">",
"      Patient information: Chlamydia (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?22/52/23362?source=related_link\">",
"      Patient information: Chlamydia and gonorrhea (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?10/22/10595?source=related_link\">",
"      Patient information: Food poisoning (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?28/30/29156?source=related_link\">",
"      Patient information: Food poisoning (food-borne illness) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?16/2/16421?source=related_link\">",
"      Patient information: General travel advice (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?1/44/1730?source=related_link\">",
"      Patient information: Gonorrhea (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?10/63/11248?source=related_link\">",
"      Patient information: Group B streptococcus and pregnancy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?14/51/15155?source=related_link\">",
"      Patient information: Insect bites and stings (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/29/28114?source=related_link\">",
"      Patient information: Listeria (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?3/47/3826?source=related_link\">",
"      Patient information: Malaria (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?26/42/27298?source=related_link\">",
"      Patient information: Staying healthy when you travel (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/7/17522?source=related_link\">",
"      Patient information: Vaccination during pregnancy (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?7/52/8003?source=related_link\">",
"      Patient information: Vaccines and pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?27/22/28003?source=related_link\">",
"      Patient information: Vaccines for babies and children age 0 to 6 years (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?16/19/16690?source=related_link\">",
"      Patient information: West Nile virus infection (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_39_33396="AF in EAVNC";
var content_f32_39_33396=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F81361&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F81361&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    AF in EAVNC",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 444px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The 12 lead ECG during sinus rhythm (panel A) in a patient with enhanced atrioventricular nodal conduction (EAVNC). The ECG shows a normal PR interval and QRS complex without evidence of preexcitation. During atrial fibrillation (AF) (panel B), there is a rapid ventricular response of up to 270 beats/min, a result of EAVNC and a short AV nodal refractory period.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_39_33396=[""].join("\n");
var outline_f32_39_33396=null;
var title_f32_39_33397="Voriconazole: Patient drug information";
var content_f32_39_33397=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Voriconazole: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/38/17002?source=see_link\">",
"     see \"Voriconazole: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?11/60/12234?source=see_link\">",
"     see \"Voriconazole: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F234784\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      VFEND&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F855140\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      VFEND&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10028539\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10028541\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691491",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or treat yeast infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10028540\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703134",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to voriconazole or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701033",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to lactose, talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10028545\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697133",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a fast heartbeat, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697297",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have low potassium levels, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696649",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid driving at night.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10028546\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697926",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Bright lights may bother you. Wear sunglasses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697912",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blurred eyesight. Use care when driving or doing other tasks that call for clear eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10028548\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699077",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of infection. These include a fever of 100.5&deg;F (38&deg;C) or higher, chills, very bad sore throat, ear or sinus pain, cough, more sputum or change in color of sputum, pain with passing urine, mouth sores, wound that will not heal, or anal itching or pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698981",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to eat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698634",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dark urine or yellow skin or eyes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2769659",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad bone pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10028543\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695811",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take 1 hour before or 1 hour after a meal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694329",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (suspension) if you cannot swallow pills. Shake well before use.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given into a vein for a period of time.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10028544\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10028549\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705490",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Oral:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705429",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Shot:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699585",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       The shot will be given to you in a hospital or doctor's office. You will not store it at home.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10028550\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11146 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-221.10.40.236-8B04AB009B-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_39_33397=[""].join("\n");
var outline_f32_39_33397=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F234784\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F855140\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028539\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028541\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028540\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028545\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028546\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028548\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028543\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028544\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028549\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028550\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?16/38/17002?source=related_link\">",
"      Voriconazole: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?11/60/12234?source=related_link\">",
"      Voriconazole: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_39_33398="Functional exercise testing: Ventilatory gas analysis";
var content_f32_39_33398=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Functional exercise testing: Ventilatory gas analysis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/39/33398/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/39/33398/contributors\">",
"     Frank G Yanowitz, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/39/33398/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/39/33398/contributors\">",
"     Wilson S Colucci, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/39/33398/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/39/33398/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/39/33398/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 4, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although exercise physiologists and pulmonary physicians have used exercise testing with respiratory gas analysis for many years, its application to cardiovascular medicine is relatively new. The purpose of this review is to discuss the physiologic basis for functional exercise testing, methodologic considerations, and clinical applications. Cardiologists have used this technique most often in the evaluation and management of patients with heart failure. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/4/7241?source=see_link\">",
"     \"Exercise capacity and VO2 in heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHYSIOLOGIC ASPECTS OF EXERCISE",
"    </span>",
"    &nbsp;&mdash;&nbsp;An understanding of exercise physiology and the Fick equation is a prerequisite for appreciating the utility of functional exercise testing. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/35/25144?source=see_link\">",
"     \"Exercise physiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Aerobic parameters",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Fick equation states that oxygen uptake equals cardiac output times the arterial-mixed venous oxygen content difference. This is usually expressed as follows:",
"   </p>",
"   <p>",
"    &nbsp;VO",
"    <sub>",
"     2",
"    </sub>",
"    &nbsp;= &nbsp;(SV &nbsp;x &nbsp;HR) &nbsp;x &nbsp;(CaO",
"    <sub>",
"     2",
"    </sub>",
"    &nbsp;- &nbsp;CvO",
"    <sub>",
"     2",
"    </sub>",
"    )",
"   </p>",
"   <p>",
"    where VO",
"    <sub>",
"     2",
"    </sub>",
"    is the oxygen (O",
"    <sub>",
"     2",
"    </sub>",
"    ) uptake, SV is the stroke volume, HR is heart rate, CaO",
"    <sub>",
"     2",
"    </sub>",
"    is arterial oxygen content, and CvO",
"    <sub>",
"     2",
"    </sub>",
"    is the mixed venous oxygen content. Oxygen uptake is often normalized for body weight and expressed in units of mL",
"    <span class=\"nowrap\">",
"     O2/kg",
"    </span>",
"    per min. One metabolic equivalent (MET) is the resting oxygen uptake in a sitting position and equals 3.5",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per min.",
"   </p>",
"   <p>",
"    At maximal exercise, the Fick equation is expressed as follows:",
"   </p>",
"   <p>",
"    &nbsp;VO",
"    <sub>",
"     2",
"    </sub>",
"    max &nbsp;= &nbsp;(SVmax &nbsp;x &nbsp;HRmax) &nbsp;x &nbsp;(CaO",
"    <sub>",
"     2",
"    </sub>",
"    max &nbsp;- &nbsp;CvO",
"    <sub>",
"     2",
"    </sub>",
"    min)",
"   </p>",
"   <p>",
"    The VO",
"    <sub>",
"     2",
"    </sub>",
"    max reflects the maximal ability of a person to take in, transport, and use oxygen, and it defines that person's functional aerobic capacity. VO",
"    <sub>",
"     2",
"    </sub>",
"    max has become the \"gold standard\" laboratory measure of cardiorespiratory fitness and is the most important parameter measured during functional exercise testing. Although some investigators insist that a VO",
"    <sub>",
"     2",
"    </sub>",
"    plateau occurs at near maximal exercise, this is not always seen. It has been suggested that the term \"peak VO",
"    <sub>",
"     2",
"    </sub>",
"    \" be used instead of VO",
"    <sub>",
"     2",
"    </sub>",
"    max to define this situation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33398/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several important changes occur in the Fick equation as a healthy person goes from rest to maximal exercise before and after exercise training (",
"    <a class=\"graphic graphic_figure graphicRef63505 \" href=\"mobipreview.htm?40/8/41102\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33398/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The VO",
"      <sub>",
"       2",
"      </sub>",
"      max response to exercise is linear until maximal VO",
"      <sub>",
"       2",
"      </sub>",
"      is achieved. In many individuals, there is a plateau at near maximal exercise beyond which the VO",
"      <sub>",
"       2",
"      </sub>",
"      does not change. Exercise training enables the person to achieve a greater maximal workload and a higher VO",
"      <sub>",
"       2",
"      </sub>",
"      max.",
"     </li>",
"     <li>",
"      The heart rate response is linear up to a maximal heart rate that approximately equals \"220",
"      <span class=\"nowrap\">",
"       beats/min",
"      </span>",
"      - age.\" After training, the heart rate is lower at rest and at each stage of exercise, but the maximal heart rate does not change.",
"     </li>",
"     <li>",
"      The stroke volume response is curvilinear, increasing early in exercise with little change thereafter. The training effect increases the resting stroke volume and the stroke volume at each workload.",
"     </li>",
"     <li>",
"      The a-v O",
"      <sub>",
"       2",
"      </sub>",
"      content difference widens as the mixed venous O",
"      <sub>",
"       2",
"      </sub>",
"      content falls since arterial O",
"      <sub>",
"       2",
"      </sub>",
"      content does not change in normal subjects. The maximal a-v O",
"      <sub>",
"       2",
"      </sub>",
"      content difference increases after training.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Functional aerobic impairment (ie, exercise intolerance) is defined as an abnormally low VO",
"    <sub>",
"     2",
"    </sub>",
"    max. This can occur with any factor that affects one or more of the four parameters of the Fick equation that determine VO",
"    <sub>",
"     2",
"    </sub>",
"    max: a reduction in maximal heart rate, maximal stroke volume, or maximal CaO",
"    <sub>",
"     2",
"    </sub>",
"    ; or an increase in minimal CvO",
"    <sub>",
"     2",
"    </sub>",
"    (",
"    <a class=\"graphic graphic_figure graphicRef57900 \" href=\"mobipreview.htm?23/35/24126\">",
"     figure 2",
"    </a>",
"    ). As an example, the major factor limiting VO",
"    <sub>",
"     2",
"    </sub>",
"    max in patients with heart failure (HF) is the marked reduction in stroke volume response to exercise with smaller reductions in maximal heart rate and maximal a-v O",
"    <sub>",
"     2",
"    </sub>",
"    content difference [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33398/abstract/3-5\">",
"     3-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other conditions that can compromise stroke volume are segmental wall motion abnormalities and valvular stenosis or regurgitation. On the other hand, diseases of the lungs, skeletal muscles, and hematologic system often have a profound effect on VO",
"    <sub>",
"     2",
"    </sub>",
"    max by affecting arterial or mixed venous oxygen content.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Anaerobic parameters",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there is still considerable debate in the literature concerning the validity of the ventilatory anaerobic threshold (VAT), functional exercise testing often includes such measurements because it is clinically useful in assessing functional impairment in patients with HF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33398/abstract/1,4,6,7\">",
"     1,4,6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    During the initial (aerobic) phase of a progressive exercise test, which lasts until 50 to 60 percent of VO",
"    <sub>",
"     2",
"    </sub>",
"    max is reached, expired ventilation (VE) increases linearly with VO",
"    <sub>",
"     2",
"    </sub>",
"    and reflects aerobically produced CO",
"    <sub>",
"     2",
"    </sub>",
"    in the muscles (",
"    <a class=\"graphic graphic_figure graphicRef69342 \" href=\"mobipreview.htm?37/12/38093\">",
"     figure 3",
"    </a>",
"    ). Blood lactate levels do not change substantially during this phase, since muscle lactic acid production is minimal.",
"   </p>",
"   <p>",
"    During the latter half of exercise, anaerobic metabolism occurs because oxygen supply cannot keep up with the increasing metabolic requirements of exercising muscle. At this time, there is a significant increase in lactic acid production in the muscles and in the blood lactate concentration. The VO",
"    <sub>",
"     2",
"    </sub>",
"    at the onset of blood lactate accumulation is called the lactate threshold or anaerobic threshold.",
"   </p>",
"   <p>",
"    In the peripheral blood, almost all the lactic acid is buffered by",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?0/52/840?source=see_link\">",
"     sodium bicarbonate",
"    </a>",
"    according to the following reactions:",
"   </p>",
"   <p>",
"    &nbsp;Lactic acid &nbsp;+ &nbsp;NaHCO",
"    <sub>",
"     3",
"    </sub>",
"    &nbsp; = &nbsp; Na lactate &nbsp;+ &nbsp;CO",
"    <sub>",
"     2",
"    </sub>",
"    &nbsp;+ &nbsp;H",
"    <sub>",
"     2",
"    </sub>",
"    O",
"   </p>",
"   <p>",
"    The excess CO",
"    <sub>",
"     2",
"    </sub>",
"    produced during the buffering process is added to the aerobically produced CO",
"    <sub>",
"     2",
"    </sub>",
"    , causing expired ventilation to increase more steeply during the later stages of exercise. It is during this phase that exercising subjects begin to experience dyspnea.",
"   </p>",
"   <p>",
"    Because the change in expired ventilation at the onset of anaerobic metabolism is reasonably well defined, noninvasive methods have been developed to detect this transition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33398/abstract/7\">",
"     7",
"    </a>",
"    ]. The VO",
"    <sub>",
"     2",
"    </sub>",
"    at the onset of this ventilatory change is appropriately called the ventilatory threshold (VAT) (",
"    <a class=\"graphic graphic_figure graphicRef69342 \" href=\"mobipreview.htm?37/12/38093\">",
"     figure 3",
"    </a>",
"    ). However, the validity of these noninvasive measures and whether or not a true threshold exists remain controversial.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     METHODS OF FUNCTIONAL EXERCISE TESTING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several different methods exist for measuring ventilation and respiratory gas parameters during exercise. Most clinical systems rely on breath-by breath analysis techniques because they provide the best measures of the metabolic response to exercise.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Gas analysis techniques",
"    </span>",
"    &nbsp;&mdash;&nbsp;Three basic parameters are continuously monitored at the mouthpiece during a breath-by-breath exercise study:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Percent O",
"      <sub>",
"       2",
"      </sub>",
"     </li>",
"     <li>",
"      Percent CO",
"      <sub>",
"       2",
"      </sub>",
"     </li>",
"     <li>",
"      Respiratory airflow",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A nonrebreathing valve is connected to the mouthpiece to prevent mixing of inspired and expired air. Oxygen and carbon dioxide gas analyzers are usually incorporated in a \"metabolic cart\" designed specifically for functional testing. Respiratory volumes are computed by integrating the air flow signals over the time of inspiration and expiration. Breath-by-breath volumes of O",
"    <sub>",
"     2",
"    </sub>",
"    intake, CO",
"    <sub>",
"     2",
"    </sub>",
"    output, and expired ventilation are obtained by integrating the continuous variables over the time course of inspiration (for O",
"    <sub>",
"     2",
"    </sub>",
"    ), and expiration (for CO",
"    <sub>",
"     2",
"    </sub>",
"    and VE). Average minute volumes are derived from the breath-by-breath data multiplied by the respiratory rate. The gas volumes obtained under ambient conditions are then converted to STPD (standard temperature and pressure, dry) conditions using the appropriate conversion equations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Exercise test protocols",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many different protocols are used for functional testing. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/6/35945?source=see_link\">",
"     \"Performance of exercise ECG testing\"",
"    </a>",
"    .) The purpose of the test and the functional capabilities of the patient determine the choice of protocol. In evaluating patients with HF, both bicycle and treadmill protocols have been used (",
"    <a class=\"graphic graphic_figure graphicRef79768 \" href=\"mobipreview.htm?10/30/10734\">",
"     figure 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The rate of workload progression is somewhat arbitrary, although it has been suggested that optimal exercise duration for functional assessment on the bicycle is between 8 and 17 minutes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33398/abstract/8\">",
"     8",
"    </a>",
"    ]. Bicycle work is quantified in watts or in kilopond meters per min",
"    <span class=\"nowrap\">",
"     (kpm/min;",
"    </span>",
"    1 watt equals about 6",
"    <span class=\"nowrap\">",
"     kpm/min).",
"    </span>",
"    The initial workload for patients with HF patients is usually 20 to 25 watts and increased by 15 to 25 watts every two minutes until maximal exertion is reached. Alternatively, the workload can be computer controlled for electronically-braked bicycle ergometers, and a ramp protocol (eg, 10",
"    <span class=\"nowrap\">",
"     watts/min)",
"    </span>",
"    is often used.",
"   </p>",
"   <p>",
"    The modified Naughton protocol is recommended for treadmill exercise testing in patients with heart failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33398/abstract/9\">",
"     9",
"    </a>",
"    ]. This protocol is designed to increase the workload by approximately 1 MET (3.5 mL",
"    <span class=\"nowrap\">",
"     O",
"     <sub>",
"      2",
"     </sub>",
"     /kg/min)",
"    </span>",
"    for each two minute stage.",
"   </p>",
"   <p>",
"    Patients with heart disease require continuous ECG monitoring and frequent blood pressure measurements during exercise testing. Hand signals (eg, 1 to 5 fingers for perceived intensity and thumbs down to stop) are used by the patient during exercise, since verbal communication is usually not possible with the mouthpiece apparatus.",
"   </p>",
"   <p>",
"    Symptoms at maximal exercise that result in test termination include muscle fatigue, exhaustion, extreme dyspnea, and lightheadedness. Cardiac arrhythmias are usually not an indication to stop the test unless sustained tachyarrhythmias develop or the physician monitoring the test feels that further exercise is contraindicated.",
"   </p>",
"   <p>",
"    A decrease in systolic blood pressure below the resting pressure is a sign of severe left ventricular dysfunction and an indication to stop the test. However, many patients with HF fail to significantly increase their systolic pressure during exercise because of left ventricular dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Ventilatory anaerobic threshold determination",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several methods for estimating the VAT from the respiratory gas data [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33398/abstract/10\">",
"     10",
"    </a>",
"    ]. The VAT or the VO",
"    <sub>",
"     2",
"    </sub>",
"    at the onset of anaerobic metabolism is visually identified as the onset of a disproportionate rise in",
"    <span class=\"nowrap\">",
"     VE/VO",
"     <sub>",
"      2",
"     </sub>",
"    </span>",
"    relative to",
"    <span class=\"nowrap\">",
"     VE/VCO",
"     <sub>",
"      2",
"     </sub>",
"     .",
"    </span>",
"    This occurs because CO",
"    <sub>",
"     2",
"    </sub>",
"    production rather than O",
"    <sub>",
"     2",
"    </sub>",
"    consumption is driving ventilation; a rise in",
"    <span class=\"nowrap\">",
"     VE/VO",
"     <sub>",
"      2",
"     </sub>",
"    </span>",
"    without a change in",
"    <span class=\"nowrap\">",
"     VE/VCO",
"     <sub>",
"      2",
"     </sub>",
"    </span>",
"    indicates that ventilation is increasing in parallel with the increased CO",
"    <sub>",
"     2",
"    </sub>",
"    production that occurs with anaerobic metabolism.",
"   </p>",
"   <p>",
"    The VAT is usually visually detected from the plotted breath-by-breath data. The VAT can also be visually identified as a disproportionate rise of VCO",
"    <sub>",
"     2",
"    </sub>",
"    or VE relative to VO",
"    <sub>",
"     2",
"    </sub>",
"    or a disproportionate rise in end-tidal O",
"    <sub>",
"     2",
"    </sub>",
"    relative to end-tidal CO",
"    <sub>",
"     2",
"    </sub>",
"    .",
"   </p>",
"   <p>",
"    Unfortunately, there is considerable inter- and intra-observer variability in the visual detection of the onset of anaerobic metabolism from the breath-by-breath data [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33398/abstract/11\">",
"     11",
"    </a>",
"    ]. To overcome this problem, computer-detection algorithms have been developed to more objectively measure the anaerobic threshold. One successful approach is called the \"V-slope method\" (",
"    <a class=\"graphic graphic_figure graphicRef50602 \" href=\"mobipreview.htm?20/37/21085\">",
"     figure 5",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33398/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    With this method, the breath-by-breath VCO",
"    <sub>",
"     2",
"    </sub>",
"    data are plotted against VO",
"    <sub>",
"     2",
"    </sub>",
"    , and the computer selects the upper and lower slopes by a least-square linear regression technique. The intersection of the two slopes identifies the anaerobic threshold. One can also visually select the breakpoint from the plot of VCO",
"    <sub>",
"     2",
"    </sub>",
"    versus VO",
"    <sub>",
"     2",
"    </sub>",
"    with less ambiguity than when using the ventilatory equivalent data.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     CLINICAL APPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    Update of Practice Guidelines for Exercise Testing, published in 2002, list the following indications for ordering a functional VO",
"    <sub>",
"     2",
"    </sub>",
"    exercise test (",
"    <a class=\"graphic graphic_table graphicRef65640 \" href=\"mobipreview.htm?2/53/2908\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33398/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Evaluation of exercise capacity and response to therapy in patients with heart failure who are being considered for heart transplantation. A reproducible VO",
"      <sub>",
"       2",
"      </sub>",
"      max of less than 10 to 12",
"      <span class=\"nowrap\">",
"       mL/kg",
"      </span>",
"      per min is one of the minimum requirements for consideration for transplantation. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/31/34297?source=see_link\">",
"       \"Indications and contraindications for cardiac transplantation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Assistance in the differentiation of cardiac versus pulmonary limitations as a cause of exercise-induced dyspnea or impaired exercise capacity when the cause is uncertain.",
"     </li>",
"     <li>",
"      Evaluation of exercise capacity when indicated for medical reasons in patients in whom the estimates of exercise capacity from exercise test time or work rate are unreliable.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The functional VO",
"    <sub>",
"     2",
"    </sub>",
"    exercise test is a global test of a patient's cardiorespiratory capacity, since it reflects the entire oxygen transport system beginning with the lungs and pulmonary circulation, including the heart, the oxygen-carrying capacity of the blood, the peripheral circulation, and the skeletal muscles. This objective global assessment offers advantages over other methods to assess the severity of HF:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The traditional New York Heart Association (NYHA) classification of functional impairment in HF is not always accurate because it is based upon a patient's symptoms rather than on objective criteria (",
"      <a class=\"graphic graphic_table graphicRef52683 \" href=\"mobipreview.htm?3/2/3117\">",
"       table 2",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/39/33398/abstract/5\">",
"       5",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Resting central hemodynamics, such as cardiac index, ejection fraction, and pulmonary capillary wedge pressures do not always correlate well with functional impairment measured during exercise testing [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/39/33398/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The symptoms of exercise intolerance in HF, such as dyspnea on minimal exertion, fatigue, or both, result from a complex interplay of mechanisms originating from both the central and peripheral components of the oxygen transport system. These symptoms are nonspecific and may also be due to medication side effects or other coexisting conditions that may or may not be related to the underlying heart disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, the exercise test is often helpful for classifying disease severity for treatment decisions and in the differential diagnosis of exercise intolerance and symptoms of dyspnea and fatigue (",
"    <a class=\"graphic graphic_figure graphicRef57900 \" href=\"mobipreview.htm?23/35/24126\">",
"     figure 2",
"    </a>",
"    ). Knowledge of the factors that can adversely affect the Fick equation parameters and result in a low VO",
"    <sub>",
"     2",
"    </sub>",
"    max combined with the results of functional exercise testing and other ancillary tests (eg, pulmonary function tests) often leads to the correct diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Prognosis of heart disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;The parameters obtained during functional exercise testing also have prognostic importance. Several studies have found that ventilatory parameters are better predictors of heart failure mortality than VO",
"    <sub>",
"     2",
"    </sub>",
"    max [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33398/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. In a study of 470 patients, for example, an abnormal elevation in the ratio of peak minute ventilation to CO",
"    <sub>",
"     2",
"    </sub>",
"    production (peak",
"    <span class=\"nowrap\">",
"     VE/VCO",
"     <sub>",
"      2",
"     </sub>",
"    </span>",
"    &ge;44.7) was the strongest predictor of death during 1.5 year followup [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33398/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An enhanced ventilatory response to exercise is a marker of decreased ventilatory efficiency, and is predictive of outcome in patients with preserved exercise capacity. In one study of 123 patients with a VO",
"    <sub>",
"     2",
"    </sub>",
"    max &ge;18",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per minute, the three year survival was significantly lower in those with a peak",
"    <span class=\"nowrap\">",
"     VE/VCO",
"     <sub>",
"      2",
"     </sub>",
"    </span>",
"    &ge;34 (57 versus 93 percent for",
"    <span class=\"nowrap\">",
"     VE/VCO",
"     <sub>",
"      2",
"     </sub>",
"    </span>",
"    &le;34) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33398/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/4/7241?source=see_link\">",
"     \"Exercise capacity and VO2 in heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Most studies of functional exercise testing in heart failure focused primarily on patients with systolic dysfunction. The prognostic importance of peak VO",
"    <sub>",
"     2",
"    </sub>",
"    and",
"    <span class=\"nowrap\">",
"     VE/VCO",
"     <sub>",
"      2",
"     </sub>",
"    </span>",
"    was evaluated in a mixed population of 409 HF patients with both systolic and diastolic dysfunction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33398/abstract/17\">",
"     17",
"    </a>",
"    ]. Depending upon the definition of diastolic HF that was applied (ie, HF with an LVEF &ge;40, &ge;45 or &ge; 50 percent), the number of patients with diastolic HF and the optimal predictors of outcome varied. However, regardless of which definition was used, both peak VO",
"    <sub>",
"     2",
"    </sub>",
"    and the",
"    <span class=\"nowrap\">",
"     VE/VCO",
"     <sub>",
"      2",
"     </sub>",
"    </span>",
"    slope were predictors of one year event-free survival (mortality and cardiac-related hospitalization) in patients with diastolic HF.",
"   </p>",
"   <p>",
"    An objective grading system that is based upon values of VO",
"    <sub>",
"     2",
"    </sub>",
"    max and the anaerobic threshold has been proposed that is especially applicable to patients with chronic heart failure (",
"    <a class=\"graphic graphic_table graphicRef82568 \" href=\"mobipreview.htm?34/41/35483\">",
"     table 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33398/abstract/18\">",
"     18",
"    </a>",
"    ]. Because of the close relationship between VO",
"    <sub>",
"     2",
"    </sub>",
"    max and the maximal cardiac index, the grading system provides an excellent measure of disease severity.",
"   </p>",
"   <p>",
"    This classification, although widely used, can be criticized because it fails to consider age, sex, and weight differences in VO",
"    <sub>",
"     2",
"    </sub>",
"    max that occur in normal subjects. VO",
"    <sub>",
"     2",
"    </sub>",
"    max declines with age and is lower in women than in men; as a result, it may be more appropriate to use age- and sex-specific normal values and to classify impairment as a percentage reduction from these normal values. Formulas for predicting VO",
"    <sub>",
"     2",
"    </sub>",
"    max in normal sedentary adults have been published for both cycle ergometry and treadmill testing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33398/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Functional exercise testing may have long-term predictive value in patients with coronary heart disease. This was illustrated in a study of over 12,000 men who were referred for cardiac rehabilitation (post-MI, post-CABG, or new ischemic heart disease) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33398/abstract/19\">",
"     19",
"    </a>",
"    ]. At a median follow-up of 7.9 years, VO",
"    <sub>",
"     2",
"    </sub>",
"    max &lt;15, 15 to 22, and &gt;22",
"    <span class=\"nowrap\">",
"     mL/kg",
"    </span>",
"    per min were associated with adjusted hazard ratios for cardiac death of 1.0, 0.62, and 0.39, respectively; similar values were noted for all-cause mortality. The only other significant predictors of cardiac mortality in the different groups were smoking and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?28/27/29113?source=see_link\">",
"     digoxin",
"    </a>",
"    therapy.",
"   </p>",
"   <p>",
"    It is important that physicians performing these tests understand the different procedures for analyzing and interpreting the respiratory gas data. Knowledge of calibration techniques and equipment maintenance is also an important prerequisite in providing accurate functional assessments in the exercise laboratory. It is likely that the number of exercise VO",
"    <sub>",
"     2",
"    </sub>",
"    studies will increase in the future as new and innovative therapies for chronic HF become available.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3829741\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Fick equation states that oxygen uptake equals cardiac output times the arterial-mixed venous oxygen content difference. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Aerobic parameters'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The VO",
"      <sub>",
"       2",
"      </sub>",
"      max reflects the maximal ability of a person to take in, transport, and use oxygen, and it defines that person's functional aerobic capacity. VO",
"      <sub>",
"       2",
"      </sub>",
"      max has become the \"gold standard\" laboratory measure of cardiorespiratory fitness and is the most important parameter measured during functional exercise testing. Although some investigators insist that a VO",
"      <sub>",
"       2",
"      </sub>",
"      plateau occurs at near maximal exercise, this is not always seen. It has been suggested that the term \"peak VO",
"      <sub>",
"       2",
"      </sub>",
"      \" be used instead of VO",
"      <sub>",
"       2",
"      </sub>",
"      max to define this situation. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Aerobic parameters'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The major factor limiting VO",
"      <sub>",
"       2",
"      </sub>",
"      max in patients with heart failure (HF) is the marked reduction in stroke volume response to exercise with smaller reductions in maximal heart rate and maximal a-v O",
"      <sub>",
"       2",
"      </sub>",
"      content difference. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Aerobic parameters'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The modified Naughton protocol is recommended for treadmill exercise testing in patients with heart failure. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Exercise test protocols'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A reproducible VO",
"      <sub>",
"       2",
"      </sub>",
"      max of less than 10 to 12",
"      <span class=\"nowrap\">",
"       mL/kg",
"      </span>",
"      per min is one of the minimum requirements for consideration for transplantation. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Clinical applications'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/31/34297?source=see_link\">",
"       \"Indications and contraindications for cardiac transplantation\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The exercise test is often helpful for classifying disease severity for treatment decisions and in the differential diagnosis of exercise intolerance and symptoms of dyspnea and fatigue (",
"      <a class=\"graphic graphic_figure graphicRef57900 \" href=\"mobipreview.htm?23/35/24126\">",
"       figure 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Clinical applications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An objective grading system that is based upon values of VO",
"      <sub>",
"       2",
"      </sub>",
"      max and the anaerobic threshold has been proposed that is especially applicable to patients with chronic heart failure (",
"      <a class=\"graphic graphic_table graphicRef82568 \" href=\"mobipreview.htm?34/41/35483\">",
"       table 3",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Prognosis of heart disease'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33398/abstract/1\">",
"      Brooks GA. Anaerobic threshold: review of the concept and directions for future research. Med Sci Sports Exerc 1985; 17:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33398/abstract/2\">",
"      Mitchell JH, Blomqvist G. Maximal oxygen uptake. N Engl J Med 1971; 284:1018.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33398/abstract/3\">",
"      Simonton CA, Higginbotham MB, Cobb FR. The ventilatory threshold: quantitative analysis of reproducibility and relation to arterial lactate concentration in normal subjects and in patients with chronic congestive heart failure. Am J Cardiol 1988; 62:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33398/abstract/4\">",
"      Matsumura N, Nishijima H, Kojima S, et al. Determination of anaerobic threshold for assessment of functional state in patients with chronic heart failure. Circulation 1983; 68:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33398/abstract/5\">",
"      Neuberg GW, Friedman SH, Weiss MB, Herman MV. Cardiopulmonary exercise testing. The clinical value of gas exchange data. Arch Intern Med 1988; 148:2221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33398/abstract/6\">",
"      Davis JA. Anaerobic threshold: review of the concept and directions for future research. Med Sci Sports Exerc 1985; 17:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33398/abstract/7\">",
"      Jennings GL, Esler MD. Circulatory regulation at rest and exercise and the functional assessment of patients with congestive heart failure. Circulation 1990; 81:II5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33398/abstract/8\">",
"      Buchfuhrer MJ, Hansen JE, Robinson TE, et al. Optimizing the exercise protocol for cardiopulmonary assessment. J Appl Physiol 1983; 55:1558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33398/abstract/9\">",
"      NAUGHTON J, SEVELIUS G, BALKE B. PHYSIOLOGICAL RESPONSES OF NORMAL AND PATHOLOGICAL SUBJECTS TO A MODIFIED WORK CAPACITY TEST. J Sports Med Phys Fitness 1963; 44:201.",
"     </a>",
"    </li>",
"    <li>",
"     Wasserman K, Hansen JE, Sue DY, Whipp BJ. Principles of Exercise Testing and Interpretation, Lea &amp; Febiger, Philadelphia 1987.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33398/abstract/11\">",
"      Yeh MP, Gardner RM, Adams TD, et al. \"Anaerobic threshold\": problems of determination and validation. J Appl Physiol 1983; 55:1178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33398/abstract/12\">",
"      Beaver WL, Wasserman K, Whipp BJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol 1986; 60:2020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33398/abstract/13\">",
"      Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation 2002; 106:1883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33398/abstract/14\">",
"      Gibbons RJ, Balady GJ, Beasley JW, et al. ACC/AHA Guidelines for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol 1997; 30:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33398/abstract/15\">",
"      Robbins M, Francis G, Pashkow FJ, et al. Ventilatory and heart rate responses to exercise : better predictors of heart failure mortality than peak oxygen consumption. Circulation 1999; 100:2411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33398/abstract/16\">",
"      Ponikowski P, Francis DP, Piepoli MF, et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation 2001; 103:967.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33398/abstract/17\">",
"      Guazzi M, Myers J, Arena R. Cardiopulmonary exercise testing in the clinical and prognostic assessment of diastolic heart failure. J Am Coll Cardiol 2005; 46:1883.",
"     </a>",
"    </li>",
"    <li>",
"     Weber KT, Janicki JS.. Cardiopulmonary Exercise Testing. In: Physiologic Principles and Clinical Applications, WB Saunders, Philadelphia 1986.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33398/abstract/19\">",
"      Kavanagh T, Mertens DJ, Hamm LF, et al. Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation. Circulation 2002; 106:666.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3465 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.131.240.2-C7EAEF3114-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_39_33398=[""].join("\n");
var outline_f32_39_33398=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3829741\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHYSIOLOGIC ASPECTS OF EXERCISE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Aerobic parameters",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Anaerobic parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      METHODS OF FUNCTIONAL EXERCISE TESTING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Gas analysis techniques",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Exercise test protocols",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Ventilatory anaerobic threshold determination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      CLINICAL APPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Prognosis of heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3829741\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/3465\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/3465|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?40/8/41102\" title=\"figure 1\">",
"      Exercise oxygen uptake",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?23/35/24126\" title=\"figure 2\">",
"      Determinants VO2max",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?37/12/38093\" title=\"figure 3\">",
"      Ventilation lactate exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?10/30/10734\" title=\"figure 4\">",
"      Ventilatory responses in HF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?20/37/21085\" title=\"figure 5\">",
"      Anaerobic threshold",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/3465|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/53/2908\" title=\"table 1\">",
"      ACC AHA gas exchange exercise",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?3/2/3117\" title=\"table 2\">",
"      Methods to assess cardiovascular disability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?34/41/35483\" title=\"table 3\">",
"      Functional classificat HF",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/4/7241?source=related_link\">",
"      Exercise capacity and VO2 in heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/35/25144?source=related_link\">",
"      Exercise physiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/31/34297?source=related_link\">",
"      Indications and contraindications for cardiac transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/6/35945?source=related_link\">",
"      Performance of exercise ECG testing",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_39_33399="Carmustine: Drug information";
var content_f32_39_33399=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Carmustine: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?21/48/22277?source=see_link\">",
"    see \"Carmustine: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?12/17/12566?source=see_link\">",
"    see \"Carmustine: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708652\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F146512\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      BiCNU&reg;;",
"     </li>",
"     <li>",
"      Gliadel&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F146513\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      BiCNU&reg;;",
"     </li>",
"     <li>",
"      Gliadel Wafer&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F146552\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antineoplastic Agent;",
"     </li>",
"     <li>",
"      Antineoplastic Agent, Alkylating Agent;",
"     </li>",
"     <li>",
"      Antineoplastic Agent, Alkylating Agent (Nitrosourea)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F146516\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Brain tumors, Hodgkin&rsquo;s lymphoma, multiple myeloma, non-Hodgkin&rsquo;s lymphoma (per manufacturer labeling):",
"     </b>",
"     I.V.: 150-200 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     every 6 weeks or 75-100 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /day for 2 days every 6 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     <b>",
"      Glioblastoma multiforme (recurrent), newly-diagnosed high-grade malignant glioma:",
"     </b>",
"     Implantation (wafer): 8 wafers placed in the resection cavity (total dose 61.6 mg); should the size and shape not accommodate 8 wafers, the maximum number of wafers allowed (up to 8) should be placed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Indication-specific dosing:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Brain tumor, primary (unlabeled doses):",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     80 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     /day for 3 days every 8 weeks for 6 cycles (Brandes, 2004)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     200 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     every 8 weeks [maximum cumulative dose: 1500 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     ] (Selker, 2002)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Hodgkin&rsquo;s lymphoma, relapsed or refractory (unlabeled dose):",
"     </b>",
"     I.V.: Mini-BEAM regimen: 60 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     day 1 every 4-6 weeks (in combination with etoposide, cytarabine, and melphalan) (Colwill, 1995; Martin, 2001)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Multiple myeloma, relapsed, refractory (unlabeled dose):",
"     </b>",
"     I.V.: VBMCP regimen: 20 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     day 1 every 35 days (in combination with vincristine, melphalan, cyclophosphamide, and prednisone) (Kyle, 2006; Oken, 1997)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Mycosis fungoides, early stage (unlabeled use; Zackheim, 2003):",
"     </b>",
"     Topical:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-top:0em;text-align:justify;\">",
"     Ointment (10 mg/100 grams petrolatum): Apply (with gloves) once daily to affected areas",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;margin-top:0em;text-align:justify;\">",
"     Solution (0.2% solution in alcohol; dilute 5 mL in 60 mL water): Apply (with gloves) once daily to affected areas",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Stem cell or bone marrow transplant, autologous (unlabeled use):",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     BEAM regimen: 300 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     6 days prior to transplant (in combination with etoposide, cytarabine, and melphalan) (Chopra, 1993; Linch, 2010)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     CBV regimen: 600 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     3 days prior to transplant (in combination with cyclophosphamide and etoposide) (Reece, 1991)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F146517\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F4426174\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     I.V.: The FDA-approved labeling does not contain renal dosing adjustment guidelines. The following dosage adjustments have been used by some clinicians (Kintzel, 1995):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     46-60 mL/minute: Administer 80% of dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     31-45 mL/minute: Administer 75% of dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &le;30 mL/minute: Consider use of alternative drug.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F146518\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Dosage adjustment may be necessary; however, no specific guidelines are available.",
"    </p>",
"   </div>",
"   <div class=\"block dot drugH1Div\" id=\"F12855270\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adjustment for Toxicity",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Hematologic toxicity:",
"     </b>",
"     Based on nadir counts with previous dose (manufacturer&rsquo;s labeling). I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     If leukocytes &gt;3000/mm",
"     <sup>",
"      3",
"     </sup>",
"     and platelets &gt;75,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     : Administer 100% of dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     If leukocytes 2000-2999/mm",
"     <sup>",
"      3",
"     </sup>",
"     or platelets 25,000-74,999/mm",
"     <sup>",
"      3",
"     </sup>",
"     : Administer 70% of dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;text-align:justify;\">",
"     If leukocytes &lt;2000/mm",
"     <sup>",
"      3",
"     </sup>",
"     or platelets &lt;25,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     : Administer 50% of dose",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F146489\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     BiCNU&reg;: 100 mg [supplied with diluent]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Wafer, for implantation:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gliadel&reg;: 7.7 mg (8s)",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F146473\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F146492\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection: Irritant (alcohol-based diluent). Significant absorption to PVC containers; should be prepared in either glass or polyolefin containers. Infuse over 2 hours (infusions &lt;2 hours may lead to injection site pain or burning); infuse through a free-flowing saline or dextrose infusion, or administer through a central catheter to alleviate venous pain/irritation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     High-dose carmustine (transplant dose; unlabeled use): Infuse over a least 2 hours to avoid excessive flushing, agitation, and hypotension; was infused over 1 hour in some trials (Chopra, 1993).",
"     <b>",
"      High-dose carmustine may be fatal if not followed by stem cell rescue.",
"     </b>",
"     Monitor vital signs frequently during infusion; patients should be supine during infusion and may require the Trendelenburg position, fluid support, and vasopressor support.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     Implant: Double glove before handling; outer gloves should be discarded as chemotherapy waste after handling wafers. Any wafer or remnant that is removed upon repeat surgery should be discarded as chemotherapy waste. The outer surface of the external foil pouch is not sterile. Open pouch gently; avoid pressure on the wafers to prevent breakage. Wafer that are broken in half may be used, however, wafers broken into more than 2 pieces should be discarded in a biohazard container. Oxidized regenerated cellulose (Surgicel&reg;) may be placed over the wafer to secure; irrigate cavity prior to closure.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:0em;\">",
"     Topical (unlabeled use): Apply solution with brush or gauze pads; ointment and solution should be applied while wearing gloves to involved areas only; avoid contact with eyes or mouth (Zackheim, 2003).",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:2em;\">",
"     Hazardous agent; use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F146558\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in NS;",
"     <b>",
"      variable stability (consult detailed reference)",
"     </b>",
"     in D",
"     <sub>",
"      5",
"     </sub>",
"     W.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Amifostine, aztreonam, cefepime, etoposide phosphate, filgrastim, fludarabine, gemcitabine, granisetron, melphalan, ondansetron, piperacillin/tazobactam, sargramostim, teniposide, thiotepa, vinorelbine.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Allopurinol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Compatibility in syringe: Compatible:",
"     </b>",
"     Cisplatin, fluorouracil.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F146490\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection: Treatment of brain tumors (glioblastoma, brainstem glioma, medulloblastoma, astrocytoma, ependymoma, and metastatic brain tumors), multiple myeloma, Hodgkin's lymphoma (relapsed or refractory), non-Hodgkin's lymphomas (relapsed or refractory)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Wafer (implant): Adjunct to surgery in patients with recurrent glioblastoma multiforme; adjunct to surgery and radiation in patients with newly-diagnosed high-grade malignant glioma",
"    </p>",
"   </div>",
"   <div class=\"block usu drugH1Div\" id=\"F4426171\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use - Unlabeled",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of mycosis fungoides (topical)",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F2136823\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Carmustine may be confused with bendamustine, lomustine",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      High alert medication:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F146550\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      I.V.:",
"     </b>",
"     Frequency not defined:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Arrhythmia (with high doses), chest pain, flushing (with rapid infusion), hypotension, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Ataxia, dizziness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Ethanol intoxication (with high doses), headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Hyperpigmentation/skin burning (after skin contact)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (common; dose related), vomiting (common; dose related), mucositis (with high doses), toxic enterocolitis (with high doses)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Leukopenia (common; onset: 5-6 weeks; recovery: after 1-2 weeks), thrombocytopenia (common: onset: ~4 weeks; recovery: after 1-2 weeks), anemia, neutropenic fever, secondary malignancies (acute leukemia, bone marrow dysplasias)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: Alkaline phosphatase increased, bilirubin increased, hepatic sinusoidal obstruction syndrome (SOS; veno-occlusive disease; with high doses), transaminases increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Injection site reactions (burning, erythema, necrosis, pain, swelling)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Conjunctival suffusion (with rapid infusion), neuroretinitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Renal: Kidney size decreased, progressive azotemia, renal failure",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Interstitial pneumonitis (with high doses), pulmonary fibrosis, pulmonary hypoplasia, pulmonary infiltrates",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Allergic reaction, infection (with high doses)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Wafer:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &ge;4% (percentages reported only where incidence was greater compared to placebo):",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular:  Deep thrombophlebitis (10%), facial edema (6%), chest pain (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Brain edema (4% to 23%), confusion (10% to 23%), depression (16%), headache (15%), somnolence (14%), fever (12%), speech disorder (11%), intracranial hypertension (9%), anxiety (7%), facial paralysis (7%), pain (7%), ataxia (6%), hypesthesia (6%), hallucination (5%), seizure (grand mal 5%), meningitis (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Abnormal wound healing (14% to 16%), rash (5% to 12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine: Diabetes (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (8% to 22%), vomiting (8% to 21%), constipation (19%), abdominal pain (8%), diarrhea (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Urinary tract infection (21%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Hemorrhage (7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Local: Abscess (4% to 8%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Weakness (22%), back pain (7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;4% (Limited to important or life-threatening): Abnormal thinking, allergic reaction, amnesia, aspiration pneumonia, cerebral hemorrhage, cerebral infarction, coma, cyst formation, diplopia, dizziness, dysphagia, eye pain, fecal incontinence, gastrointestinal hemorrhage, hydrocephalus, hyperglycemia, hyper-/hypotension, hypokalemia, hyponatremia, insomnia, leukocytosis, monoplegia, neck pain, paranoia, peripheral edema, sepsis, thrombocytopenia, urinary incontinence, visual field defect",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F146495\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to carmustine or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F146477\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bone marrow suppression: Injection:",
"     <b>",
"      [U.S. Boxed Warning]: Bone marrow suppression (primarily thrombocytopenia and leukopenia) is the major carmustine toxicity; generally is delayed.",
"     </b>",
"     Monitor blood counts weekly for at least 6 weeks after administration. Myelosuppression is cumulative. When given at the FDA-approved doses, treatment should not be administered less than 6 weeks apart. Consider nadir blood counts from prior dose for dosage adjustment. May cause bleeding (due to thrombocytopenia) or infections (due to neutropenia); monitor closely. Patients must have platelet counts &gt;100,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     and leukocytes &gt;4000/mm",
"     <sup>",
"      3",
"     </sup>",
"     for a repeat dose. Anemia may occur (less common and less severe than leukopenia or thrombocytopenia).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic: Reversible increases in transaminases, bilirubin, and alkaline phosphatase have been reported (rare). Monitor liver function tests periodically during treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Infusion site reactions: Injection site burning and local tissue reactions, including swelling, pain, erythema, and necrosis have been reported. Monitor infusion site closely for infiltration or injection site reactions.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Ocular toxicity: Unlabeled administration (intraarterial intracarotid route) has been associated with ocular toxicity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pulmonary toxicity: Injection:",
"     <b>",
"      [U.S. Boxed Warnings]: Dose-related pulmonary toxicity may occur; patients receiving cumulative doses &gt;1400 mg/m",
"      <sup>",
"       2",
"      </sup>",
"      are at higher risk. Delayed onset of pulmonary fibrosis (may be fatal) has occurred in children up to 17 years after treatment;",
"     </b>",
"     this occurred in ages 1-16 for the treatment of intracranial tumors; cumulative doses ranged from 770-1800 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     (in combination with cranial radiotherapy). Pulmonary toxicity is characterized by pulmonary infiltrates and/or fibrosis and has been reported from 9 days to 43 months after nitrosourea treatment (including carmustine). Although pulmonary toxicity generally occurs in patients who have received prolonged treatment, pulmonary fibrosis has been reported with cumulative doses &lt;1400 mg/m",
"     <sup>",
"      2",
"     </sup>",
"     . In addition to high cumulative doses, other risk factors for pulmonary toxicity include history of lung disease and baseline predicted forced vital capacity (FVC) or carbon monoxide diffusing capacity (DL",
"     <sub>",
"      CO",
"     </sub>",
"     ) &lt;70%. Baseline and periodic pulmonary function tests are recommended. For high-dose treatment (transplant; unlabeled dose), acute lung injury may occur ~1-3 months post transplant; advise patients to contact their transplant physician for dyspnea, cough, or fever; interstitial pneumonia may be managed with a course of corticosteroids.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal: Renal failure, progressive azotemia, and decreased kidney size have been reported in patients who have received large cumulative doses or prolonged treatment. Renal toxicity has also been reported in patients who have received lower cumulative doses. Monitor renal function tests periodically during treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Secondary malignancies: Long-term use is associated with the development of secondary malignancies (acute leukemias and bone marrow dysplasias).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Consider initiating treatment at the lower end of the dose range.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pediatrics: Children are at higher risk of delayed pulmonary toxicity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Injection: Diluent contains ethanol.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Wafer: Monitor closely for known craniotomy-related complications (seizure, intracranial infection, abnormal wound healing, brain edema). Intracerebral mass effect (unresponsive to corticosteroids) has been reported; may lead to brain herniation. Avoid communication between the resection cavity and the ventricular system to prevent wafer migration; communications larger than the wafer should be closed prior to implantation; wafer migration may cause obstructive hydrocephalus.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special handling:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hazardous agent: Use appropriate precautions for handling and disposal",
"     <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"      (NIOSH, 2012)",
"     </a>",
"     .",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Experienced physician: Injection:",
"     <b>",
"      [U.S. Boxed Warning]: Should be administered under the supervision of an experienced cancer chemotherapy physician.",
"     </b>",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298978\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F146483\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Immunosuppressants may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiac Glycosides: Antineoplastic Agents may decrease the absorption of Cardiac Glycosides. This may only affect digoxin tablets.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Digitoxin.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cimetidine: May enhance the myelosuppressive effect of Carmustine. Management: Consider alternatives to cimetidine in patients receiving carmustine.  If the combination cannot be avoided, monitor for enhanced carmustine myelotoxicity.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloZAPine: Myelosuppressive Agents may enhance the adverse/toxic effect of CloZAPine. Specifically, the risk for agranulocytosis may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Coccidioidin Skin Test: Immunosuppressants may diminish the diagnostic effect of Coccidioidin Skin Test.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Denosumab: May enhance the adverse/toxic effect of Immunosuppressants. Specifically, the risk for serious infections may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Echinacea: May diminish the therapeutic effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Leflunomide: Immunosuppressants may enhance the adverse/toxic effect of Leflunomide. Specifically, the risk for hematologic toxicity such as pancytopenia, agranulocytosis, and/or thrombocytopenia may be increased.  Management: Consider not using a leflunomide loading dose in patients receiving other immunosuppressants.  Patients receiving both leflunomide and another immunosuppressant should be monitored for bone marrow suppression at least monthly.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Melphalan: May enhance the adverse/toxic effect of Carmustine. Specifically, melphalan may sensitize patients to carmustine lung toxicity.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Natalizumab: Immunosuppressants may enhance the adverse/toxic effect of Natalizumab. Specifically, the risk of concurrent infection may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimecrolimus: May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Roflumilast: May enhance the immunosuppressive effect of Immunosuppressants.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sipuleucel-T: Immunosuppressants may diminish the therapeutic effect of Sipuleucel-T.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tacrolimus (Topical): May enhance the adverse/toxic effect of Immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tofacitinib: Immunosuppressants may enhance the immunosuppressive effect of Tofacitinib.  Management: Concurrent use with antirheumatic doses of methotrexate or other non-disease modifying antirheumatic drugs (non-DMARDs) is permitted, and this warning seems to particularly focused on more potent immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Trastuzumab: May enhance the neutropenic effect of Immunosuppressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Inactivated): Immunosuppressants may diminish the therapeutic effect of Vaccines (Inactivated).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vaccines (Live): Immunosuppressants may enhance the adverse/toxic effect of Vaccines (Live). Vaccinial infections may develop. Immunosuppressants may diminish the therapeutic effect of Vaccines (Live).  Management: Avoid use of live organism vaccines with immunosuppressants; live-attenuated vaccines should not be given for at least 3 months after immunosuppressants.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F146485\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     D (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F146498\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenicity and embryotoxicity have been demonstrated in animal studies. Carmustine can cause fetal harm if administered to a pregnant woman. There are no adequate and well-controlled studies in pregnant women. Women of childbearing potential should avoid becoming pregnant while on treatment.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F146527\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/not recommended",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F146499\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Due to the potential for serious adverse reactions in the nursing infant, breast-feeding should be discontinued.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F5100296\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution (reconstituted)",
"     </b>",
"     (BiCNU Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     100 mg (1): $205.69",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Wafer",
"     </b>",
"     (Gliadel Wafer Implant)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     7.7 mg (8): $34841.40",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F146487\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     CBC with differential and platelet count (weekly for at least 6 weeks after a dose), pulmonary function tests (FVC, DL",
"     <sub>",
"      CO",
"     </sub>",
"     ; at baseline and frequently during treatment), liver function (periodically), renal function tests (periodically); monitor blood pressure and vital signs during administration, monitor infusion site for possible infiltration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Wafer: Complications of craniotomy (seizures, intracranial infection, brain edema)",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F146500\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Bcnu (BG, HN);",
"     </li>",
"     <li>",
"      Becenun (BR, FI, NO);",
"     </li>",
"     <li>",
"      BiCNU (AR, AU, CN, CO, CZ, FR, GB, IE, MX, NZ, PH, PT, TW, UY, ZA);",
"     </li>",
"     <li>",
"      Bicnu (CL, HU);",
"     </li>",
"     <li>",
"      Carmubris (AT, DE);",
"     </li>",
"     <li>",
"      Gliadel (GR, IL, IT, MY, NL, SG, TH, TW);",
"     </li>",
"     <li>",
"      Gliadel Implant (AU, ES);",
"     </li>",
"     <li>",
"      Nitrumon (BE, LU)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F146476\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Interferes with the normal function of DNA and RNA by alkylation and cross-linking the strands of DNA and RNA, and by possible protein modification; may also inhibit enzyme processes by carbamylation of amino acids in protein",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F146494\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: 3.3 L/kg; readily crosses blood-brain barrier producing CSF levels &gt;50% of blood plasma levels; highly lipid soluble",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Rapidly hepatic; forms active metabolites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Biphasic: Initial: 1.4 minutes; Secondary: 20 minutes (active metabolites: plasma half-life of 67 hours)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine (~60% to 70%) within 96 hours; lungs (6% to 10% as CO",
"     <sub>",
"      2",
"     </sub>",
"     )",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Benekli M, Smiley SL, Younis T, et al, &ldquo;Intensive Conditioning Regimen of Etoposide (VP-16), Cyclophosphamide and Carmustine (VCB) Followed by Autologous Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin's Lymphoma,&rdquo;",
"      <i>",
"       Bone Marrow Transplant",
"      </i>",
"      , 2008, 41(7):613-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/39/33399/abstract-text/18071290/pubmed\" id=\"18071290\" target=\"_blank\">",
"        18071290",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Brandes AA, Tosoni A, Amist&agrave; P, et al, &ldquo;How Effective is BCNU in Recurrent Glioblastoma in the Modern Era? A Phase II Trial,&rdquo;",
"      <i>",
"       Neurology",
"      </i>",
"      , 2004, 63(7):1281-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/39/33399/abstract-text/15477552/pubmed\" id=\"15477552\" target=\"_blank\">",
"        15477552",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Chopra R, McMillan AK, Linch DC, et al, &ldquo;The Place of High-Dose BEAM Therapy and Autologous Bone Marrow Transplantation in Poor-Risk Hodgkin's Disease. A Single-Center Eight-Year Study of 155 Patients,&rdquo;",
"      <i>",
"       Blood",
"      </i>",
"      , 1993, 81(5):1137-45.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/39/33399/abstract-text/8443375/pubmed\" id=\"8443375\" target=\"_blank\">",
"        8443375",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Colwill R, Crump M, Couture F, et al,, &ldquo;Mini-BEAM as Salvage Therapy for Relapsed or Refractory Hodgkin's Disease Before Intensive Therapy and Autologous Bone Marrow Transplantation,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 1995, 13(2):396-402.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/39/33399/abstract-text/7844600/pubmed\" id=\"7844600\" target=\"_blank\">",
"        7844600",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Durando X, Lemaire JJ, Tortochaux J, et al, &ldquo;High-Dose BCNU Followed by Autologous Hematopoietic Stem Cell Transplantation in Supratentorial High-Grade Malignant Gliomas: A Retrospective Analysis of 114 Patients,&rdquo;",
"      <i>",
"       Bone Marrow Transplant",
"      </i>",
"      , 2003, 31(7):559-64.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/39/33399/abstract-text/12692621/pubmed\" id=\"12692621\" target=\"_blank\">",
"        12692621",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Fleming AB and Saltzman WM, &ldquo;Pharmacokinetics of the Carmustine Implant,&rdquo;",
"      <i>",
"       Clin Pharmacokinet",
"      </i>",
"      , 2002, 41(6):403-19.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/39/33399/abstract-text/12074689/pubmed\" id=\"12074689\" target=\"_blank\">",
"        12074689",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kim JE, Lee DH, Yoo C, et al, &ldquo;BEAM or BuCyE High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation in Non-Hodgkin's Lymphoma Patients: A Single Center Comparative Analysis of Efficacy and Toxicity,&rdquo;",
"      <i>",
"       Leuk Res",
"      </i>",
"      , 2011, 35(2):183-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/39/33399/abstract-text/20684990/pubmed\" id=\"20684990\" target=\"_blank\">",
"        20684990",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kintzel PE and Dorr RT, \"Anticancer Drug Renal Toxicity and Elimination: Dosing Guidelines for Altered Renal Function,\"",
"      <i>",
"       Cancer Treat Rev",
"      </i>",
"      , 1995, 21(1):33-64.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/39/33399/abstract-text/7859226/pubmed\" id=\"7859226\" target=\"_blank\">",
"        7859226",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kyle RA, Leong T, Li S, et al, &ldquo;Complete Response in Multiple Myeloma: Clinical Trial E9486, an Eastern Cooperative Oncology Group Study Not Involving Stem Cell Transplantation,&rdquo;",
"      <i>",
"       Cancer",
"      </i>",
"      , 2006, 106(9):1958-66.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/39/33399/abstract-text/16565956/pubmed\" id=\"16565956\" target=\"_blank\">",
"        16565956",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Linch DC, Yung L, Smith P, et al, &ldquo;Final Analysis of the UKLG LY02 Trial Comparing 6-8 Cycles of CHOP With 3 Cycles of CHOP Followed by a BEAM Autograft in Patients &lt;65 Years With Poor Prognosis Histologically Aggressive NHL,&rdquo;",
"      <i>",
"       Br J Haematol",
"      </i>",
"      , 2010, 149(2):237-43.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/39/33399/abstract-text/20201949/pubmed\" id=\"20201949\" target=\"_blank\">",
"        20201949",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mahendra P, Johnson D, Scott MA, et al, &ldquo;Peripheral Blood Progenitor Cell Transplantation: A Single Centre Experience Comparing Two Mobilisation Regimens in 67 Patients,&rdquo;",
"      <i>",
"       Bone Marrow Transplant",
"      </i>",
"      , 1996, 17(4):503-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/39/33399/abstract-text/8722346/pubmed\" id=\"8722346\" target=\"_blank\">",
"        8722346",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mart&iacute;n A, Fern&aacute;ndez-Jim&eacute;nez MC, Caballero MD, et al, &ldquo;Long-Term Follow-Up in Patients Treated With Mini-BEAM as Salvage Therapy for Relapsed or Refractory Hodgkin's Disease,&rdquo;",
"      <i>",
"       Br J Haematol",
"      </i>",
"      , 2001, 113(1):161-71.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/39/33399/abstract-text/11328296/pubmed\" id=\"11328296\" target=\"_blank\">",
"        11328296",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      National Institute for Occupational Safety and Health (NIOSH), \"NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings 2012.\" Available at",
"      <a href=\"file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf\" target=\"_blank\">",
"       file://www.cdc.gov/niosh/docs/2012-150/pdfs/2012-150.pdf",
"      </a>",
"      . Accessed January 21, 2013.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Oken MM, Harrington DP, Abramson N, et al, &ldquo;Comparison of Melphalan and Prednisone With Vincristine, Carmustine, Melphalan, Cyclophosphamide, and Prednisone in the Treatment of Multiple Myeloma: Results of Eastern Cooperative Oncology Group Study E2479,&rdquo;",
"      <i>",
"       Cancer",
"      </i>",
"      , 1997, 79(8):1561-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/39/33399/abstract-text/9118039 /pubmed\" id=\"9118039 \" target=\"_blank\">",
"        9118039",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Reece DE, Barnett MJ, Connors JM, et al, &ldquo;Intensive Chemotherapy With Cyclophosphamide, Carmustine, and Etoposide Followed by Autologous Bone Marrow Transplantation for Relapsed Hodgkin's Disease,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 1991, 9(10):1871-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/39/33399/abstract-text/1919637/pubmed\" id=\"1919637\" target=\"_blank\">",
"        1919637",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Selker RG, Shapiro WR, Burger P, et al, &ldquo;The Brain Tumor Cooperative Group NIH Trial 87-01: A Randomized Comparison of Surgery, External Radiotherapy, and Carmustine Versus Surgery, Interstitial Radiotherapy Boost, External Radiation Therapy, and Carmustine,&rdquo;",
"      <i>",
"       Neurosurgery",
"      </i>",
"      , 2002, 51(2):343-55.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/39/33399/abstract-text/12182772/pubmed\" id=\"12182772\" target=\"_blank\">",
"        12182772",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Trissel LA, Xu QA, and Baker M, &ldquo;Drug Compatibility With New Polyolefin Infusion Solution Containers,&rdquo;",
"      <i>",
"       Am J Health-Syst Pharm",
"      </i>",
"      , 2006, 63(23):2379-82.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/39/33399/abstract-text/17106012/pubmed\" id=\"17106012\" target=\"_blank\">",
"        17106012",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Weingart JD and Brem H, &ldquo;Carmustine Implants: Potential in the Treatment of Brain Tumors,&rdquo;",
"      <i>",
"       CNS Drugs",
"      </i>",
"      , 1996, 4:263-9.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Zackheim HS, &ldquo;Topical Carmustine (BCNU) in the Treatment of Mycosis Fungoides,&rdquo;",
"      <i>",
"       Dermatol Ther",
"      </i>",
"      , 2003,16(4):299-302.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?32/39/33399/abstract-text/14686972/pubmed\" id=\"14686972\" target=\"_blank\">",
"        14686972",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9206 Version 41.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-122.72.76.133-EBA391572F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_39_33399=[""].join("\n");
var outline_f32_39_33399=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708652\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146512\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146513\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146552\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146516\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146517\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4426174\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146518\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12855270\">",
"      Dosing: Adjustment for Toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146489\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146473\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146492\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146558\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146490\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4426171\">",
"      Use - Unlabeled",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2136823\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146550\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146495\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146477\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298978\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146483\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146485\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146498\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146527\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146499\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5100296\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146487\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146500\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146476\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F146494\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9206\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9206|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?21/48/22277?source=related_link\">",
"      Carmustine: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?12/17/12566?source=related_link\">",
"      Carmustine: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_39_33400="Shwachman-Diamond syndrome";
var content_f32_39_33400=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(true",
"	);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <!-- TC:SLA_MESSAGE -->",
" <div id=\"slaMessageContainer\">",
"  <div id=\"closeMessage\">",
"   <a href=\"\" id=\"close\">",
"    Close",
"   </a>",
"  </div>",
"  <div id=\"slaMessage\">",
"   The use of UpToDate is subject to the",
"   <a href=\"#\" id=\"sla_message\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
" </div>",
" <div id=\"slaDialog\">",
"  <div id=\"slaDialogTitle\">",
"   Subscription and License Agreement&nbsp;",
"   <a class=\"icontxt\" href=\"./license?view=print\" onclick=\"\" target=\"_blank\">",
"    <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\">",
"     Print",
"    </img>",
"   </a>",
"  </div>",
"  <div id=\"boxDialog\">",
"   <strong class=\"largeGreenHeader\">",
"    Subscription and License Agreement",
"   </strong>",
"   <p>",
"    By clicking the \"accept\" button (or opening and using",
"the software/content package if applicable), you agree to become bound",
"by the terms of this Subscription and License Agreement (the",
"\"Agreement\"). If you do not agree to these terms, if using the",
"online version of UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    software/content, click \"decline\"",
"or do not open the package (and promptly return it). READ THE FOLLOWING",
"TERMS IN THIS AGREEMENT CAREFULLY BEFORE INDICATING YOUR ACCEPTANCE. In",
"this Agreement, the term \"you\" refers to: (i) an entity",
"entering into this Agreement for use of its employees, (ii) an",
"individual purchasing an UpToDate subscription under this Agreement,",
"either on his or her own behalf (or as agent for a corporation or other",
"entity or organization); or (iii) an individual entering into this",
"Agreement as a condition of using UpToDate through a subscription",
"purchased by a hospital, medical school, or other institution",
"(\"Institution\"), where the individual is employed by or",
"affiliated with the Institution.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"LICENSE: UpToDate, Inc. (\"UpToDate\"), in consideration of the",
"subscription fee and acceptance of this Agreement, grants you a",
"non-exclusive, non-transferable license and right to use and access the",
"UpToDate database and software (the \"Licensed Materials\") in",
"accordance with the applicable subscription terms (as may be provided in",
"UpToDate&amp;apos;s separate invoice terms):",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"a.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"INDIVIDUAL: An individual subscription permits one individual to access",
"and use the Licensed Materials for his or her own use only by loading",
"the software on a single computer (i.e., within a single CPU) at a fixed",
"location, by loading the PDA software on a single Personal Digital",
"Assistant (PDA), or by using his or her unique user name and password to",
"access the Licensed Materials from any location via the Internet.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"b.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"STANDALONE WORKSTATION: A standalone subscription permits multiple users",
"employed by or affiliated with you to access and use the Licensed",
"Materials only for a purpose related to your business by loading the",
"software on a single computer (i.e., within a single CPU) owned or",
"controlled by you, with a hard drive owned or controlled by you",
"connected directly to such computer. You may not install the software on",
"more than one computer. A Standalone Workstation license does not",
"include Internet access to the Licensed Materials.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"c.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"INSTITUTIONAL SUBSCRIPTION: An Institutional Subscription permits only",
"individuals who are employed by or affiliated with the relevant",
"institution to access and use the Licensed Materials at any",
"Internet-connected computer validated for such use by UpToDate, but only",
"for the clinical, educational or research purposes of the Institution.",
"Further, access may be restricted to particular websites per the",
"applicable invoice terms.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"OWNERSHIP: The Licensed Materials, including without limitation all",
"copyrights and other intellectual property rights therein, are the sole",
"and exclusive property of UpToDate (or its parents, subsidiaries,",
"affiliates, or designees) or its suppliers. By indicating that you",
"accept these terms, you do not become the owner of the Licensed",
"Materials, but are entitled to use them only according to the terms of",
"this Agreement.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"PERMITTED USES: You may print out, or email to a colleague, individual",
"articles containing only insubstantial portions of the most current",
"version of the Licensed Materials, but only for a) your personal",
"clinical, educational or research use; b) teaching healthcare",
"professionals; or c) consulting with individual colleagues, provided",
"that any printed or emailed articles include a source reference to",
"UpToDate and its copyright notice. You are not permitted to print or",
"email substantial portions of the Licensed Materials, nor to email",
"individual articles to large numbers of recipients.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"PROHIBITED USES: Except as expressly permitted in this Agreement, any",
"copying, distribution or modification of the Licensed Materials is",
"strictly prohibited. No part of the Licensed Materials may be copied for",
"resale or other commercial use, or posted on public bulletin boards, web",
"sites, Internet domains, or online chatrooms. No part of the Licensed",
"Materials may be reverse engineered or included in other software.",
"UpToDate electronically monitors compliance with this Agreement, and",
"reserves the right in its sole discretion to change and or cancel an",
"individual's user name and password or to disable an IP address without",
"notice in the event of multiple concurrent logins, excessive search",
"quantities or excessive download traffic volumes. You agree to comply",
"with all applicable laws, including all US export laws and regulations,",
"in connection with the Licensed Materials.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"SUBSCRIPTION TERM: You have obtained the right to use and access the",
"Licensed Materials for a specific limited period of time, i.e., the",
"subscription period for which you or your Institution have agreed to pay",
"subscription fees. At the end of this period, your license and your",
"associated rights, such as technical support, will expire automatically,",
"unless you or your Institution have renewed your subscription on",
"UpToDate's then-current terms. UpToDate may embed technology in the",
"Licensed Materials causing them to become inaccessible after your",
"subscription term. The Agreement and your license to use the Licensed",
"Materials will also terminate if you fail to comply with any term or",
"condition in this Agreement.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"RESTRICTION AGAINST TRANSFER: You may not sublicense, assign, share,",
"sell, rent, lease, or otherwise transfer your right to use the Licensed",
"Materials (including your username and password) whether by merger,",
"operation of law, or otherwise.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"USE OF PROFESSIONAL JUDGMENT: The editors and authors of the Licensed",
"Materials have conscientiously and carefully tried to create the",
"identified diagnosis measures, treatment alternatives and drug dosages",
"in the Licensed Materials that conform to the standards of professional",
"practice that prevailed at the time of publication. However, standards",
"and practices in medicine change as new data become available and the",
"individual medical professional should consult a variety of sources. For",
"this reason, only the most current release of the Licensed Materials",
"should be consulted when information is sought. New updates of the",
"Licensed Materials are issued periodically; do not rely on older",
"versions. In addition, when prescribing medications, the user is advised",
"to check the product information sheet accompanying each drug to verify",
"conditions of use and identify any changes in dosage schedule or",
"contraindications, particularly if the agent to be administered is new,",
"infrequently used or has a narrow therapeutic range.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"The Licensed Materials describe basic principles of diagnosis and",
"therapy. The information provided in the Licensed Materials is no",
"substitute for individual patient assessment based upon the healthcare",
"provider's examination of each patient and consideration of laboratory",
"data and other factors unique to the patient. The Licensed Materials",
"should be used as a tool to help the user reach diagnostic and treatment",
"decisions, bearing in mind that individual and unique circumstances may",
"lead the user to reach decisions not presented in the Licensed",
"Materials. The opinions expressed in the Licensed Materials are those of",
"its authors and editors and may or may not represent the official",
"position of any medical societies cooperating with, endorsing or",
"recommending the Licensed Materials.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"LIMITED RIGHTS NOTICE. Any access to the Licensed Materials provided",
"under contract to the Government are provided with limited rights. The",
"Licensed Materials may be reproduced and used by the Government with the",
"express limitation that they will not, without written permission of",
"UpToDate, be used for purposes of manufacture nor disclosed outside the",
"Government. The term \"Government\" as used herein shall have",
"the meaning ascribed to it in 48 CFR 52.227-14.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"LIMITED WARRANTY: If UpToDate has supplied physical media to you",
"containing the Licensed Materials and they are defective, such media",
"will be replaced without charge if returned to the place of purchase",
"within 60 days after date of payment of the license fee. EXCEPT AS SET",
"FORTH IN THE FOREGOING SENTENCE, NEITHER UPTODATE NOR ANY OTHER PARTY OR",
"MEDICAL SOCIETY MAKES ANY WARRANTY OR REPRESENTATION, EXPRESSED OR",
"IMPLIED, WITH RESPECT TO THE LICENSED MATERIALS, WHICH ARE LICENSED",
"\"AS IS\". ALL OTHER WARRANTIES ARE EXPRESSLY EXCLUDED AND",
"DISCLAIMED, INCLUDING WITHOUT LIMITATION IMPLIED WARRANTIES OF",
"MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, AND ANY WARRANTIES",
"ARISING BY STATUTE OR OTHERWISE IN LAW OR FROM COURSE OF DEALING, COURSE",
"OF PERFORMANCE, OR USE OF TRADE. ANY STATEMENTS OR REPRESENTATIONS MADE",
"BY ANY OTHER PERSON OR ENTITY ARE VOID. YOU ASSUME ALL RISK AS TO THE",
"QUALITY, FUNCTION, PERFORMANCE, AND ACCURACY OF THE LICENSED MATERIALS.",
"   </p>",
"   <p>",
"    LIMITATION OF LIABILITY: IN NO EVENT WILL UPTODATE OR ANY OTHER",
"PARTY WHO HAS BEEN INVOLVED IN THE CREATION, PRODUCTION, PROMOTION OR",
"MARKETING OF THE LICENSED MATERIALS BE LIABLE TO YOU OR ANY OTHER PARTY",
"FOR ANY SPECIAL, INDIRECT, INCIDENTAL, RELIANCE, EXEMPLARY, OR",
"CONSEQUENTIAL DAMAGES, INCLUDING LOSS OF DATA OR PROFITS, OR FOR",
"INABILITY TO USE THE LICENSED MATERIALS, EVEN IF UPTODATE OR SUCH OTHER",
"PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. IN NO EVENT",
"SHALL UPTODATE OR SUCH OTHER PARTY'S LIABILITY FOR ANY DAMAGES OR LOSS",
"TO YOU OR ANY OTHER PARTY EXCEED THE LICENSE FEE PAID FOR THE LICENSED",
"MATERIALS.",
"   </p>",
"   <p>",
"    Some jurisdictions do not allow limitations on how long an",
"implied warranty lasts and some jurisdictions do not allow the exclusion",
"or limitation of special, indirect, incidental, exemplary, or",
"consequential damages, or the limitation of liability to specified",
"amounts, so the above limitation and exclusion may not apply to you if",
"prohibited by applicable law. You may also have other rights which vary",
"from jurisdiction to jurisdiction. You agree that this Agreement shall",
"not be subject to the United Nations Convention on Contracts for the",
"International Sale of Goods.",
"   </p>",
"   <p>",
"    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"GENERAL: If any provision of this Agreement is determined to be invalid",
"or unenforceable under any applicable law, it shall be deemed omitted",
"and the remaining provisions shall continue in full force and effect.",
"This Agreement may be modified only in writing authorized by UpToDate.",
"UpToDate's waiver of any right shall not constitute a waiver of that or",
"any other right in the future. This Agreement shall be governed by and",
"construed in accordance with the laws and in the state and federal",
"courts of the Commonwealth of Massachusetts, USA. This Agreement",
"constitutes the entire understanding between the parties with respect to",
"the subject matter hereof, and all prior agreements, representations,",
"statements, and undertakings, oral or written, are hereby expressly",
"superseded and canceled. Sections 2 and 4-9 survive in full force and",
"effect following expiration or termination of this Agreement.",
"   </p>",
"   <p>",
"    Should you have any questions regarding this Agreement, you may",
"contact UpToDate at the email address or telephone numbers set forth",
"below.",
"   </p>",
"   <p>",
"    UpToDate, Inc.",
"    <br/>",
"    <a href=\"#\" id=\"infoEmail\">",
"     info@uptodate.com",
"    </a>",
"    <br/>",
"    Telephone: 1-800-998-6374 or +1-781-392-2000",
"   </p>",
"  </div>",
"  <div id=\"slaButtons\">",
"   <input id=\"closeSLABtn\" type=\"button\" value=\"Close\"/>",
"  </div>",
" </div>",
" <div id=\"slaMask\">",
" </div>",
" <script type=\"text/javascript\">",
"  $(function(){		",
"				$.extend($$.showSLAMessage,{",
"					checkUrl: '/services/AgreementWebService?type=sla_msg_check',",
"					acceptDrugUrl: '/services/AgreementWebService?type=drug'",
"				});",
"				$$.showSLAMessage.init();",
"			});",
" </script>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"headerLogo\">",
"    <a href=\"./search\">",
"     <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"     </img>",
"    </a>",
"   </div>",
"   <div id=\"headerLinks\">",
"    <a href=\"/home/about-us\" target=\"_blank\">",
"     About Us",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"file://learn.uptodate.com/global\" id=\"newsLink\" target=\"_blank\">",
"     News from UpToDate",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"/home/contact-us\" target=\"_blank\">",
"     Contact Us",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"/help\">",
"     Help",
"    </a>",
"   </div>",
"   <div id=\"headerFeedback\">",
"    <img alt=\"white circle\" src=\"./../images/icn_feedback_arw.myextg\">",
"     <a href=\"/login\" id=\"headerLogin\">",
"      Log in",
"     </a>",
"    </img>",
"   </div>",
"   <div id=\"headerMenu\">",
"    <ul>",
"     <li>",
"      <img alt=\"\" class=\"menuUp\" height=\"23\" src=\"./../images/menu_up.myextg\" width=\"14\"/>",
"     </li>",
"     <li>",
"      <img alt=\"\" class=\"menuDots\" height=\"24\" src=\"./../images/menu_dots.myextg\" width=\"2\"/>",
"     </li>",
"     <li id=\"searchTab\">",
"      <a href=\"./search\">",
"       New Search",
"      </a>",
"     </li>",
"     <li>",
"      <img alt=\"\" class=\"menuDots\" height=\"24\" src=\"./../images/menu_dots.myextg\" width=\"2\"/>",
"     </li>",
"     <li id=\"patientInfoTab\">",
"      <a href=\"mobipreview.htm?18/22/18798\">",
"       Patient Info",
"      </a>",
"     </li>",
"     <li>",
"      <img alt=\"\" class=\"menuDots\" height=\"24\" src=\"./../images/menu_dots.myextg\" width=\"2\"/>",
"     </li>",
"     <li id=\"whatsNewTab\" }>",
"      <a href=\"mobipreview.htm?3/13/3294\">",
"       What's New",
"      </a>",
"     </li>",
"     <li>",
"      <img alt=\"\" class=\"menuDots\" height=\"24\" src=\"./../images/menu_dots.myextg\" width=\"2\"/>",
"     </li>",
"     <li id=\"calcTab\">",
"      <a href=\"mobipreview.htm?0/37/606\">",
"       Calculators",
"      </a>",
"     </li>",
"     <li>",
"      <img alt=\"\" class=\"menuDots\" height=\"24\" src=\"./../images/menu_dots.myextg\" width=\"2\"/>",
"     </li>",
"     <li style=\"background-image: url(/images/spacer.myextg);\">",
"      <img alt=\"\" height=\"23\" src=\"./../images/right_shim.myextg\" width=\"16\"/>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"topSearchBar\">",
"    <form action=\"./search.do\" method=\"get\" name=\"SearchForm\">",
"     <div id=\"smallSearchBox\">",
"      <div id=\"new_search\">",
"       <div id=\"searchbox_dd\">",
"        <input autocomplete=\"off\" id=\"txtSearch\" maxlength=\"200\" name=\"search\" type=\"text\" value=\"\"/>",
"        <span id=\"searchbox_dd_submit\">",
"         Search",
"        </span>",
"        <span id=\"searchbox_dd_type\" title=\"Change Search Type\">",
"         <span id=\"searchbox_dd_type_name\">",
"         </span>",
"        </span>",
"       </div>",
"       <div id=\"searchbox_dd_dropdown\">",
"        <ul id=\"searchbox_dd_dropdown_topics\">",
"         <li class=\"active\" id=\"searchoption_topic_all\">",
"          All Topics",
"         </li>",
"         <li id=\"searchoption_topic_adult\">",
"          Adult",
"         </li>",
"         <li id=\"searchoption_topic_pediatric\">",
"          Pediatric",
"         </li>",
"         <li id=\"searchoption_topic_patient\">",
"          Patient",
"         </li>",
"        </ul>",
"        <ul id=\"searchbox_dd_dropdown_graphics\">",
"         <li id=\"searchoption_graphics\">",
"          Graphics",
"         </li>",
"        </ul>",
"       </div>",
"       <input id=\"spinput\" name=\"sp\" type=\"hidden\" value=\"0\"/>",
"       <!-- the real searchType input, value is copied from above radio buttons with jquery",
"		because the radio buttons are moved outside of the form (for display purposes) -->",
"       <input id=\"searchType\" name=\"searchType\" type=\"hidden\" value=\"0\"/>",
"       <input id=\"source\" name=\"source\" type=\"hidden\" value=\"USER_INPUT\">",
"        <input id=\"searchControl\" name=\"searchControl\" type=\"hidden\" value=\"TOP_PULLDOWN\">",
"         <input name=\"searchOffset\" type=\"hidden\" value=\"\">",
"         </input>",
"        </input>",
"       </input>",
"      </div>",
"     </div>",
"    </form>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      Shwachman-Diamond syndrome",
"     </span>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <!-- <a href=\"#\" onclick=\"javascript:$('body').removeClass('fontSmall fontMed fontLarge').addClass('fontSmall');return false;\" id=\"fontSmall\" class=\"fontControl\" title=\"Smaller Font\"></a><a href=\"#\" onclick=\"javascript:$('body').removeClass('fontSmall fontMed fontLarge').addClass('fontMed');return false;\" id=\"fontMed\" class=\"fontControl\" title=\"Normal Font\"></a><a href=\"#\" onclick=\"javascript:$('body').removeClass('fontSmall fontMed fontLarge').addClass('fontLarge');return false;\" id=\"fontLarge\" class=\"fontControl\" title=\"Larger Font\"></a>-->",
"     <a class=\"findInPageLink\" href=\"#\">",
"      <img alt=\"Find in Topic\" src=\"./../images/icn_fop.myextg\" title=\"Find in Topic\"/>",
"     </a>",
"     <a class=\"findInPageLink icontxt textLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a href=\"mobipreview.htm?32/39/33400?topicKey=HEME%2F5914&amp;elapsedTimeMs=4&amp;view=print&amp;displayedView=full\">",
"      <img alt=\"Print This Topic\" src=\"./../images/icn_print.myextg\" title=\"Print This Topic\"/>",
"     </a>",
"     <a class=\"icontxt textLink\" href=\"mobipreview.htm?32/39/33400?topicKey=HEME%2F5914&amp;elapsedTimeMs=4&amp;view=print&amp;displayedView=full\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"etacLink\" href=\"#\">",
"      <img alt=\"Email This Topic\" src=\"./../images/icn_email.myextg\" title=\"Email This Topic\"/>",
"     </a>",
"     <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"   </div>",
"   <div id=\"findInPage\" title=\"Find in Topic\">",
"    <div id=\"findInPageInput\" style=\"display: none;\">",
"     <input id=\"findInPageTerm\" maxlength=\"30\" size=\"30\" type=\"text\">",
"      <p>",
"       <input checked=\"checked\" name=\"findInPageSearchType\" type=\"radio\" value=\"syn\">",
"        <span class=\"icontxt\">",
"         Find synonyms",
"        </span>",
"        <input name=\"findInPageSearchType\" type=\"radio\" value=\"exact\">",
"         <span class=\"icontxt\">",
"          Find exact match",
"         </span>",
"        </input>",
"       </input>",
"      </p>",
"      <div id=\"findInPageButtons\">",
"       <input class=\"icontxt\" id=\"findInPageFind\" type=\"button\" value=\"Find\">",
"        <input class=\"icontxt\" id=\"findInPageClear\" type=\"button\" value=\"Clear\">",
"        </input>",
"       </input>",
"      </div>",
"     </input>",
"    </div>",
"    <div id=\"findInPageProgress\" style=\"display: none;\">",
"     <img src=\"./../images/progress.myextg\">",
"      Searching for",
"      <span class=\"emphasis\" id=\"findInPageProgressTerm\">",
"      </span>",
"     </img>",
"    </div>",
"    <div id=\"findInPageResults\" style=\"display: none;\">",
"     We found",
"     <span class=\"emphasis findInPageResultsCount\">",
"     </span>",
"     &nbsp;",
"     <span class=\"emphasis\" id=\"findInPageResultsInstance\">",
"     </span>",
"     &nbsp;of&nbsp;",
"     <span class=\"emphasis\" id=\"findInPageResultsTerm\">",
"     </span>",
"     <div id=\"findInPageResultsIterator\" style=\"display: none;\">",
"      <span class=\"emphasis\" id=\"findInPageResultsIndex\">",
"       1",
"      </span>",
"      &nbsp;of&nbsp;",
"      <span class=\"findInPageResultsCount\">",
"      </span>",
"      &nbsp;highlighted",
"      <input class=\"icontxt\" id=\"findInPageResultsNext\" type=\"button\" value=\"Next\">",
"       <input class=\"icontxt\" id=\"findInPageResultsClear\" type=\"button\" value=\"Clear\">",
"       </input>",
"      </input>",
"     </div>",
"     <div id=\"findInPageResultsNone\" style=\"display: none;\">",
"      <input class=\"icontxt\" id=\"findInPageResultsNewFind\" type=\"button\" value=\"New Find\">",
"      </input>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"     <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"      <br>",
"       <div id=\"printHeaderText\">",
"        Official reprint from  UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"        <br>",
"         <a href=\"file://www.uptodate.com\">",
"          www.uptodate.com",
"         </a>",
"         &copy;2013 UpToDate",
"         <sup>",
"          &reg;",
"         </sup>",
"        </br>",
"       </div>",
"      </br>",
"     </img>",
"    </img>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <!-- TC:TOPIC_PAGE -->",
"  <div id=\"topicContent\">",
"   <div id=\"topicTitle\">",
"    Shwachman-Diamond syndrome",
"   </div>",
"   <div id=\"topicContributors\">",
"    <div>",
"     <a id=\"authors\">",
"     </a>",
"     <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/39/33400/contributors\">",
"      Author",
"     </a>",
"     <br/>",
"     <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/39/33400/contributors\">",
"      Akiko Shimamura, MD, PhD",
"     </a>",
"     <br/>",
"    </div>",
"    <div>",
"     <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/39/33400/contributors\">",
"      Section Editors",
"     </a>",
"     <br/>",
"     <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/39/33400/contributors\">",
"      Donald H Mahoney, Jr, MD",
"     </a>",
"     <br/>",
"     <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/39/33400/contributors\">",
"      William J Klish, MD",
"     </a>",
"     <br/>",
"    </div>",
"    <div>",
"     <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/39/33400/contributors\">",
"      Deputy Editor",
"     </a>",
"     <br/>",
"     <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/39/33400/contributors\">",
"      Stephen A Landaw, MD, PhD",
"     </a>",
"     <br/>",
"    </div>",
"   </div>",
"   <div id=\"disclosures\">",
"    <a href=\"mobipreview.htm?32/39/33400/contributor-disclosure\" target=\"_blank\">",
"     Disclosures",
"    </a>",
"   </div>",
"   <div id=\"reviewProcess\">",
"    <span>",
"     All topics are updated as new evidence becomes available and our",
"    </span>",
"    <a href=\"/home/editorial-policy\" target=\"_blank\">",
"     peer review process",
"    </a>",
"    <span>",
"     is complete.",
"    </span>",
"   </div>",
"   <div id=\"literatureReviewDate\">",
"    <span class=\"emphasis\">",
"     Literature review current through:",
"    </span>",
"    Oct 2013.",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"emphasis\">",
"     This topic last updated:",
"    </span>",
"    Dec 27, 2012.",
"   </div>",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      INTRODUCTION",
"     </span>",
"     &nbsp;&mdash;&nbsp;Shwachman-Diamond syndrome (SDS, also known as Shwachman-Diamond-Oski syndrome) generally presents in infancy with exocrine pancreatic dysfunction and bone marrow failure. Since its initial description in the early 1960s [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/1-3\">",
"      1-3",
"     </a>",
"     ], clinical features associated with SDS have been identified. In addition, advances in molecular genetics have established that SDS is an autosomal recessive disorder.",
"    </p>",
"    <p>",
"     The genetic abnormalities, clinical manifestations, diagnosis, and management of Shwachman-Diamond syndrome will be reviewed here.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      GENETICS",
"     </span>",
"     &nbsp;&mdash;&nbsp;SDS is a rare autosomal recessive disorder. In 90 percent of affected patients who have been studied, mutations have been detected in the Shwachman-Bodian-Diamond syndrome (SBDS) gene located on chromosome 7q11 [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/4,5\">",
"      4,5",
"     </a>",
"     ]. The SBDS gene has an adjacent pseudogene (a nonfunctional but almost identical gene), and in the majority of cases, gene conversion mutations recombine portions of the pseudogene and SBDS gene, resulting in a dysfunctional SBDS gene [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/5\">",
"      5",
"     </a>",
"     ]. At the present time, there is no known correlation between identified mutations and severity of disease [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/6\">",
"      6",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     The SBDS gene is highly conserved throughout evolution and is expressed in all human tissues tested to date [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/5,7,8\">",
"      5,7,8",
"     </a>",
"     ]. The SBDS gene product has been implicated in ribosome biogenesis and mitotic spindle stabilization [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/5,7-13\">",
"      5,7-13",
"     </a>",
"     ]. SBDS protein colocalizes with the mitotic spindle and binds to and stabilizes purified microtubules [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/11,14\">",
"      11,14",
"     </a>",
"     ]. Using human and animal models, investigators have shown that the SBDS gene product has an important role in the maturation of the 60S ribosomal subunit and ribosome assembly [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/15-19\">",
"      15-19",
"     </a>",
"     ]. How this defect in ribosomal function leads to the clinical manifestations of SDS has not been established. One hypothesis is that the high protein secretory capacity of neutrophils, pancreatic acinar cells, and chondrocytes makes them particularly vulnerable to defects in ribosomal assembly. It is currently unclear which functions of SBDS contribute to marrow failure. &nbsp;",
"    </p>",
"    <p>",
"     In a mouse model, homozygous expression of SBDS gene mutations leads to early fetal death [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/20\">",
"      20",
"     </a>",
"     ] consistent with an essential role for SBDS in early mammalian development.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      EPIDEMIOLOGY",
"     </span>",
"     &nbsp;&mdash;&nbsp;Prior to the availability of genetic testing, the estimated incidence of SDS was 1 in 75,000 [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/21\">",
"      21",
"     </a>",
"     ]. This likely represents an underestimate since the full phenotypic spectrum of SDS remains poorly understood. Although SDS is an autosomal recessive disorder, there is a slightly increased incidence in males, resulting in a male to female ratio of 1.6 to 1 [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/22\">",
"      22",
"     </a>",
"     ]. Patients with SDS have been reported in all racial and ethnic groups [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/22\">",
"      22",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h1\">",
"      CLINICAL MANIFESTATIONS",
"     </span>",
"     &nbsp;&mdash;&nbsp;In the initial descriptions of SDS [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/1-3\">",
"      1-3",
"     </a>",
"     ], SDS was defined by the presentation of exocrine pancreatic dysfunction and bone marrow failure. These findings are currently used to clinically diagnose SDS. Skeletal abnormalities have emerged as additional characteristics of SDS, prompting some investigators to redefine the syndrome as a triad of pancreatic, hematologic, and skeletal findings [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/20\">",
"      20",
"     </a>",
"     ]. Other reported findings include immunologic, dental, hepatic, cardiac, neurologic, dermatologic, and endocrine abnormalities. (See",
"     <a class=\"local\" href=\"#H17\">",
"      'Diagnosis'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H5\">",
"     <span class=\"h2\">",
"      Presentation",
"     </span>",
"     &nbsp;&mdash;&nbsp;In general, patients present in infancy or early childhood with one of more of the following symptoms:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Diarrhea with fatty, foul-smelling stools",
"      </li>",
"      <li>",
"       Growth failure",
"      </li>",
"      <li>",
"       Recurrent infections",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Patients without severe pancreatic disease can present later in childhood or, rarely, as adults. Symptoms of pancreatic dysfunction may resolve over time, rendering the diagnosis more obscure. Patients also can present with acute myeloid leukemia (AML) or aplastic anemia as the initial manifestation of their underlying disease.",
"    </p>",
"    <p>",
"     The nonspecific nature of the presenting symptoms and rarity of the disorder often can result in a delay or incorrect diagnosis. &nbsp;The full clinical spectrum of SDS remains poorly understood, and SDS patient registries have been developed in several countries to address this issue.",
"    </p>",
"    <p>",
"     Clinical manifestations of SDS were described in several retrospective observational studies of 88 patients with SDS [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/23-27\">",
"      23-27",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     In the largest of these case series, patients were diagnosed at a median age of one year (range 0.1 to 13 years) [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/23\">",
"      23",
"     </a>",
"     ]. The following clinical findings also were noted:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Pancreatic dysfunction &mdash; Steatorrhea (fat malabsorption) was seen in 86 percent of 66 patients tested. Low serum trypsinogen levels were seen in 91 percent of 86 patients tested. The eight patients with normal trypsinogen levels were all older than three years of age.",
"      </li>",
"      <li>",
"       Hematological abnormalities &mdash; Neutropenia was seen in 98 percent of patients, followed by anemia (42 percent), thrombocytopenia (34 percent), and pancytopenia (19 percent). Bone marrow results were available in 40 patients. Hypocellular marrow specimens were seen in 24 patients, granulocyte hypoplasia in 4, reduced megakaryocytes in 1, and a normal bone marrow specimen in 6 patients.",
"      </li>",
"      <li>",
"       Skeletal abnormalities &mdash; Skeletal abnormalities were reported in about half of the patients. Skeletal anomalies include metaphyseal dysostosis, thoracic dystrophies, and low-turnover osteopenia [",
"       <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/28,29\">",
"        28,29",
"       </a>",
"       ].",
"      </li>",
"      <li>",
"       Poor growth &mdash; Both mean height and weight were below the age and sex adjusted medians for the general population, (mean Z score for height: -2.2, and mean Z score for weight: -1.8). Fifty-six percent of patients were &lt;3rd percentile for height, and 47 percent were &lt;3rd percentile for weight.",
"      </li>",
"      <li>",
"       Infection &mdash; Infections were frequent and included the following:",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"hyphen-block\">",
"      <li>",
"       Lower respiratory infection: 21 patients",
"      </li>",
"      <li>",
"       Recurrent otitis media: 18 patients",
"      </li>",
"      <li>",
"       Sepsis: 6 patients",
"      </li>",
"      <li>",
"       Oral",
"       <span class=\"nowrap\">",
"        cellulitis/dental",
"       </span>",
"       abscesses: 3 patients",
"      </li>",
"      <li>",
"       Abscesses: 3 patients",
"      </li>",
"      <li>",
"       Osteomyelitis: 1 patient",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Hepatic abnormalities &mdash; Hepatomegaly (defined as liver edge &gt;3 cm below the right costal margin) was detected in 13 patients. Elevated serum aminotransferase concentrations, on at least one occasion, were seen in 60 percent of 80 patients tested. These abnormalities typically occur early in life and resolve spontaneously over time. Six patients with the highest serum aminotransferase measurements (fourfold increase) were less than three years of age.",
"      </li>",
"      <li>",
"       Other abnormalities included developmental delay and learning disorders (14 patients), tooth enamel defects (9 patients), and cleft palate (3 patients).",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h2\">",
"      Pancreatic abnormalities",
"     </span>",
"     &nbsp;&mdash;&nbsp;SDS is the second most common cause of inherited exocrine pancreatic dysfunction in children after cystic fibrosis.",
"    </p>",
"    <p>",
"     The pancreatic defect in SDS appears to arise from fatty replacement of pancreatic acini. Histological examination demonstrates normal ductal architecture and islets of Langerhans but absent or few acinar cells that are replaced with fatty tissue (",
"     <a class=\"graphic graphic_picture graphicRef58390 \" href=\"mobipreview.htm?37/31/38389\">",
"      picture 1",
"     </a>",
"     ). Ultrasonography or computed tomography (CT) may reveal a small shrunken pancreas or lipomatosis (",
"     <a class=\"graphic graphic_diagnosticimage graphicRef74272 \" href=\"mobipreview.htm?4/6/4198\">",
"      image 1",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     Steatorrhea (diarrhea with pale, greasy, voluminous, foul-smelling stools due to fat malabsorption) is noted in most infants with SDS. When tested for pancreatic function, almost all patients with SDS will have levels of lipolytic (lipase and colipase) and proteolytic (trypsin) enzymes below the mean reference for healthy controls [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/30,31\">",
"      30,31",
"     </a>",
"     ]. Fecal elastase is a useful marker of pancreatic function but has not yet been validated as a screen for SDS. There are subsets of patients with clinically silent pancreatic dysfunction.",
"    </p>",
"    <p>",
"     Pancreatic function often improves with age, in many cases to the level of sufficient function. About half of individuals with SDS have normal digestion without the need for pancreatic enzyme replacement therapy by the age of four years [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/20,25,32\">",
"      20,25,32",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     Helpful laboratory tests demonstrating pancreatic dysfunction include low concentrations of serum trypsinogen in patients younger than three years of age or low pancreatic isoamylase in those older than three years [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/33\">",
"      33",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     In patients with mutations in the SBDS gene, fatty replacement of the pancreas appears to be a characteristic finding on abdominal magnetic resonance imaging [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/34\">",
"      34",
"     </a>",
"     ]. However, the sensitivity of imaging studies as a screen for SDS remains to be determined",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H7\">",
"     <span class=\"h2\">",
"      Hematologic abnormalities",
"     </span>",
"     &nbsp;&mdash;&nbsp;Patients with SDS demonstrate varying degrees of bone marrow failure, generally occurring at an early age. However, there are reports of patients with SDS presenting with hematologic abnormalities later in childhood.",
"    </p>",
"    <p>",
"     A few cases of patients with aplastic anemia have been reported to have heterozygous mutations in the SBDS gene [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/35\">",
"      35",
"     </a>",
"     ]. The frequency of SBDS mutations in the general population is under investigation and has been estimated at around 1:110 [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/21\">",
"      21",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h3\">",
"      Neutrophils",
"     </span>",
"     &nbsp;&mdash;&nbsp;Neutropenia, defined as an absolute neutrophil count (ANC) &lt;1500",
"     <span class=\"nowrap\">",
"      counts/microL,",
"     </span>",
"     is the most common feature found in &gt;90 percent of patients and is often severe with ANC &lt;500",
"     <span class=\"nowrap\">",
"      counts/microL",
"     </span>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/26\">",
"      26",
"     </a>",
"     ]. It is intermittent in approximately two-thirds of patients and constant in the remaining one-third [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/23,26\">",
"      23,26",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     In addition to neutropenia, neutrophil dysfunction is seen in patients with SDS. In vitro studies describe impaired neutrophil chemotaxis and capping [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/36-40\">",
"      36-40",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H9\">",
"     <span class=\"h3\">",
"      Red blood cells",
"     </span>",
"     &nbsp;&mdash;&nbsp;Mild anemia is reported in 42 to 66 percent of patients with SDS [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/23,26\">",
"      23,26",
"     </a>",
"     ]. Red blood cells may be macrocytic. Because anemia is due to bone marrow failure, the reticulocyte count is not elevated. Hemoglobin F levels are often increased [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/26\">",
"      26",
"     </a>",
"     ], a finding that is true for many of the inherited marrow failure syndromes.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h3\">",
"      Platelets",
"     </span>",
"     &nbsp;&mdash;&nbsp;Thrombocytopenia, defined as a platelet count &lt;150,000",
"     <span class=\"nowrap\">",
"      counts/microL,",
"     </span>",
"     occurs in 24 to 60 percent of patients [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/23,26\">",
"      23,26",
"     </a>",
"     ]. Severe thrombocytopenia (platelet count &lt;20,000",
"     <span class=\"nowrap\">",
"      counts/microL)",
"     </span>",
"     does occur rarely and is seen in association with acute myeloid leukemia (AML) [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/6\">",
"      6",
"     </a>",
"     ]. Fatal bleeding in the setting of severe thrombocytopenia has been reported [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/41\">",
"      41",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h3\">",
"      Pancytopenia",
"     </span>",
"     &nbsp;&mdash;&nbsp;Pancytopenia, including severe aplastic anemia, has been reported in 10 to 44 percent of patients with SDS [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/24,40-42\">",
"      24,40-42",
"     </a>",
"     ]. There is one case report of SDS presenting as aplastic anemia at birth [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/43\">",
"      43",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H12\">",
"     <span class=\"h3\">",
"      Myelodysplasia and leukemia",
"     </span>",
"     &nbsp;&mdash;&nbsp;As is true of other inherited marrow failure disorders, patients with SDS are at increased risk for developing myelodysplastic syndrome (MDS) and AML. The incidence of these sequelae is unknown. In a retrospective report of 21 patients followed over a 25-year period, MDS occurred in seven patients, and five of these patients went on to develop AML [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/26\">",
"      26",
"     </a>",
"     ]. A review of the literature identified an additional 26 cases of AML in patients with SDS [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/41\">",
"      41",
"     </a>",
"     ]. Males have a 10-fold greater risk of developing leukemia [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/41\">",
"      41",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     In the report of 231 patients with severe chronic neutropenia from the French Severe Chronic Neutropenia (SCN) Registry, which included a total of 55 patients with SDS, 13 cases of",
"     <span class=\"nowrap\">",
"      MDS/AML",
"     </span>",
"     occurred, with 7 cases arising in with patients with SDS. Risk factors associated with",
"     <span class=\"nowrap\">",
"      MDS/AML",
"     </span>",
"     included severity of neutropenia, younger age at diagnosis, and increasing exposure to",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?43/27/44470?source=see_link\">",
"      granulocyte colony-stimulating factor",
"     </a>",
"     (G-CSF). It remains unclear whether the use of G-CSF merely reflected disease severity or whether G-CSF administration constituted an independent risk factor for malignancy.",
"     <span class=\"nowrap\">",
"      MDS/AML",
"     </span>",
"     only developed in patients with severe congenital neutropenia and SDS but not in patients with cyclic neutropenia.",
"    </p>",
"    <p>",
"     The prognosis of AML in patients with SDS is poor even with chemotherapy. Experience with hematopoietic cell transplantation (HCT) has been limited in patients with SDS. In case reports and small case series of HCT, survival rates for patients with SDS who have developed MDS or AML remain low. (See",
"     <a class=\"local\" href=\"#H25\">",
"      'Management'",
"     </a>",
"     below.)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H22340182\">",
"     <span class=\"h2\">",
"      Solid tumors",
"     </span>",
"     &nbsp;&mdash;&nbsp;A case of breast cancer developing in a young woman with biallelic mutations in SBDS has been reported [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/44\">",
"      44",
"     </a>",
"     ]. Dermatofibrosarcoma protuberans has been reported in a patient diagnosed clinically with SDS [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/45\">",
"      45",
"     </a>",
"     ]. Whether SDS is associated with an increased risk of solid tumors warrants further investigations.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H13\">",
"     <span class=\"h2\">",
"      Skeletal abnormalities",
"     </span>",
"     &nbsp;&mdash;&nbsp;Reported skeletal abnormalities in patients with SDS include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Abnormal development of the growth plate and metaphyses",
"      </li>",
"      <li>",
"       Delayed bone age",
"      </li>",
"      <li>",
"       Progressive deformities",
"      </li>",
"      <li>",
"       Pathologic fractures",
"      </li>",
"      <li>",
"       Osteopenia",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     The femoral head has been reported as the most commonly involved site. Other affected sites include the knee, humeral head, wrist, ankle, and vertebrae.",
"    </p>",
"    <p>",
"     Case series of patients with SDS likely underestimate the prevalence of skeletal abnormalities because most patients are asymptomatic, and only a subset of symptomatic patients underwent radiologic evaluation. This was illustrated in a study of 15 patients (mean age 9.7 years) with SDS and documented SBDS gene mutations [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/28\">",
"      28",
"     </a>",
"     ]. Serial radiographs were available in 10 of the patients. Skeletal radiographs revealed abnormalities in all patients that included:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Delayed secondary ossification was noted most frequently in infants. Epiphyseal maturation improved with age.",
"      </li>",
"      <li>",
"       Varying degrees of widening and irregularity of the metaphyses were common in the ribs, and proximal and distal femur in early childhood (&le;4 years of age).",
"      </li>",
"      <li>",
"       With advancing age, progressive thickening and irregularity of growth plates were noted.",
"      </li>",
"      <li>",
"       Generalized osteopenia.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Most patients with metaphyseal alterations were asymptomatic. Some patients had asymmetric growth that can progress to severe joint deformities, particularly involving the femur. There was no correlation between specific gene mutations and the severity of bony abnormalities.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H14\">",
"     <span class=\"h2\">",
"      Short stature",
"     </span>",
"     &nbsp;&mdash;&nbsp;Approximately one-half of patients with SDS are below the third percentile for height and weight [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/23\">",
"      23",
"     </a>",
"     ]. Children with SDS are small but typically are normally proportioned with a normal weight expressed as ideal weight for height throughout childhood.",
"    </p>",
"    <p>",
"     Short stature appears to be an intrinsic primary defect. Malnutrition may contribute initially to poor growth prior to the diagnosis of SDS and initiation of pancreatic enzyme replacement. However, short stature can persist despite the prompt administration of pancreatic enzyme replacement and adequate nutrition and improved growth rate [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/32\">",
"      32",
"     </a>",
"     ]. In addition, there are no differences in the stature of patients with pancreatic dysfunction and those with normal pancreatic function. Even at birth, infants with SDS have decreased birth weights and heights compared to normal healthy newborns [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/27\">",
"      27",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H15\">",
"     <span class=\"h2\">",
"      Infections",
"     </span>",
"     &nbsp;&mdash;&nbsp;Neutropenia, neutrophil dysfunction, and possibly other immunologic abnormalities (eg, dysgammaglobulinemia and T-cell dysfunction) increase the risk of infection in patients with SDS. In a review of 153 patients with SDS, 80 percent of patients had an infection that included pneumonia, recurrent otitis media, and skin",
"     <span class=\"nowrap\">",
"      infections/abscesses",
"     </span>",
"     in 33, 29, and 15 percent of patients, respectively [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/46\">",
"      46",
"     </a>",
"     ]. Other infections included meningitis, osteomyelitis, and urinary tract infections. Etiologic agents included Staphylococcus aureus, Haemophilus influenzae, and gram-negative rods (eg, Pseudomonas species). The incidence and severity of infections were greater among patients with more severe neutropenia.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H16\">",
"     <span class=\"h2\">",
"      Other findings",
"     </span>",
"     &nbsp;&mdash;&nbsp;Other clinical manifestations include:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Hepatic dysfunction &mdash; Elevated serum aminotransferase concentrations are seen in most patients at an earlier age, if tested [",
"       <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/23\">",
"        23",
"       </a>",
"       ]. Hepatomegaly is seen in 15 percent of patients. In the previously mentioned large cohort study, liver biopsies were performed in 13 patients [",
"       <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/23\">",
"        23",
"       </a>",
"       ]. In 12 of the 13 cases, abnormalities included microvesicular and macrovesicular steatosis (n = 4), evidence of periportal and portal inflammation (n = 4), fibrosis (n = 5), and glycogenosis (n = 2). Hepatomegaly and elevated serum aminotransferase typically resolve with age [",
"       <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/47\">",
"        47",
"       </a>",
"       ].",
"      </li>",
"      <li>",
"       Dental dysplasia &mdash; Tooth enamel defects (hypomaturation, hypocalcification, and hypoplasia) are commonly seen in patients with SDS [",
"       <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/6\">",
"        6",
"       </a>",
"       ]. Dental caries and tooth surface loss are seen in about a third of patients [",
"       <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/38\">",
"        38",
"       </a>",
"       ].",
"      </li>",
"      <li>",
"       Learning and behavioral difficulties &mdash; Observations from case series have suggested that some patients with SDS can have learning and behavioral difficulties [",
"       <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/26,48\">",
"        26,48",
"       </a>",
"       ]. One report compared the cognitive, behavioral, and adaptive functioning of 32 children with SDS to that of their unaffected siblings and a comparison group of children with cystic fibrosis, using standardized neuropsychological tests [",
"       <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/49\">",
"        49",
"       </a>",
"       ]. The children with SDS performed less well than the comparison groups on measures of intellectual reasoning, higher-order language skills, perceptual reasoning, visual-motor processing, attention, and several other neuropsychological measures. Children with SDS were also more likely to report behavioral diagnoses and difficulties.",
"      </li>",
"      <li>",
"       Central nervous system structural abnormalities have been noted on imaging studies [",
"       <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/50\">",
"        50",
"       </a>",
"       ]. These findings may be related to neurodevelopmental outcome.",
"      </li>",
"      <li>",
"       Immunologic abnormalities &mdash; In addition to neutropenia and neutrophil dysfunction, defects in B-cell and T-cell lymphocytic function have been observed in some patients with SDS [",
"       <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/40\">",
"        40",
"       </a>",
"       ]. These include low immunoglobulin G (IgG) levels, decreased number of circulating B-cell lymphocytes, and a lack of specific antibody production.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H17\">",
"     <span class=\"h1\">",
"      DIAGNOSIS",
"     </span>",
"     &nbsp;&mdash;&nbsp;The diagnosis of SDS is based upon characteristic clinical findings. At the present time, there is no single disease characteristic or laboratory test that definitely establishes the diagnosis. Clinical genotyping may be used for diagnostic confirmation. However, a negative test for SBDS gene mutations does not exclude the diagnosis, because 10 percent of patients clinically diagnosed with SDS lack SBDS mutations.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H18\">",
"     <span class=\"h2\">",
"      Clinical criteria",
"     </span>",
"     &nbsp;&mdash;&nbsp;In 2002, clinical criteria for the diagnosis of SDS were established by the First International Scientific meeting on SDS [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/51\">",
"      51",
"     </a>",
"     ]. Currently, the diagnosis of SDS is based upon demonstrating both exocrine pancreatic dysfunction and bone marrow failure as follows:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Exocrine pancreatic dysfunction established by the presence of at least one of the following:",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"hyphen-block\">",
"      <li>",
"       Low serum trypsinogen in patients &lt;3 years of age or low serum trypsinogen or pancreatic isoamylase in patients &gt;3 years of age",
"      </li>",
"      <li>",
"       Elevated fecal fat excretion following a 72-hour collection (provided that intestinal mucosal disease or cholestatic liver disease is excluded)",
"       <strong>",
"        and",
"       </strong>",
"       radiologic imaging demonstrating a small or fatty pancreas",
"      </li>",
"      <li>",
"       Low levels of pancreatic enzymes following pancreatic stimulation testing with intravenous pancreozymin",
"       <span class=\"nowrap\">",
"        with/without",
"       </span>",
"       <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?19/45/20179?source=see_link\">",
"        secretin",
"       </a>",
"       . However, pancreatic stimulation testing is no longer used widely in the diagnosis of SDS with the advent of alternative noninvasive testing.",
"      </li>",
"      <li>",
"       Low fecal elastase is a useful screen for exocrine pancreatic dysfunction but has yet to be validated as a screen for SDS.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Bone marrow failure established by the presence of at least one of the following:",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"hyphen-block\">",
"      <li>",
"       Persistent neutropenia defined as an absolute neutrophil count &lt;1500",
"       <span class=\"nowrap\">",
"        neutrophils/mm3",
"       </span>",
"       at least on three different occasions over a time period of &ge;3 months",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Anemia defined as a hemoglobin concentration below the age-related normal range (",
"       <a class=\"graphic graphic_table graphicRef57465 \" href=\"mobipreview.htm?5/34/5679\">",
"        table 1",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"hyphen-block\">",
"      <li>",
"       Thrombocytopenia defined as a platelet count &lt;150,000",
"       <span class=\"nowrap\">",
"        counts/mm3",
"       </span>",
"      </li>",
"      <li>",
"       Pancytopenia",
"      </li>",
"      <li>",
"       Myelodysplastic syndrome documented on bone marrow examination",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Other findings that support the diagnosis of SDS (but their absence does not exclude the diagnosis) include additional features of SDS, such as skeletal abnormalities, hepatomegaly, elevation of serum aminotransferase, immunologic abnormalities, and short stature.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H19\">",
"     <span class=\"h2\">",
"      Laboratory testing",
"     </span>",
"     &nbsp;&mdash;&nbsp;Laboratory testing provides the data to establish the diagnosis of SDS, adds further supportive evidence, and assesses pancreatic, hepatic, and bone marrow function.",
"    </p>",
"    <p>",
"     The following diagnostic laboratory tests are useful in the diagnostic workup.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Complete blood count with differential count and platelet count",
"      </li>",
"      <li>",
"       72-hour fecal fat collection",
"       <span class=\"nowrap\">",
"        and/or",
"       </span>",
"       fecal elastase, with additional testing to rule out enteropathies or other non-pancreatic causes of fat malabsorption",
"      </li>",
"      <li>",
"       Serum trypsinogen and pancreatic isoamylase",
"      </li>",
"      <li>",
"       Bone marrow aspiration, biopsy, and cytogenetic analysis",
"      </li>",
"      <li>",
"       Radiologic imaging of the pancreas (ultrasonography, CT, or magnetic resonance imaging)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Supportive laboratory testing and further tests that differentiate SDS from other disorders or address patient needs include the following:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Serum aminotransferase levels",
"      </li>",
"      <li>",
"       Skeletal survey",
"      </li>",
"      <li>",
"       Vitamin A, D, E, and K levels because these fat-soluble vitamins can be deficient due to fat malabsorption and require replenishment",
"      </li>",
"      <li>",
"       Sweat test to differentiate SDS from cystic fibrosis, especially in younger patients who have not yet developed hematological abnormalities of SDS (see",
"       <a class=\"local\" href=\"#H22\">",
"        'Differential diagnosis'",
"       </a>",
"       below)",
"      </li>",
"      <li>",
"       Immunoglobulin levels, and T and B cell subsets and functional studies",
"      </li>",
"      <li>",
"       Other marrow failure syndromes should be excluded (see",
"       <a class=\"local\" href=\"#H24\">",
"        'Bone marrow failure'",
"       </a>",
"       below)",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H20\">",
"     <span class=\"h3\">",
"      Genetic testing",
"     </span>",
"     &nbsp;&mdash;&nbsp;Genetic testing is helpful in confirming the clinical diagnosis of SDS, but as previously mentioned, 10 percent of diagnosed patients with SDS will not have an SBDS gene mutation. Whether these patients without the SBDS gene mutations have mutations of another gene is unknown. Thus, a positive test confirms the diagnosis of SDS, but a negative genetic test does not exclude the diagnosis of SDS. Genetic testing may be useful in screening family members of an affected patient with a known SBDS gene mutation.",
"    </p>",
"    <p>",
"     Genetic testing is available in Europe and North America. In addition, national registries and an international collaborative database have been established to better understand the genetic basis of SDS and, if possible, correlate genetic abnormalities with clinical disease and outcome [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/6\">",
"      6",
"     </a>",
"     ]. Information regarding genetic testing for SDS can be obtained from",
"     <a class=\"external\" href=\"file://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/clinical_disease_id/213270?db=genetests\">",
"      GeneTests.org",
"     </a>",
"     .",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H21\">",
"     <span class=\"h3\">",
"      Bone marrow evaluation",
"     </span>",
"     &nbsp;&mdash;&nbsp;There are no pathognomonic bone marrow findings in patients with SDS. Bone marrow testing reveals a wide range of findings, including a normal marrow specimen, particularly in young patients.",
"    </p>",
"    <p>",
"     Obtaining bone marrow specimens is important to exclude other diagnoses, monitor for marrow aplasia, and to detect emergent clonal disease. Marrow cytogenetic abnormalities include abnormalities of chromosome 7 (monosomy 7,",
"     <span class=\"nowrap\">",
"      deletions/translocations",
"     </span>",
"     of 7q, isochromosome 7). With the exception of some high-risk cytogenetic clones, the prognostic significance of cytogenetic findings in the absence of morphologic evidence for MDS is unclear. Some of these cytogenetic clonal populations may wax and wane over time, or even disappear [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/52\">",
"      52",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H22\">",
"     <span class=\"h1\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </span>",
"     &nbsp;&mdash;&nbsp;In the presence of both exocrine pancreatic dysfunction and bone marrow failure, the diagnosis of SDS is generally straightforward. However, the diagnosis is more difficult if there is an incomplete presentation of SDS, because exocrine pancreatic dysfunction or cytopenia can be intermittent or symptoms may be sub-clinical. The differential diagnosis can be divided into disorders of pancreatic dysfunction or bone marrow failure.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H23\">",
"     <span class=\"h2\">",
"      Pancreatic dysfunction",
"     </span>",
"     &nbsp;&mdash;&nbsp;Other causes of exocrine pancreatic dysfunction include cystic fibrosis and two rare disorders, Pearson syndrome and Johanson-Blizzard syndrome.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Cystic fibrosis &mdash; Cystic fibrosis (CF) is the most common inherited cause of exocrine pancreatic dysfunction. SDS is differentiated from CF by a negative sweat test. (See",
"       <a class=\"medical medical_review\" href=\"mobipreview.htm?27/49/28442?source=see_link&amp;anchor=H19#H19\">",
"        \"Cystic fibrosis: Clinical manifestations and diagnosis\", section on 'Sweat chloride'",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Pearson marrow pancreas syndrome &mdash; Pearson marrow pancreas syndrome was described in 1979, and is caused by deletions of mitochondrial DNA. It is distinguished from SDS by the hematologic findings of sideroblastic anemia, bone marrow changes that include cell vacuolization and ringed sideroblasts, pancreatic fibrosis rather than lipomatosis, and the absence of bone lesions. Mitochondrial DNA sequencing demonstrating deletions confirms the diagnosis of Pearson syndrome and differentiates it from SDS.",
"      </li>",
"      <li>",
"       Johanson-Blizzard syndrome &mdash; The clinical characteristics of this disorder include pancreatic exocrine deficiency, aplasia or hypoplasia of the alae nasi, congenital deafness, hypothyroidism, developmental delay, ectodermal scalp defects, absence of permanent teeth, urogenital malformations, and imperforate anus. This disorder is distinguished from SDS by the above clinical features and the absence of bone marrow and skeletal abnormalities seen in SDS.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H24\">",
"     <span class=\"h2\">",
"      Bone marrow failure",
"     </span>",
"     &nbsp;&mdash;&nbsp;When tested for pancreatic function, almost all patients with SDS (even those who are asymptomatic with adequate pancreatic function) will have low serum trypsinogen or pancreatic isoamylase levels, which differentiates SDS from other causes of bone marrow failure.",
"    </p>",
"    <p>",
"     Fanconi anemia is the most common cause of inherited bone marrow failure in children. It is diagnosed by the presence of increased chromosomal breakage in lymphocytes or fibroblasts cultured in the presence of DNA cross-linking agents, such as",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?37/16/38144?source=see_link\">",
"      mitomycin",
"     </a>",
"     C (MMC) or diepoxybutane (DEB). Alternative marrow failure syndromes should be considered if clinically indicated and are discussed separately. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/13/26842?source=see_link\">",
"      \"Inherited aplastic anemia in children\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H25\">",
"     <span class=\"h1\">",
"      MANAGEMENT",
"     </span>",
"     &nbsp;&mdash;&nbsp;Therapy in patients with SDS is directed at specific clinical manifestations. Management with a multidisciplinary team (gastroenterologist, hematologist, and consultations with other subspecialists as clinically indicated) provides optimal care.",
"    </p>",
"    <p>",
"     The following discussion regarding management in patients with SDS is based upon clinical experience rather than on randomized clinical trials due to the rarity of this syndrome.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H26\">",
"     <span class=\"h2\">",
"      Pancreatic",
"     </span>",
"     &nbsp;&mdash;&nbsp;Clinically significant pancreatic dysfunction is treated with oral pancreatic enzyme supplementation. In addition, the fat-soluble vitamins A, D, E, and K should be supplemented as needed.",
"    </p>",
"    <p>",
"     Ongoing monitoring is recommended as exocrine pancreatic function may improve over time. Steatorrhea resolves in about half of the patients by the age of four years [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/25\">",
"      25",
"     </a>",
"     ]. Assessment of pancreatic function can be done by measurements of serum trypsinogen or pancreatic isoamylase levels [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/25\">",
"      25",
"     </a>",
"     ]. After a patient has discontinued enzyme supplementation, ongoing monitoring of fat absorption is recommended [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/51\">",
"      51",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H27\">",
"     <span class=\"h2\">",
"      Hematologic",
"     </span>",
"     &nbsp;&mdash;&nbsp;In patients with SDS, complete blood counts with white cell differential count and platelet count should be monitored every six months (or more frequently if clinically indicated) [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/39\">",
"      39",
"     </a>",
"     ]. Serial monitoring of the bone marrow is recommended for early detection of progressive aplasia, clonal disease, or malignant transformation, although the prognostic value of detection of clonal cytogenetic abnormalities (eg, isochromosome) in the absence of myelodysplastic syndrome (MDS) is uncertain [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/53\">",
"      53",
"     </a>",
"     ]. (See",
"     <a class=\"local\" href=\"#H21\">",
"      'Bone marrow evaluation'",
"     </a>",
"     above.)",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Neutropenia &mdash; Febrile patients should be evaluated promptly for potential infections and treated with broad-spectrum antibiotics pending culture results. (See",
"       <a class=\"medical medical_review\" href=\"mobipreview.htm?20/3/20537?source=see_link\">",
"        \"Evaluation and management of fever in children with non-chemotherapy-induced neutropenia\"",
"       </a>",
"       .)",
"       <br/>",
"       <br/>",
"       <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?43/27/44470?source=see_link\">",
"        Granulocyte colony-stimulating factor",
"       </a>",
"       (G-CSF) has been used in patients with recurrent infections [",
"       <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/54\">",
"        54",
"       </a>",
"       ] or in cases of life-threatening infections [",
"       <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/6,55\">",
"        6,55",
"       </a>",
"       ]. Although there is a theoretical concern of stimulating a malignant preleukemic clone resulting in an increased risk of myelodysplasia and acute myeloid leukemia [",
"       <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/54\">",
"        54",
"       </a>",
"       ], no clear association has been established. The benefits and risks of G-CSF treatment should be considered for each patient depending upon the clinical setting. When feasible, a bone marrow evaluation prior to the initiation of G-CSF therapy should also be considered.",
"      </li>",
"      <li>",
"       Anemia &mdash; For each patient, the indications for transfusion are guided by the blood counts and clinical setting. Red blood cell transfusions are recommended in patients symptomatic from anemia (eg, decreased activity level, excessive fatigue, shortness of breath, and poor growth). Leuko-depleted and irradiated blood products are recommended. (See",
"       <a class=\"medical medical_review\" href=\"mobipreview.htm?27/11/27832?source=see_link\">",
"        \"Red cell transfusion in infants and children: Selection of blood products\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       Thrombocytopenia &mdash; For each patient, the indications for transfusion are guided by the blood counts and clinical setting. Platelet transfusion is indicated in patients with severe bruising or bleeding, or to attain an adequate platelet count prior to an invasive procedure. Anti-fibrinolytic medications (eg, Amicar) may also be considered.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H25883460\">",
"     <span class=\"h3\">",
"      Hematopoietic cell transplantation (HCT)",
"     </span>",
"     &nbsp;&mdash;&nbsp;There is no clear consensus on when to perform HCT in a patient with SDS, and clinical decisions also depend on the availability of an appropriate donor. Current indications usually include [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/56\">",
"      56",
"     </a>",
"     ]:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Severe persistent or symptomatic cytopenia(s)",
"      </li>",
"      <li>",
"       Development of leukemia",
"      </li>",
"      <li>",
"       Development of myelodysplasia (MDS) with excess blasts (5 to 20 percent)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     However, data are limited by the small number of patients with SDS who have undergone HCT [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/53,56\">",
"      53,56",
"     </a>",
"     ]. Outcomes appear best when transplant is initiated for the treatment of severe marrow failure or MDS rather than after leukemia has developed [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/57-59\">",
"      57-59",
"     </a>",
"     ]. MDS in children usually is characterized by an aggressive clinical course and poor response to chemotherapeutic agents. However, patients with SDS appear to be particularly at risk for toxicities from intensive bone marrow conditioning regimens; in most cases poor outcome is related to end-organ toxicities rather than graft failure [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/53,60\">",
"      53,60",
"     </a>",
"     ]. In one series of seven SDS patients who underwent HCT with a reduced intensity conditioning regimen, all survived at a median follow up of 548 days (range 93 to 920 days) [",
"     <a class=\"abstract\" href=\"mobipreview.htm?32/39/33400/abstract/61\">",
"      61",
"     </a>",
"     ]. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/40/17030?source=see_link&amp;anchor=H3#H3\">",
"      \"Hematopoietic cell transplantation for Diamond-Blackfan anemia and the myelodysplastic syndromes in children\", section on 'Myelodysplastic syndrome'",
"     </a>",
"     .) &nbsp;",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H28\">",
"     <span class=\"h2\">",
"      Bone and dental evaluation",
"     </span>",
"     &nbsp;&mdash;&nbsp;Because a significant number of patients suffer from skeletal and dental abnormalities, anticipatory monitoring is recommended.",
"    </p>",
"    <p>",
"     Patients should be referred to a dentist at an early age. Information should be provided to the dentist on the association of tooth enamel defects and SDS, and the increased risk of dental caries in patients with SDS.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H29\">",
"     <span class=\"h2\">",
"      Growth",
"     </span>",
"     &nbsp;&mdash;&nbsp;Growth parameters should be monitored. If the patient has short stature, factors that are amenable to treatment (eg, malnutrition or endocrine abnormalities) should be sought and addressed.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H30\">",
"     <span class=\"h1\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </span>",
"     &nbsp;&mdash;&nbsp;Shwachman-Diamond syndrome (SDS) is a relatively rare autosomal recessive disorder that generally presents in infancy with exocrine pancreatic dysfunction and bone marrow failure.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Mutations of the Shwachman-Bodian-Diamond syndrome gene are found in 90 percent of affected patients who have been tested. (See",
"       <a class=\"local\" href=\"#H2\">",
"        'Genetics'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       Clinical manifestations of SDS include the following (see",
"       <a class=\"local\" href=\"#H4\">",
"        'Clinical manifestations'",
"       </a>",
"       above):",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"hyphen-block\">",
"      <li>",
"       Exocrine pancreatic dysfunction.",
"      </li>",
"      <li>",
"       Bone marrow failure with neutropenia is the most frequent abnormality, although anemia and thrombocytopenia also may occur.",
"      </li>",
"      <li>",
"       Increased risk for developing myelodysplastic syndrome",
"       <span class=\"nowrap\">",
"        and/or",
"       </span>",
"       acute myeloid leukemia.",
"      </li>",
"      <li>",
"       Skeletal abnormalities.",
"      </li>",
"      <li>",
"       Short stature.",
"      </li>",
"      <li>",
"       Increased risk of infections, especially serious infections that may be life threatening.",
"      </li>",
"      <li>",
"       Hepatomegaly and elevated serum aminotransferase levels, early in life.",
"      </li>",
"      <li>",
"       Other findings include dental, immunologic, cardiac, endocrine, and central nervous system abnormalities. Children with SDS are at risk for learning and behavioral difficulties.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The diagnosis of SDS is currently based upon clinical criteria that demonstrate exocrine pancreatic dysfunction",
"       <strong>",
"        and",
"       </strong>",
"       bone marrow failure. (See",
"       <a class=\"local\" href=\"#H18\">",
"        'Clinical criteria'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       The diagnosis is more difficult if there is an incomplete presentation of SDS. Other causes for exocrine pancreatic dysfunction or bone marrow failure must be considered. (See",
"       <a class=\"local\" href=\"#H22\">",
"        'Differential diagnosis'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       Management of SDS is directed at specific clinical manifestations and includes the following (see",
"       <a class=\"local\" href=\"#H25\">",
"        'Management'",
"       </a>",
"       above):",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"hyphen-block\">",
"      <li>",
"       In patients with symptomatic pancreatic insufficiency, oral pancreatic enzyme and fat-soluble vitamin (vitamins A, D, E, and K) supplementation are recommended (",
"       <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"        Grade 1B",
"       </a>",
"       ). (See",
"       <a class=\"local\" href=\"#H26\">",
"        'Pancreatic'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       Febrile patients should be evaluated promptly for potential infections and, if neutropenic or immunodeficient, treated with broad-spectrum antibiotics pending culture results. (See",
"       <a class=\"local\" href=\"#H27\">",
"        'Hematologic'",
"       </a>",
"       above and",
"       <a class=\"medical medical_review\" href=\"mobipreview.htm?20/3/20537?source=see_link\">",
"        \"Evaluation and management of fever in children with non-chemotherapy-induced neutropenia\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       The administration of",
"       <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?43/27/44470?source=see_link\">",
"        granulocyte colony-stimulating factor",
"       </a>",
"       (G-CSF) has been used in neutropenic patients with frequent infections or life-threatening infections, but controlled trials in this patient population are not available. (See",
"       <a class=\"local\" href=\"#H27\">",
"        'Hematologic'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       Supportive care includes transfusions of red cells in patients with symptomatic or severe anemia or platelets with those with thrombocytopenia and bleeding, bruising, or who are undergoing invasive procedures. (See",
"       <a class=\"local\" href=\"#H27\">",
"        'Hematologic'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       Hematopoietic stem cell transplantation (HCT) is the only current curative treatment for bone marrow failure in patients with SDS, but data are limited regarding the optimal transplant regimen for these patients. SDS patients exhibit increased sensitivity to chemotherapy and radiation. Successful outcomes have been reported using reduced intensity conditioning regimens. In patients with SDS, HCT should be considered for the treatment of severe or symptomatic marrow failure, MDS, and acute myeloid leukemia. (See",
"       <a class=\"local\" href=\"#H27\">",
"        'Hematologic'",
"       </a>",
"       above.)",
"      </li>",
"     </ul>",
"    </p>",
"   </div>",
"   <div id=\"topicAgreement\">",
"    Use of UpToDate is subject to the",
"    <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"     Subscription and License Agreement",
"    </a>",
"    .",
"   </div>",
"   <div class=\"headingAnchor\" id=\"references\">",
"    <h1>",
"     REFERENCES",
"    </h1>",
"    <ol id=\"reference\">",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/1\">",
"       SHWACHMAN H, DIAMOND LK, OSKI FA, KHAW KT. THE SYNDROME OF PANCREATIC INSUFFICIENCY AND BONE MARROW DYSFUNCTION. J Pediatr 1964; 65:645.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/2\">",
"       BODIAN M, SHELDON W, LIGHTWOOD R. CONGENITAL HYPOPLASIA OF THE EXOCRINE PANCREAS. Acta Paediatr 1964; 53:282.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/3\">",
"       NEZELOF C, WATCHI M. [Lipomatous congenital hypoplasia of the exocrine pancreas in children. (2 cases and review of the literature)]. Arch Fr Pediatr 1961; 18:1135.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/4\">",
"       Woloszynek JR, Rothbaum RJ, Rawls AS, et al. Mutations of the SBDS gene are present in most patients with Shwachman-Diamond syndrome. Blood 2004; 104:3588.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/5\">",
"       Boocock GR, Morrison JA, Popovic M, et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet 2003; 33:97.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/6\">",
"       Hall GW, Dale P, Dodge JA. Shwachman-Diamond syndrome: UK perspective. Arch Dis Child 2006; 91:521.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/7\">",
"       Austin KM, Leary RJ, Shimamura A. The Shwachman-Diamond SBDS protein localizes to the nucleolus. Blood 2005; 106:1253.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/8\">",
"       Boocock GR, Marit MR, Rommens JM. Phylogeny, sequence conservation, and functional complementation of the SBDS protein family. Genomics 2006; 87:758.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/9\">",
"       Savchenko A, Krogan N, Cort JR, et al. The Shwachman-Bodian-Diamond syndrome protein family is involved in RNA metabolism. J Biol Chem 2005; 280:19213.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/10\">",
"       Shammas C, Menne TF, Hilcenko C, et al. Structural and mutational analysis of the SBDS protein family. Insight into the leukemia-associated Shwachman-Diamond Syndrome. J Biol Chem 2005; 280:19221.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/11\">",
"       Austin KM, Gupta ML Jr, Coats SA, et al. Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome. J Clin Invest 2008; 118:1511.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/12\">",
"       Rujkijyanont P, Adams SL, Beyene J, Dror Y. Bone marrow cells from patients with Shwachman-Diamond syndrome abnormally express genes involved in ribosome biogenesis and RNA processing. Br J Haematol 2009; 145:806.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/13\">",
"       Hesling C, Oliveira CC, Castilho BA, Zanchin NI. The Shwachman-Bodian-Diamond syndrome associated protein interacts with HsNip7 and its down-regulation affects gene expression at the transcriptional and translational levels. Exp Cell Res 2007; 313:4180.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/14\">",
"       Orelio C, Verkuijlen P, Geissler J, et al. SBDS expression and localization at the mitotic spindle in human myeloid progenitors. PLoS One 2009; 4:e7084.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/15\">",
"       Wong CC, Traynor D, Basse N, et al. Defective ribosome assembly in Shwachman-Diamond syndrome. Blood 2011; 118:4305.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/16\">",
"       Finch AJ, Hilcenko C, Basse N, et al. Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome. Genes Dev 2011; 25:917.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/17\">",
"       Menne TF, Goyenechea B, S&aacute;nchez-Puig N, et al. The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast. Nat Genet 2007; 39:486.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/18\">",
"       Ganapathi KA, Austin KM, Lee CS, et al. The human Shwachman-Diamond syndrome protein, SBDS, associates with ribosomal RNA. Blood 2007; 110:1458.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/19\">",
"       Burwick N, Coats SA, Nakamura T, Shimamura A. Impaired ribosomal subunit association in Shwachman-Diamond syndrome. Blood 2012; 120:5143.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/20\">",
"       Zhang S, Shi M, Hui CC, Rommens JM. Loss of the mouse ortholog of the shwachman-diamond syndrome gene (Sbds) results in early embryonic lethality. Mol Cell Biol 2006; 26:6656.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/21\">",
"       Goobie S, Popovic M, Morrison J, et al. Shwachman-Diamond syndrome with exocrine pancreatic dysfunction and bone marrow failure maps to the centromeric region of chromosome 7. Am J Hum Genet 2001; 68:1048.",
"      </a>",
"     </li>",
"     <li>",
"      Alter BP. Inherited Bone Marrow Failure Syndromes. In: Nathan and Oski's Hematology of Infancy and Childhood, Nathan DG, Orkin SH, Ginsburg D, Look AT (Eds), W.B. Saunders, Philadelphia 2003. p.280.",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/23\">",
"       Ginzberg H, Shin J, Ellis L, et al. Shwachman syndrome: phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. J Pediatr 1999; 135:81.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/24\">",
"       Aggett PJ, Cavanagh NP, Matthew DJ, et al. Shwachman's syndrome. A review of 21 cases. Arch Dis Child 1980; 55:331.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/25\">",
"       Mack DR, Forstner GG, Wilschanski M, et al. Shwachman syndrome: exocrine pancreatic dysfunction and variable phenotypic expression. Gastroenterology 1996; 111:1593.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/26\">",
"       Smith OP, Hann IM, Chessells JM, et al. Haematological abnormalities in Shwachman-Diamond syndrome. Br J Haematol 1996; 94:279.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/27\">",
"       Cipolli M, D'Orazio C, Delmarco A, et al. Shwachman's syndrome: pathomorphosis and long-term outcome. J Pediatr Gastroenterol Nutr 1999; 29:265.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/28\">",
"       M&auml;kitie O, Ellis L, Durie PR, et al. Skeletal phenotype in patients with Shwachman-Diamond syndrome and mutations in SBDS. Clin Genet 2004; 65:101.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/29\">",
"       Toiviainen-Salo S, M&auml;yr&auml;np&auml;&auml; MK, Durie PR, et al. Shwachman-Diamond syndrome is associated with low-turnover osteoporosis. Bone 2007; 41:965.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/30\">",
"       Hill RE, Durie PR, Gaskin KJ, et al. Steatorrhea and pancreatic insufficiency in Shwachman syndrome. Gastroenterology 1982; 83:22.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/31\">",
"       Gaskin KJ, Durie PR, Lee L, et al. Colipase and lipase secretion in childhood-onset pancreatic insufficiency. Delineation of patients with steatorrhea secondary to relative colipase deficiency. Gastroenterology 1984; 86:1.",
"      </a>",
"     </li>",
"     <li>",
"      Durie PR, Rommens JM. Shwachman-Diamond Syndrome. In: Pediatric Gastrointestinal Disease, 4th, Walker WA, Goulet O, Kleinman RE, et al (Eds), BC Decker, Hamilton 2004. p.1624.",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/33\">",
"       Ip WF, Dupuis A, Ellis L, et al. Serum pancreatic enzymes define the pancreatic phenotype in patients with Shwachman-Diamond syndrome. J Pediatr 2002; 141:259.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/34\">",
"       Toiviainen-Salo S, Raade M, Durie PR, et al. Magnetic resonance imaging findings of the pancreas in patients with Shwachman-Diamond syndrome and mutations in the SBDS gene. J Pediatr 2008; 152:434.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/35\">",
"       Calado RT, Graf SA, Wilkerson KL, et al. Mutations in the SBDS gene in acquired aplastic anemia. Blood 2007; 110:1141.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/36\">",
"       Stepanovic V, Wessels D, Goldman FD, et al. The chemotaxis defect of Shwachman-Diamond Syndrome leukocytes. Cell Motil Cytoskeleton 2004; 57:158.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/37\">",
"       Orelio C, Kuijpers TW. Shwachman-Diamond syndrome neutrophils have altered chemoattractant-induced F-actin polymerization and polarization characteristics. Haematologica 2009; 94:409.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/38\">",
"       Aggett PJ, Harries JT, Harvey BA, Soothill JF. An inherited defect of neutrophil mobility in Shwachman syndrome. J Pediatr 1979; 94:391.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/39\">",
"       Rothbaum RJ, Williams DA, Daugherty CC. Unusual surface distribution of concanavalin A reflects a cytoskeletal defect in neutrophils in Shwachman's syndrome. Lancet 1982; 2:800.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/40\">",
"       Dror Y, Ginzberg H, Dalal I, et al. Immune function in patients with Shwachman-Diamond syndrome. Br J Haematol 2001; 114:712.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/41\">",
"       Dror Y. Shwachman-Diamond syndrome. Pediatr Blood Cancer 2005; 45:892.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/42\">",
"       Woods WG, Krivit W, Lubin BH, Ramsay NK. Aplastic anemia associated with the Shwachman syndrome. In vivo and in vitro observations. Am J Pediatr Hematol Oncol 1981; 3:347.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/43\">",
"       Kuijpers TW, Nannenberg E, Alders M, et al. Congenital aplastic anemia caused by mutations in the SBDS gene: a rare presentation of Shwachman-Diamond syndrome. Pediatrics 2004; 114:e387.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/44\">",
"       Singh SA, Vlachos A, Morgenstern NJ, et al. Breast cancer in a case of Shwachman Diamond syndrome. Pediatr Blood Cancer 2012; 59:945.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/45\">",
"       Sack JE, Kuchnir L, Demierre MF. Dermatofibrosarcoma protuberans arising in the context of Shwachman-Diamond syndrome. Pediatr Dermatol 2011; 28:568.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/46\">",
"       Grinspan ZM, Pikora CA. Infections in patients with Shwachman-Diamond syndrome. Pediatr Infect Dis J 2005; 24:179.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/47\">",
"       Toiviainen-Salo S, Durie PR, Numminen K, et al. The natural history of Shwachman-Diamond syndrome-associated liver disease from childhood to adulthood. J Pediatr 2009; 155:807.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/48\">",
"       Kent A, Murphy GH, Milla P. Psychological characteristics of children with Shwachman syndrome. Arch Dis Child 1990; 65:1349.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/49\">",
"       Kerr EN, Ellis L, Dupuis A, et al. The behavioral phenotype of school-age children with shwachman diamond syndrome indicates neurocognitive dysfunction with loss of Shwachman-Bodian-Diamond syndrome gene function. J Pediatr 2010; 156:433.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/50\">",
"       Toiviainen-Salo S, M&auml;kitie O, Mannerkoski M, et al. Shwachman-Diamond syndrome is associated with structural brain alterations on MRI. Am J Med Genet A 2008; 146A:1558.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/51\">",
"       Rothbaum R, Perrault J, Vlachos A, et al. Shwachman-Diamond syndrome: report from an international conference. J Pediatr 2002; 141:266.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/52\">",
"       Dror Y, Durie P, Ginzberg H, et al. Clonal evolution in marrows of patients with Shwachman-Diamond syndrome: a prospective 5-year follow-up study. Exp Hematol 2002; 30:659.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/53\">",
"       Shimamura A. Shwachman-Diamond syndrome. Semin Hematol 2006; 43:178.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/54\">",
"       Donadieu J, Leblanc T, Bader Meunier B, et al. Analysis of risk factors for myelodysplasias, leukemias and death from infection among patients with congenital neutropenia. Experience of the French Severe Chronic Neutropenia Study Group. Haematologica 2005; 90:45.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/55\">",
"       Adachi N, Tsuchiya H, Nunoi H, et al. rhG-CSF for Shwachman's syndrome. Lancet 1990; 336:1136.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/56\">",
"       Burroughs L, Woolfrey A, Shimamura A. Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment. Hematol Oncol Clin North Am 2009; 23:233.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/57\">",
"       Donadieu J, Michel G, Merlin E, et al. Hematopoietic stem cell transplantation for Shwachman-Diamond syndrome: experience of the French neutropenia registry. Bone Marrow Transplant 2005; 36:787.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/58\">",
"       Cesaro S, Oneto R, Messina C, et al. Haematopoietic stem cell transplantation for Shwachman-Diamond disease: a study from the European Group for blood and marrow transplantation. Br J Haematol 2005; 131:231.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/59\">",
"       Vibhakar R, Radhi M, Rumelhart S, et al. Successful unrelated umbilical cord blood transplantation in children with Shwachman-Diamond syndrome. Bone Marrow Transplant 2005; 36:855.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/60\">",
"       Mehta P, Locatelli F, Stary J, Smith FO. Bone marrow transplantation for inherited bone marrow failure syndromes. Pediatr Clin North Am 2010; 57:147.",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33400/abstract/61\">",
"       Bhatla D, Davies SM, Shenoy S, et al. Reduced-intensity conditioning is effective and safe for transplantation of patients with Shwachman-Diamond syndrome. Bone Marrow Transplant 2008; 42:159.",
"      </a>",
"     </li>",
"    </ol>",
"   </div>",
"   <div id=\"topicVersionRevision\">",
"    Topic 5914 Version 12.0",
"   </div>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"     Subscription and License Agreement",
"    </a>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.4 - C21.36",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      Southeast Alabama Med Ctr",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0603-189.41.172.26-18D72DAC39-S244013.14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
" <div id=\"leftPanel\">",
" </div>"].join("\n");
var script_f32_39_33400=[""].join("\n");
var outline_f32_39_33400=null;
var title_f32_39_33401="Stress urinary incontinence in women: Transobturator midurethral slings";
var content_f32_39_33401=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Stress urinary incontinence in women: Transobturator midurethral slings",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/39/33401/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/39/33401/contributors\">",
"     Charles W Nager, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/39/33401/contributors\">",
"     Jasmine Tan-Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/39/33401/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/39/33401/contributors\">",
"     Linda Brubaker, MD, FACS, FACOG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/39/33401/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/39/33401/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/39/33401/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 31, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H12261729\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stress urinary incontinence (SUI) affects 4 to 35 percent of women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. SUI occurs when an increase in intraabdominal pressure exceeds urethral closure pressure, resulting in the involuntary leakage of urine. This may occur with exertion, sneezing, or coughing [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Management options for SUI include conservative and surgical treatments. Midurethral slings are a relatively new treatment option, but have become the procedure of choice for many women. The first midurethral sling, introduced in 1996, was placed by passing trocars with mesh through the retropubic space [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/4\">",
"     4",
"    </a>",
"    ]. Retropubic midurethral slings are still commonly used, but transobturator slings were introduced in 2001 with the goal of avoiding some of the complications of retropubic insertion (eg, bladder perforation, vascular injury, bowel injury) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/5\">",
"     5",
"    </a>",
"    ]. Transobturator slings are placed by passing trocars with mesh through obturator canal and avoiding the retropubic space completely.",
"   </p>",
"   <p>",
"    Transobturator midurethral sling procedures are reviewed here. Retropubic midurethral slings and the approach to choosing a procedure for SUI in women are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=see_link\">",
"     \"Stress urinary incontinence in women: Retropubic midurethral slings\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/10/43177?source=see_link\">",
"     \"Stress urinary incontinence in women: Choosing a primary surgical procedure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/43/16055?source=see_link\">",
"     \"Stress urinary incontinence in women: Choosing a type of midurethral sling\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H941608\">",
"    <span class=\"h1\">",
"     TERMINOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several types of sling procedures for treatment of SUI in women. These procedures vary by the location of the sling and by the sling material. Collectively, these slings are referred to as suburethral slings, which is a sling that is inserted through a small vaginal incision and attached to another structure in the pelvis for the purpose of supporting the urethra. Suburethral slings may be either bladder neck and midurethral slings.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Midurethral sling &ndash; A suburethral sling that is placed at the level of the midurethra in a tension-free manner. These slings are made of synthetic mesh.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <strong>",
"       Retropubic midurethral slings",
"      </strong>",
"      (eg, tension-free vaginal tape [TVT]) are inserted through the retropubic space and exit through the abdominal wall in the suprapubic area (",
"      <a class=\"graphic graphic_figure graphicRef59114 \" href=\"mobipreview.htm?31/0/31744\">",
"       figure 1",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <strong>",
"       Transobturator midurethral slings",
"      </strong>",
"      are inserted through the two obturator foramens and exit through the skin of the groin area (",
"      <a class=\"graphic graphic_figure graphicRef52240 \" href=\"mobipreview.htm?31/43/32432\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      <strong>",
"       Single incision midurethral slings",
"      </strong>",
"      (eg, MiniArc) differ from full-length retropubic and transobturator slings in two ways: they are shorter (approximately 8 cm rather than 40 cm) and they require only a vaginal incision, and not an abdominal incision. Different types of these slings may be placed in a retropubic (anchored to the urogenital diaphragm) or transobturator fashion (anchored to the obturator internus muscle).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bladder neck sling &ndash; A suburethral sling that is placed at the level of the proximal urethra and bladder neck (",
"      <a class=\"graphic graphic_figure graphicRef76965 \" href=\"mobipreview.htm?15/42/16034\">",
"       figure 3",
"      </a>",
"      ). This procedure is usually performed using both vaginal and abdominal incisions. These slings can be made of either biologic materials (including the patient's own tissue) or synthetic mesh.",
"      <br/>",
"      <br/>",
"      Bladder neck slings are also referred to as proximal urethral slings. Alternatively, they are referred to as pubovaginal slings when the arms of the sling material are affixed to the anterior rectus fascia rather than the pubic bone or Cooper's ligament [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H941616\">",
"    <span class=\"h1\">",
"     MECHANISM OF ACTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Midurethral slings involve the introduction of a polypropylene tape (approximately 1 cm in width) covered in a plastic sheath beneath the midportion of the urethra. Transobturator slings, similar to their retropubic counterpart, function as a backboard, which offers resistance beneath the urethra during increases in intraabdominal pressure, but not at rest. Ultrasound data suggest that continence is achieved by compression of the urethra between the sling and the pubic symphysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/7,8\">",
"     7,8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In transobturator procedures, the sling traverses the skin in the groin, the obturator foramen, posterior to the adductor longus tendon, and a midurethral vaginal incision (",
"    <a class=\"graphic graphic_figure graphicRef52240 \" href=\"mobipreview.htm?31/43/32432\">",
"     figure 2",
"    </a>",
"    ). The sling lies under the midportion of the urethra at a less acute angle than the retropubic technique and is, therefore, thought to be less likely to cause obstruction [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/9\">",
"     9",
"    </a>",
"    ]. Once the plastic sheaths are removed, the tape is held in place without suture by its interface with the patient&rsquo;s tissue. The friction which initially secures the mesh is eventually reinforced with tissue fibrosis into the mesh. Porcine models demonstrate that 74 percent of the final strength has already been achieved by two weeks postoperatively and maximum strength of tissue in-growth into polypropylene mesh occurs at three months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H941728\">",
"    <span class=\"h1\">",
"     SURGICAL CANDIDATES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1196142\">",
"    <span class=\"h2\">",
"     Indications and special considerations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indications and special considerations are the same for transobturator as for retropubic midurethral slings. &nbsp;Indications for midurethral sling placement are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Symptomatic SUI",
"     </li>",
"     <li>",
"      Women who are planning repair of prolapse of the vaginal apex and who have known or suspected occult SUI",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Evaluating whether a woman with SUI is an appropriate candidate for surgical treatment, and a midurethral sling in particular, may depend upon additional factors (eg, intrinsic sphincter deficiency, age, obesity). The choice of anti-incontinence surgery in women with additional urinary function issues, obesity, and advanced age are discussed in detail separately.",
"   </p>",
"   <p>",
"    Indications and special considerations for women planning anti-incontinence surgery are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=see_link&amp;anchor=H25744285#H25744285\">",
"     \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Surgical candidates'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/10/43177?source=see_link&amp;anchor=H23#H23\">",
"     \"Stress urinary incontinence in women: Choosing a primary surgical procedure\", section on 'Urinary function issues'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/10/43177?source=see_link&amp;anchor=H26#H26\">",
"     \"Stress urinary incontinence in women: Choosing a primary surgical procedure\", section on 'Other patient characteristics'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1196420\">",
"    <span class=\"h2\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Contraindications to midurethral transobturator sling placement include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Current urinary tract infection",
"     </li>",
"     <li>",
"      Current pregnancy",
"     </li>",
"     <li>",
"      Anticoagulation",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Current pregnancy is an absolute contraindication to midurethral sling placement. Plans for future pregnancy are a relative contraindication. Since pelvic support may be disrupted during pregnancy, and particularly following a vaginal birth, most physicians recommend delaying surgical management of SUI until childbearing has been completed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/10/43177?source=see_link&amp;anchor=H5#H5\">",
"     \"Stress urinary incontinence in women: Choosing a primary surgical procedure\", section on 'Women finished with childbearing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Midurethral sling placement involves passing trocars through several tissue layers and may result in hematoma formation or hemorrhage. The risk of hematoma formation is probably more with retropubic approaches than with transobturator approaches, so women with bleeding diatheses (eg, Von Willebrand&rsquo;s) may be better served with administration of preoperative control measures (eg,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/60/10184?source=see_link\">",
"     desmopressin",
"    </a>",
"    ) and a transobturator approach.",
"   </p>",
"   <p>",
"    Preexisting synthetic mesh in the path of trocar placement may result in difficulty with proper sling placement, but a previous midurethral sling is not a contraindication to placement of another midurethral sling [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/11\">",
"     11",
"    </a>",
"    ]. Treatment of recurrent SUI is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/23/44409?source=see_link&amp;anchor=H19#H19\">",
"     \"Stress urinary incontinence in women: Persistent/recurrent symptoms after surgical treatment\", section on 'Midurethral sling'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1196365\">",
"    <span class=\"h1\">",
"     CHOOSING A TYPE OF TRANSOBTURATOR SLING",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two variations of transobturator midurethral sling procedures, which vary by direction of trocar insertion:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inside-out &ndash; The trocars are passed from a midurethral vaginal incision to exit through bilateral groin incisions (TVT Transobturator, often abbreviated as TVT-O).",
"     </li>",
"     <li>",
"      Outside-in &ndash; The trocars are passed from bilateral groin incisions to exit through a midurethral vaginal incision (Monarc, often abbreviated as TOT).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The two types of transobturator procedures appear to be equally effective and have similar complication rates. A meta-analysis of four randomized trials comparing the inside-out with the outside-in approach found no significant differences in subjective SUI cure rate (OR 1.37, 95% CI 0.93-2.00); objective cure rate (OR 1.06, 95% CI 0.65-1.73); voiding difficulty (OR 1.23, 95% CI 0.27-5.69); and de novo urgency symptoms (OR 0.98, 95% CI 0.42-2.31) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/12\">",
"     12",
"    </a>",
"    ]. However, this analysis was limited by insufficient statistical power.",
"   </p>",
"   <p>",
"    One disadvantage of the outside-in approach is that it results in a larger vaginal incision and has a higher rate of vaginal perforation (in a trial of 341 women, 17 versus 3 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/13\">",
"     13",
"    </a>",
"    ]), based upon data from randomized trials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/14\">",
"     14",
"    </a>",
"    ]. On the other hand, some data suggest that the inside-out approach is more likely to cause groin pain, but this finding has varied across studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. One possible explanation for a higher incidence of postoperative pain with the inside-out approach is based upon a cadaveric study, which found that the trocars of the TVT-O device were passed closer to nerves and vessels than the TOT [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In our practice, we perform the inside-out procedure, because it requires small incisions and is also easier to teach to trainees. However, the evidence is insufficient to recommend either the inside-out or outside-in approach.",
"   </p>",
"   <p>",
"    Choosing between retropubic, transobturator, and single incision midurethral slings is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/43/16055?source=see_link\">",
"     \"Stress urinary incontinence in women: Choosing a type of midurethral sling\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H941851\">",
"    <span class=\"h1\">",
"     PREOPERATIVE EVALUATION AND PREPARATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women who are planning primary midurethral transobturator sling placement should undergo preoperative evaluation to confirm the diagnosis of SUI, exclude other etiologies of urinary incontinence, and assess surgical risk.",
"   </p>",
"   <p>",
"    We recommend antibiotic prophylaxis for surgical site infection for midurethral sling placement.",
"   </p>",
"   <p>",
"    We suggest use of local or regional anesthesia rather than general anesthesia for midurethral sling placement. Local anesthesia may be combined with conscious sedation.",
"   </p>",
"   <p>",
"    Preoperative evaluation and preparation of women for midurethral sling placement are discussed in detail separately. &nbsp;(See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=see_link&amp;anchor=H297922#H297922\">",
"     \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Preoperative evaluation and preparation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12261820\">",
"    <span class=\"h1\">",
"     PROCEDURE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1198028\">",
"    <span class=\"h2\">",
"     Operative setting",
"    </span>",
"    &nbsp;&mdash;&nbsp;Midurethral sling placement is typically performed in an operating room as an outpatient procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1198035\">",
"    <span class=\"h2\">",
"     Anesthesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Midurethral sling placement may be performed under local, regional, or general anesthesia. We suggest use of local or regional anesthesia rather than general anesthesia, since general anesthesia has been associated with lower SUI cure rates in prospective studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Local anesthesia may be combined with conscious sedation. In addition, if local anesthesia is used, it should be administered to the vaginal incision site as well as the groin areas where the trocar and mesh will exit.",
"   </p>",
"   <p>",
"    Use of anesthesia for midurethral sling placement is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=see_link&amp;anchor=H579368#H579368\">",
"     \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Anesthesia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1198058\">",
"    <span class=\"h2\">",
"     Instrumentation",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Transobturator tape system &ndash; A polypropylene mesh tape (typically 40 cm long and 1 cm wide) covered by a plastic sheath and fixed to the helical trocars.",
"     </li>",
"     <li>",
"      Bladder (Foley) catheter (size 16 French)",
"     </li>",
"     <li>",
"      Cystoscope",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11396436\">",
"    <span class=\"h2\">",
"     Patient preparation",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Patient set-up",
"      </strong>",
"      &ndash; Position the patient in dorsal lithotomy with careful attention to avoid nerve compression. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/3/3129?source=see_link\">",
"       \"Nerve injury associated with pelvic surgery\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?3/3/3129?source=see_link&amp;anchor=H21#H21\">",
"       \"Nerve injury associated with pelvic surgery\", section on 'Prevention of nerve injury'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      Sterilely prepare and drape the patient. Insert the bladder catheter. The bladder should be completely drained prior to insertion of the trocars.",
"     </li>",
"     <li>",
"      <strong>",
"       Marking groin incisions",
"      </strong>",
"      - Mark the two planned groin exit points at the level of the clitoris, 2 cm lateral to the genitofemoral folds.",
"     </li>",
"     <li>",
"      <strong>",
"       Hydrodissection",
"      </strong>",
"      &ndash; Some surgeons hydrodissect the vaginal incision site",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      the path of the trocars. Either local anesthetic (with or without epinephrine) or sterile saline may be used. Fluid may be injected into the vaginal wall sub- and paraurethrally. Injection in the vaginal sulci through the vagina is another adaptation that has been reported; some surgeons aggressively hydrodissect the anterior vaginal sulci to displace the sulci posteriorly to theoretically reduce the risk of vaginal perforation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H281890\">",
"    <span class=\"h2\">",
"     Sling placement",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12261838\">",
"    <span class=\"h3\">",
"     Inside-out",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are multiple different products on the market that utilize similar techniques. The procedure described here is for the TVT Transobturator [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/19\">",
"     19",
"    </a>",
"    ]. The mean operative time for this procedure is 25 minutes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/20\">",
"     20",
"    </a>",
"    ]. A video of the procedure is included (",
"    <a class=\"graphic graphic_movie graphicRef65049 \" href=\"mobipreview.htm?30/3/30768\">",
"     movie 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Midurethral vaginal incision",
"      </strong>",
"      - Make a vaginal incision, 1 cm proximal to the urethral meatus and 1 to 1.5 cm in length to accommodate the width of the sling in the appropriate location. Place Allis clamps on the lateral edges of the incision to provide exposure by retracting the vaginal mucosa laterally.",
"      <br/>",
"      <br/>",
"      The inside-out technique may be performed with smaller incisions, since a finger does not need to be introduced into the tract, as it does for an outside-in technique.",
"     </li>",
"     <li>",
"      <strong>",
"       Dissecting the tract for the trocar and mesh",
"      </strong>",
"      &ndash; Use the Metzenbaum scissors to perform a minimal dissection lateral to the midurethra, between the vaginal mucosa and the pubocervical fascia. The scissors are aimed towards the obturator foramen behind the inferior pubic ramus.",
"      <br/>",
"      <br/>",
"      A winged guide (provided in the TVT Transobturator kit) can then be introduced into the tract to guide the trocars into the obturator region. Many surgeons use the winged guide to perforate the obturator membrane.",
"     </li>",
"     <li>",
"      <strong>",
"       Inserting the trocars",
"      </strong>",
"      &ndash; Insert the trocars through the obturator foramen, posterior and medial to the obturator vessels. The trocars traverse the periurethral endopelvic fascia, obturator internus muscle, obturator membrane, obturator externus muscle, and exit out through the skin. The trocar should pass just posterior to the adductor longus tendon.",
"      <br/>",
"      <br/>",
"      Trocars should be passed while hugging the pubic rami. The obturator canal (obturator nerve and vessels) is located at the opposite, anterolateral margin of the obturator foramen, approximately 3.5 to 4.0 cm lateral to the zone of safe needle passage [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/5\">",
"       5",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Exit through the marked groin incisions, 2 cm lateral to the genitofemoral folds at the level of the clitoris. The vaginal sulci are inspected to ensure that they have not been compromised.",
"     </li>",
"     <li>",
"      <strong>",
"       Cystourethroscopy",
"      </strong>",
"      &ndash; We suggest cystourethroscopy after both trocars have been placed. Although the risk of bladder perforation is lower than in retropubic sling procedures, bladder and urethral perforations have been reported for transobturator procedures. The morbidity of the urinary tract injury is reduced with intraoperative recognition and appropriate repositioning of the trocar. (See",
"      <a class=\"local\" href=\"#H492568\">",
"       'Bladder or urethral injury'",
"      </a>",
"      below.)",
"      <br/>",
"      <br/>",
"      A 70 degree cystoscope should be used and the bladder filled adequately to allow complete examination of the urethra and bladder surface [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Adjusting sling tension",
"      </strong>",
"      &ndash; To ensure that the sling is tension-free and does not compress the urethra while the patient is at rest, many surgeons insert an instrument (eg, Kelly clamp, needle driver, number 8 Hegar dilator) between the sling and the urethra while adjusting the sling tension.",
"      <br/>",
"      <br/>",
"      An intraoperative urinary (cough) stress test may be performed at this time if the patient is under local anesthesia. If leakage occurs, the sling is tightened slightly. Performing the urinary stress test during sling placement is discussed separately. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=see_link&amp;anchor=H579368#H579368\">",
"       \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Anesthesia'",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      With the spacer in place, remove the plastic sheaths; this prevents excess tightening of the mesh. The surgeon should assess the entire plastic sheath to confirm that it has been completely removed.",
"      <br/>",
"      <br/>",
"      Trim the mesh at the groin incisions. Mesh protrusion and irritation at the skin surface can be prevented by depressing the skin slightly to trim the mesh just below the skin surface. The mesh does not require suturing, since it is held in by friction and then fibrosis [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Closure of incisions",
"      </strong>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      <strong>",
"       Vaginal incision",
"      </strong>",
"      &ndash; At our institution, we close the vaginal mucosa with a horizontal mattress configuration to evert the incisional edges and theoretically reduce the risk of mesh exposure. We use an absorbable suture [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/21\">",
"       21",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Groin incisions",
"      </strong>",
"      &ndash; This can be performed in a variety of ways (suture, adhesive strips, surgical glue, no closure), based upon surgeon preference.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12261845\">",
"    <span class=\"h3\">",
"     Outside-in",
"    </span>",
"    &nbsp;&mdash;&nbsp;The unique steps of the outside-in are described in this section [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Midurethral vaginal incision",
"      </strong>",
"      - Make a vaginal incision, 1 cm proximal to the urethral meatus and 1 to 1.5 cm in length to accommodate the width of the sling and the surgeon&rsquo;s finger in the appropriate location. Place Allis clamps on the lateral edges of the incision to provide exposure by retracting the vaginal mucosa laterally.",
"     </li>",
"     <li>",
"      <strong>",
"       Dissecting the tract for the trocar and mesh",
"      </strong>",
"      &ndash; Use the Metzenbaum scissors to perform a dissection lateral to the midurethra, between the vaginal mucosa and the pubocervical fascia. The tract should be large enough that a finger can be introduced into it. The scissors are aimed towards the obturator foramen behind the inferior pubic ramus.",
"      <br/>",
"      <br/>",
"      The operator&rsquo;s finger is then placed into the tract created by the Metzenbaum scissors to the obturator foramen.",
"     </li>",
"     <li>",
"      <strong>",
"       Making groin incisions and inserting the trocars",
"      </strong>",
"      &ndash; Make incisions bilaterally, 2 cm lateral to the genitofemoral folds at the level of the clitoris.",
"      <br/>",
"      <br/>",
"      Pass the trocars through the groin incisions and rotate the trocars through the obturator membrane. The trocars traverse the skin, obturator externus muscle, obturator membrane, obturator internus muscle, periurethral endopelvic fascia, and out through the vaginal incision. The trocar should pass just posterior to the adductor longus tendon.",
"      <br/>",
"      <br/>",
"      A finger is placed via the vaginal incision through the tract to guide the trocars and avoid injury of the vaginal sulci. The trocars exit at the vaginal incision.",
"      <br/>",
"      <br/>",
"      The mesh is attached to the tips of the trocars and the trocars are backed out, bringing the mesh out through the level of the skin in the groin region.",
"      <br/>",
"      <br/>",
"      The vaginal sulci are inspected to ensure that they have not been compromised.",
"     </li>",
"     <li>",
"      <strong>",
"       Continue as for inside-out placement",
"      </strong>",
"      &ndash; Perform cystourethroscopy, and then continue with the subsequent steps of inside-out placement. (See",
"      <a class=\"local\" href=\"#H12261838\">",
"       'Inside-out'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H372844\">",
"    <span class=\"h2\">",
"     Postoperative voiding trial",
"    </span>",
"    &nbsp;&mdash;&nbsp;A voiding trial is performed prior to patient discharge or four to six hours after surgery, if an inpatient admission is planned. A voiding trial can be performed in two different ways: retrograde or spontaneous filling of the bladder. A discussion of the two types of bladder filling can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=see_link&amp;anchor=H22194879#H22194879\">",
"     \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Postoperative voiding trial'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12261852\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Transobturator insertion of midurethral slings was developed to avoid some of the complications of retropubic slings (eg, bladder perforation, vascular injury, bowel injury). This appears to have been largely successful and few serious or long-term complications have been reported following transobturator midurethral sling procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/22-25\">",
"     22-25",
"    </a>",
"    ]. Since transobturator slings were introduced several years after retropubic slings, however, there are fewer data regarding complications for this approach.",
"   </p>",
"   <p>",
"    Similar to retropubic slings, transobturator slings may result in voiding dysfunction. In addition, women who have undergone transobturator sling placement may experience groin pain, a complication that is not found with retropubic placement.",
"   </p>",
"   <p>",
"    Choosing between retropubic and transobturator midurethral sling procedures is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/43/16055?source=see_link&amp;anchor=H2822326#H2822326\">",
"     \"Stress urinary incontinence in women: Choosing a type of midurethral sling\", section on 'Transobturator versus retropubic midurethral slings'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H492448\">",
"    <span class=\"h2\">",
"     Urinary tract complications",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12261866\">",
"    <span class=\"h3\">",
"     Voiding dysfunction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Voiding dysfunction is commonly reported after midurethral sling placement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/26\">",
"     26",
"    </a>",
"    ]. The reported rate of voiding dysfunction following transobturator sling procedures is 4 to 11 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. The diagnostic criteria for voiding dysfunction vary across studies and institutions. In our practice, we define incomplete bladder emptying as a postvoid residual volume of &gt;150 ml.",
"   </p>",
"   <p>",
"    Postoperative voiding dysfunction is typically managed initially with bladder catheterization",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    urethral dilation. Urinary retention that persists for four to six weeks may require a release of the sling. In one study of 205 women who underwent transobturator sling placement, for example, 1.5 percent required sling release or urethrolysis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Evaluation and management of voiding dysfunction associated with midurethral sling procedures are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=see_link&amp;anchor=H4701484#H4701484\">",
"     \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Voiding dysfunction'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H493584\">",
"    <span class=\"h3\">",
"     Urinary urgency",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinary urge symptoms (eg, urgency, urge incontinence, frequency) develop in approximately 6 percent of women following transobturator midurethral sling placement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Evaluation and management of urinary urgency symptoms are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/14/29929?source=see_link\">",
"     \"Clinical presentation and diagnosis of urinary incontinence\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H492881\">",
"    <span class=\"h3\">",
"     Urinary tract infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrent urinary tract infection has been reported in some patients after midurethral sling placement (6.4 percent in one series of 117 women who underwent transobturator sling placement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/30\">",
"     30",
"    </a>",
"    ]) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/29,31\">",
"     29,31",
"    </a>",
"    ]. Urinary tract infection should be treated, as appropriate. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13561?source=see_link&amp;anchor=H899949198#H899949198\">",
"     \"Acute uncomplicated cystitis and pyelonephritis in women\", section on 'Treatment'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H492568\">",
"    <span class=\"h3\">",
"     Bladder or urethral injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bladder injury has been reported in 0 to 1 percent of women following transobturator sling placement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/25,28,32,33\">",
"     25,28,32,33",
"    </a>",
"    ]. Urethral injury is a rare, but potentially morbid, complication. Urethral perforation was reported in 2 of 2543 transobturator procedures in a voluntary registry study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/33\">",
"     33",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Evaluation and management of bladder or urethral injury associated with midurethral sling procedures are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=see_link&amp;anchor=H4700528#H4700528\">",
"     \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Bladder injury'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H492931\">",
"    <span class=\"h3\">",
"     Other urinary tract complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinary tract fistula is a rare, but serious, complication of midurethral sling placement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/34,35\">",
"     34,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Evaluation and management of urinary tract fistulas are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/47/44792?source=see_link\">",
"     \"Urogenital tract fistulas in women\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H492470\">",
"    <span class=\"h2\">",
"     Postoperative pain",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H373075\">",
"    <span class=\"h3\">",
"     Groin pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Groin pain occurs in approximately 12 to 16 percent of women following a transobturator sling procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/28,31,36\">",
"     28,31,36",
"    </a>",
"    ]. The pain is usually described as in the groin area as the patient abducts or adducts her legs. Usually the pain is deep within the muscle rather than superficial at the skin. The patient can usually feel this pain immediately after surgery and typically it improves over time.",
"   </p>",
"   <p>",
"    Some data suggest that obesity may be protective against postoperative groin pain. In one study of 226 women who underwent transobturator sling procedures,",
"    <span class=\"nowrap\">",
"     hip/proximal",
"    </span>",
"    lower extremity pain was 2.5 times more likely to develop in women with a normal body mass index (18.5 to 24.9) than in obese women (&ge;30) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In most cases, postoperative groin pain resolves within a few days to weeks, and pain can be managed with application of ice to the site, nonsteroidal antiinflammatory medications, short-term oral narcotics, or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    Persistent pain occurs in some women and may warrant additional measures. Local injection with steroids and anesthetic agents has been proposed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/37\">",
"     37",
"    </a>",
"    ]. In patients in whom groin pain persists for six or more weeks, sling release may be required. Patients should be counseled that removal of all or part of the mesh may result in recurrent SUI. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=see_link&amp;anchor=H4702658#H4702658\">",
"     \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Sling release'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    Some data suggest that groin pain is more likely following inside-out placement of the sling. (See",
"    <a class=\"local\" href=\"#H1196365\">",
"     'Choosing a type of transobturator sling'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H492485\">",
"    <span class=\"h3\">",
"     Dyspareunia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dyspareunia has been reported in 1 to 9 percent of women following transobturator sling placement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/25,38\">",
"     25,38",
"    </a>",
"    ]. In a prospective trial of 300 women who underwent transobturator sling placement, 4 (1.3 percent) reported dyspareunia; all 4 were managed with sling release and had complete resolution of their complaints and no recurrence of incontinence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H493238\">",
"    <span class=\"h2\">",
"     Vaginal injury",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H373082\">",
"    <span class=\"h3\">",
"     Vaginal mesh erosion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mesh exposure, also known as erosion, is a common complication when synthetic mesh is used for surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/39-41\">",
"     39-41",
"    </a>",
"    ]. There are few data about the incidence of mesh erosion through the vaginal mucosa following transobturator midurethral sling placement. In one series in which 157 women underwent transobturator sling placement (TVT Obturator or Aris), at 26-month follow-up, 0 to 4 percent had experienced vaginal mesh erosion [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis of mesh erosion is made with visual inspection of the vagina. Evaluation and management of vaginal mesh erosion are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=see_link&amp;anchor=H3907598#H3907598\">",
"     \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Vaginal mesh erosion'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    Erosion of mesh into the bladder or urethra is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=see_link&amp;anchor=H4700528#H4700528\">",
"     \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Bladder injury'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=see_link&amp;anchor=H4701082#H4701082\">",
"     \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Urethral injury'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=see_link&amp;anchor=H3907444#H3907444\">",
"     \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Bowel injury'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H493332\">",
"    <span class=\"h3\">",
"     Vaginal perforation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vaginal perforation has been reported in 0.4 to 1.3 percent of women in studies of 500 or more transobturator procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/33,43\">",
"     33,43",
"    </a>",
"    ]. There is an increased risk of vaginal perforation with the transobturator slings compared to retropubic slings because the course of the sling is flatter and closer to the anterior vaginal fornices. In the Trial of Midurethral Slings (TOMUS) (n = 597; the largest randomized trial comparing retropubic and midurethral slings to-date), more vaginal perforations occurred in the transobturator sling group (4 versus 2 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/20\">",
"     20",
"    </a>",
"    ]. In women undergoing transobturator sling placement, the outside-in procedure appears to be associated with a greater risk of vaginal perforation. (See",
"    <a class=\"local\" href=\"#H1196365\">",
"     'Choosing a type of transobturator sling'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The vaginal sulci should be inspected and palpated after insertion of the trocars. If a perforation is identified, we remove the trocar and replace the trocar in the appropriate position; sometimes this requires closure of the vaginal perforation defect.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H493095\">",
"    <span class=\"h2\">",
"     Vascular injury",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vascular injury is uncommon during transobturator sling placement. Injury to the obturator, external iliac, femoral, or inferior epigastric vessels may occur. Vascular injury may result in hematoma formation (1 of 2543 women required reoperation for a retropubic hematoma in a registry study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/33\">",
"     33",
"    </a>",
"    ]) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/44-47\">",
"     44-47",
"    </a>",
"    ] or hemorrhage (0 to 3 percent of procedures) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/33,48\">",
"     33,48",
"    </a>",
"    ]. Rarely, a vascular injury is associated with nerve injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Evaluation and management of vascular injury during midurethral sling procedures are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=see_link&amp;anchor=H4700557#H4700557\">",
"     \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Vascular injury'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H373089\">",
"    <span class=\"h2\">",
"     Other complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rare complications that have been described include necrotizing fasciitis, abscess, and myositis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/49-53\">",
"     49-53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H372937\">",
"    <span class=\"h1\">",
"     FOLLOW-UP",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H372944\">",
"    <span class=\"h2\">",
"     Postoperative care and instructions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women may experience vaginal, periurethral, or lower abdominal discomfort and pain at incision sites for up to two weeks following the procedure. These symptoms are typically well controlled with oral narcotics and non-steroidal antiinflammatory drugs. Many women also have vaginal spotting for up to two weeks.",
"   </p>",
"   <p>",
"    We counsel patients to call their surgeon if they experience symptoms that may be associated with a serious complication, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Fever",
"     </li>",
"     <li>",
"      Heavy vaginal bleeding",
"     </li>",
"     <li>",
"      Light-headedness",
"     </li>",
"     <li>",
"      Severe or persistent abdominal pain",
"     </li>",
"     <li>",
"      Vomiting or persistent nausea",
"     </li>",
"     <li>",
"      Discharge of clear fluid or blood from the incision sites that is copious or persistent or any amount of purulent or feculent discharge",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients who present with these symptoms should be promptly evaluated.",
"   </p>",
"   <p>",
"    Urinary retention may occur even after a successful postoperative voiding trial. Patients who feel a persistent sense of urinary retention or incomplete bladder emptying should have postvoid residual volume measured and may require catheterization. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=see_link&amp;anchor=H22194935#H22194935\">",
"     \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Postoperative catheter management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The sling is initially held in place by solely frictional tissue forces, and patients must allow adequate time for tissue in-growth to occur before significant intraabdominal pressure is applied to the mesh. Patients are advised to avoid heavy lifting, actions that increase intraabdominal pressure, or exercise for at least two to four weeks. Ambulation, however, is encouraged. Sexual activity should be avoided until the vaginal epithelium is healed, which takes approximately four to six weeks.",
"   </p>",
"   <p>",
"    The patient may return to work when she feels sufficiently comfortable.",
"   </p>",
"   <p>",
"    We see patients for a routine follow-up visit at four to six weeks. We perform abdominal and vaginal examinations to ensure that the incisions have adequately healed and to check for vaginal mesh erosion. The vaginal sulci are visualized and palpated to confirm that there are no occult extrusions of mesh. We check a postvoid residual volume to assess whether the patient has been adequately emptying her bladder. This can be measured with a bladder ultrasound or catheterization.",
"   </p>",
"   <p>",
"    Patient information regarding care after pelvic surgery can be found separately. (See",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/27/28083?source=see_link\">",
"     \"Patient information: Care after gynecologic surgery (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H372951\">",
"    <span class=\"h2\">",
"     Subsequent pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since pelvic support may be disrupted during pregnancy, and particularly following a vaginal birth, most physicians recommend delaying midurethral sling placement until childbearing has been completed. Pregnancy following midurethral sling placement is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=see_link&amp;anchor=H298966#H298966\">",
"     \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Subsequent pregnancy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H941767\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"    &nbsp;&mdash;&nbsp;A meta-analysis of 17 randomized trials found subjective SUI cure rates of 73 percent for transobturator midurethral sling procedures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/28\">",
"     28",
"    </a>",
"    ]. In the Trial of Midurethral Slings (TOMUS) (n = 597; the largest randomized trial comparing retropubic and transobturator slings to-date), for retropubic slings, the 12-month subjective success rate was 56 percent and the objective cure rate 81 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33401/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, and answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon. (See",
"    <a class=\"medical medical_basics\" href=\"mobipreview.htm?22/8/22658?source=see_link\">",
"     \"Patient information: Urinary incontinence (The Basics)\"",
"    </a>",
"    and",
"    <a class=\"medical medical_patient\" href=\"mobipreview.htm?19/19/19764?source=see_link\">",
"     \"Patient information: Urinary incontinence treatments for women (Beyond the Basics)\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12261895\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Stress urinary incontinence (SUI) is the involuntary leakage of urine with increased intraabdominal pressure. Midurethral sling placement is the procedure of choice for treatment of SUI in many women. Midurethral sling can be placed either through the retropubic or transobturator spaces. (See",
"      <a class=\"local\" href=\"#H12261729\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Contraindications for transobturator midurethral sling placement include current pregnancy or urinary tract infection. Plans for a future pregnancy are a relative contraindication. (See",
"      <a class=\"local\" href=\"#H1196420\">",
"       'Contraindications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are two variations of transobturator midurethral sling procedures: inside-out (trocars are passed from a midurethral vaginal incision to exit through bilateral groin incisions) and outside-in (trocars are passed from bilateral groin incisions to exit through a midurethral vaginal incision). The evidence is insufficient to recommend the choice of one of these procedures rather than the other, and surgeons should use the procedure with which they are most comfortable. (See",
"      <a class=\"local\" href=\"#H1196365\">",
"       'Choosing a type of transobturator sling'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"     <li>",
"      Women who are planning primary midurethral transobturator sling placement should undergo preoperative evaluation to confirm the diagnosis of SUI, exclude other etiologies of urinary incontinence, and assess surgical risk. (See",
"      <a class=\"local\" href=\"#H941851\">",
"       'Preoperative evaluation and preparation'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?16/58/17319?source=see_link\">",
"       \"Stress urinary incontinence in women: Preoperative evaluation for a primary procedure\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We recommend antibiotic prophylaxis for surgical site infection for midurethral sling placement (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=see_link&amp;anchor=H297929#H297929\">",
"       \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Antibiotic prophylaxis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      We suggest use of local anesthesia with conscious sedation or regional anesthesia rather than general anesthesia for midurethral sling placement (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). General anesthesia may be used if it is strongly preferred by the patient or if it is required for a concomitant procedure. (See",
"      <a class=\"local\" href=\"#H941851\">",
"       'Preoperative evaluation and preparation'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=see_link&amp;anchor=H579368#H579368\">",
"       \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Anesthesia'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Common complications of midurethral transobturator sling placement include voiding dysfunction, mesh erosion, or groin pain. (See",
"      <a class=\"local\" href=\"#H12261852\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Voiding dysfunction following sling placement may be treated initially with bladder catheterization or urethral dilation. Persistent symptoms may require sling release, which may result in recurrent SUI. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=see_link&amp;anchor=H22194935#H22194935\">",
"       \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Postoperative catheter management'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=see_link&amp;anchor=H4702658#H4702658\">",
"       \"Stress urinary incontinence in women: Retropubic midurethral slings\", section on 'Sling release'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Long-term data show an SUI cure rate of approximately 73 percent following transobturator midurethral sling placement. (See",
"      <a class=\"local\" href=\"#H941767\">",
"       'Outcome'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/1\">",
"      Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 2010; 29:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/2\">",
"      Luber KM. The definition, prevalence, and risk factors for stress urinary incontinence. Rev Urol 2004; 6 Suppl 3:S3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/3\">",
"      Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003; 61:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/4\">",
"      Ulmsten U, Henriksson L, Johnson P, Varhos G. An ambulatory surgical procedure under local anesthesia for treatment of female urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 1996; 7:81.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/5\">",
"      Delorme E. [Transobturator urethral suspension: mini-invasive procedure in the treatment of stress urinary incontinence in women]. Prog Urol 2001; 11:1306.",
"     </a>",
"    </li>",
"    <li>",
"     Walters, MD, Karram, MM. Sling procedures for stress urinary incontinence. In: Urogynecology and Reconstructive Pelvic Surgery, 3rd ed, Mosby Elsevier, Philadelphia 2007. p. 197.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/7\">",
"      Sarlos D, Kuronen M, Schaer GN. How does tension-free vaginal tape correct stress incontinence? investigation by perineal ultrasound. Int Urogynecol J Pelvic Floor Dysfunct 2003; 14:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/8\">",
"      Dietz HP, Wilson PD. The 'iris effect': how two-dimensional and three-dimensional ultrasound can help us understand anti-incontinence procedures. Ultrasound Obstet Gynecol 2004; 23:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/9\">",
"      Whiteside JL, Walters MD. Anatomy of the obturator region: relations to a trans-obturator sling. Int Urogynecol J Pelvic Floor Dysfunct 2004; 15:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/10\">",
"      Majercik S, Tsikitis V, Iannitti DA. Strength of tissue attachment to mesh after ventral hernia repair with synthetic composite mesh in a porcine model. Surg Endosc 2006; 20:1671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/11\">",
"      Liapis A, Bakas P, Creatsas G. Tension-free vaginal tape in the management of recurrent urodynamic stress incontinence after previous failed midurethral tape. Eur Urol 2009; 55:1450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/12\">",
"      Latthe PM, Singh P, Foon R, Toozs-Hobson P. Two routes of transobturator tape procedures in stress urinary incontinence: a meta-analysis with direct and indirect comparison of randomized trials. BJU Int 2010; 106:68.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/13\">",
"      Abdel-Fattah M, Ramsay I, Pringle S, et al. Randomised prospective single-blinded study comparing 'inside-out' versus 'outside-in' transobturator tapes in the management of urodynamic stress incontinence: 1-year outcomes from the E-TOT study. BJOG 2010; 117:870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/14\">",
"      But I, Faganelj M. Complications and short-term results of two different transobturator techniques for surgical treatment of women with urinary incontinence: a randomized study. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:857.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/15\">",
"      Liapis A, Bakas P, Creatsas G. Monarc vs TVT-O for the treatment of primary stress incontinence: a randomized study. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/16\">",
"      Zahn CM, Siddique S, Hernandez S, Lockrow EG. Anatomic comparison of two transobturator tape procedures. Obstet Gynecol 2007; 109:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/17\">",
"      Duckett JR, Patil A, Papanikolaou NS. Predicting early voiding dysfunction after tension-free vaginal tape. J Obstet Gynaecol 2008; 28:89.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/18\">",
"      Koops SE, Bisseling TM, van Brummen HJ, et al. What determines a successful tension-free vaginal tape? A prospective multicenter cohort study: results from The Netherlands TVT database. Am J Obstet Gynecol 2006; 194:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/19\">",
"      de Leval J. Novel surgical technique for the treatment of female stress urinary incontinence: transobturator vaginal tape inside-out. Eur Urol 2003; 44:724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/20\">",
"      Richter HE, Albo ME, Zyczynski HM, et al. Retropubic versus transobturator midurethral slings for stress incontinence. N Engl J Med 2010; 362:2066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/21\">",
"      Giri SK, Sil D, Narasimhulu G, et al. Management of vaginal extrusion after tension-free vaginal tape procedure for urodynamic stress incontinence. Urology 2007; 69:1077.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/22\">",
"      Daneshgari F, Kong W, Swartz M. Complications of mid urethral slings: important outcomes for future clinical trials. J Urol 2008; 180:1890.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/23\">",
"      Long CY, Hsu CS, Wu MP, et al. Comparison of tension-free vaginal tape and transobturator tape procedure for the treatment of stress urinary incontinence. Curr Opin Obstet Gynecol 2009; 21:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/24\">",
"      Tahseen S, Reid PC, Charan P. Short-term complications of the trans-obturator foramen procedure for urinary stress incontinence. J Obstet Gynaecol 2007; 27:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/25\">",
"      Kaelin-Gambirasio I, Jacob S, Boulvain M, et al. Complications associated with transobturator sling procedures: analysis of 233 consecutive cases with a 27 months follow-up. BMC Womens Health 2009; 9:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/26\">",
"      Klutke C, Siegel S, Carlin B, et al. Urinary retention after tension-free vaginal tape procedure: incidence and treatment. Urology 2001; 58:697.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/27\">",
"      Morey AF, Medendorp AR, Noller MW, et al. Transobturator versus transabdominal mid urethral slings: a multi-institutional comparison of obstructive voiding complications. J Urol 2006; 175:1014.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/28\">",
"      Ogah J, Cody JD, Rogerson L. Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev 2009; :CD006375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/29\">",
"      Barber MD, Gustilo-Ashby AM, Chen CC, et al. Perioperative complications and adverse events of the MONARC transobturator tape, compared with the tension-free vaginal tape. Am J Obstet Gynecol 2006; 195:1820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/30\">",
"      Groutz A, Levin I, Gold R, et al. \"Inside-out\" transobturator tension-free vaginal tape for management of occult stress urinary incontinence in women undergoing pelvic organ prolapse repair. Urology 2010; 76:1358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/31\">",
"      Laurikainen E, Valpas A, Kivel&auml; A, et al. Retropubic compared with transobturator tape placement in treatment of urinary incontinence: a randomized controlled trial. Obstet Gynecol 2007; 109:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/32\">",
"      Abdel-Fattah M, Ramsay I, Pringle S. Lower urinary tract injuries after transobturator tape insertion by different routes: a large retrospective study. BJOG 2006; 113:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/33\">",
"      Tamussino K, Hanzal E, K&ouml;lle D, et al. Transobturator tapes for stress urinary incontinence: Results of the Austrian registry. Am J Obstet Gynecol 2007; 197:634.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/34\">",
"      Jasaitis Y, Sergent F, Tanneau Y, Marpeau L. [Vesicovaginal fistula after transobturator tape]. Prog Urol 2007; 17:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/35\">",
"      Starkman JS, Meints L, Scarpero HM, Dmochowski RR. Vesicovaginal fistula following a transobturator midurethral sling procedure. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/36\">",
"      Cadish LA, Hacker MR, Dodge LE, et al. Association of body mass index with hip and thigh pain following transobturator midurethral sling placement. Am J Obstet Gynecol 2010; 203:508.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/37\">",
"      Roth TM. Management of persistent groin pain after transobturator slings. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:1371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/38\">",
"      Neuman M. TVT-obturator: short-term data on an operative procedure for the cure of female stress urinary incontinence performed on 300 patients. Eur Urol 2007; 51:1083.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/39\">",
"      Kobashi KC, Govier FE. Management of vaginal erosion of polypropylene mesh slings. J Urol 2003; 169:2242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/40\">",
"      Mesens T, Aich A, Bhal PS. Late erosions of mid-urethral tapes for stress urinary incontinence--need for long-term follow-up? Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:1113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/41\">",
"      Wijffels SA, Elzevier HW, Lycklama a Nijeholt AA. Transurethral mesh resection after urethral erosion of tension-free vaginal tape: report of three cases and review of literature. Int Urogynecol J Pelvic Floor Dysfunct 2009; 20:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/42\">",
"      Abouassaly R, Steinberg JR, Lemieux M, et al. Complications of tension-free vaginal tape surgery: a multi-institutional review. BJU Int 2004; 94:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/43\">",
"      Collinet P, Ciofu C, Costa P, et al. The safety of the inside-out transobturator approach for transvaginal tape (TVT-O) treatment in stress urinary incontinence: French registry data on 984 women. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:711.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/44\">",
"      Atassi Z, Reich A, Rudge A, et al. Haemorrhage and nerve damage as complications of TVT-O procedure: case report and literature review. Arch Gynecol Obstet 2008; 277:161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/45\">",
"      Rajan S, Kohli N. Retropubic hematoma after transobturator sling procedure. Obstet Gynecol 2005; 106:1199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/46\">",
"      Huffaker RK, Copas P. Blood loss in the space of Retzius and pelvis with tension-free vaginal tape and trans-obturator tape procedures. Tenn Med 2006; 99:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/47\">",
"      Sun MJ, Chen GD, Lin KC. Obturator hematoma after the transobturator suburethral tape procedure. Obstet Gynecol 2006; 108:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/48\">",
"      Mellier G, Mistrangelo E, Gery L, et al. Tension-free obturator tape (Monarc Subfascial Hammock) in patients with or without associated procedures. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/49\">",
"      Rardin CR, Moore R, Ward RM, Myers DL. Recurrent thigh abscess with necrotizing fasciitis from a retained transobturator sling segment. J Minim Invasive Gynecol 2009; 16:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/50\">",
"      Zumb&eacute; J, Porres D, Degiorgis PL, Wyler S. Obturator and thigh abscess after transobturator tape implantation for stress urinary incontinence. Urol Int 2008; 81:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/51\">",
"      Leanza V, Garozzo V, Accardi M, et al. A late complication of transobturator tape: abscess and myositis. Minerva Ginecol 2008; 60:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/52\">",
"      DeSouza R, Shapiro A, Westney OL. Adductor brevis myositis following transobturator tape procedure: a case report and review of the literature. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33401/abstract/53\">",
"      Lee SY, Kim JY, Park SJ, et al. Bilateral recurrent thigh abscesses for five years after a transobturator tape implantation for stress urinary incontinence. Korean J Urol 2010; 51:657.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14218 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-67CE5B8581-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_39_33401=[""].join("\n");
var outline_f32_39_33401=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12261895\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12261729\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H941608\">",
"      TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H941616\">",
"      MECHANISM OF ACTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H941728\">",
"      SURGICAL CANDIDATES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1196142\">",
"      Indications and special considerations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1196420\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1196365\">",
"      CHOOSING A TYPE OF TRANSOBTURATOR SLING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H941851\">",
"      PREOPERATIVE EVALUATION AND PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12261820\">",
"      PROCEDURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1198028\">",
"      Operative setting",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1198035\">",
"      Anesthesia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1198058\">",
"      Instrumentation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11396436\">",
"      Patient preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H281890\">",
"      Sling placement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12261838\">",
"      - Inside-out",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12261845\">",
"      - Outside-in",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H372844\">",
"      Postoperative voiding trial",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12261852\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H492448\">",
"      Urinary tract complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12261866\">",
"      - Voiding dysfunction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H493584\">",
"      - Urinary urgency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H492881\">",
"      - Urinary tract infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H492568\">",
"      - Bladder or urethral injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H492931\">",
"      - Other urinary tract complications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H492470\">",
"      Postoperative pain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H373075\">",
"      - Groin pain",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H492485\">",
"      - Dyspareunia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H493238\">",
"      Vaginal injury",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H373082\">",
"      - Vaginal mesh erosion",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H493332\">",
"      - Vaginal perforation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H493095\">",
"      Vascular injury",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H373089\">",
"      Other complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H372937\">",
"      FOLLOW-UP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H372944\">",
"      Postoperative care and instructions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H372951\">",
"      Subsequent pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H941767\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12261895\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/14218\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/14218|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?31/0/31744\" title=\"figure 1\">",
"      Location of retropubic midurethral sling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?31/43/32432\" title=\"figure 2\">",
"      Location of transobturator midurethral sling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?15/42/16034\" title=\"figure 3\">",
"      Sling placement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/14218|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"mobipreview.htm?30/3/30768\" title=\"movie 1\">",
"      Midurethral transobturator sling",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/15/13561?source=related_link\">",
"      Acute uncomplicated cystitis and pyelonephritis in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/14/29929?source=related_link\">",
"      Clinical presentation and diagnosis of urinary incontinence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/3/3129?source=related_link\">",
"      Nerve injury associated with pelvic surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?27/27/28083?source=related_link\">",
"      Patient information: Care after gynecologic surgery (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?22/8/22658?source=related_link\">",
"      Patient information: Urinary incontinence (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?19/19/19764?source=related_link\">",
"      Patient information: Urinary incontinence treatments for women (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/10/43177?source=related_link\">",
"      Stress urinary incontinence in women: Choosing a primary surgical procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/43/16055?source=related_link\">",
"      Stress urinary incontinence in women: Choosing a type of midurethral sling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/23/44409?source=related_link\">",
"      Stress urinary incontinence in women: Persistent/recurrent symptoms after surgical treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/58/17319?source=related_link\">",
"      Stress urinary incontinence in women: Preoperative evaluation for a primary procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/49/33562?source=related_link\">",
"      Stress urinary incontinence in women: Retropubic midurethral slings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/47/44792?source=related_link\">",
"      Urogenital tract fistulas in women",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_39_33402="Evaluation and management of elevated intracranial pressure in adults";
var content_f32_39_33402=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Evaluation and management of elevated intracranial pressure in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/39/33402/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/39/33402/contributors\">",
"     Edward R Smith, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/39/33402/contributors\">",
"     Sepideh Amin-Hanjani, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/39/33402/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/39/33402/contributors\">",
"     Michael J Aminoff, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?32/39/33402/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?32/39/33402/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?32/39/33402/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 29, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevated intracranial pressure (ICP) is a potentially devastating complication of neurologic injury. Elevated ICP may complicate trauma, central nervous system (CNS) tumors, hydrocephalus, hepatic encephalopathy, and impaired CNS venous outflow (",
"    <a class=\"graphic graphic_table graphicRef69683 \" href=\"mobipreview.htm?8/25/8603\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/1\">",
"     1",
"    </a>",
"    ]. Successful management of patients with elevated ICP requires prompt recognition, the judicious use of invasive monitoring, and therapy directed at both reducing ICP and reversing its underlying cause.",
"   </p>",
"   <p>",
"    The evaluation and management of adult patients with elevated ICP will be reviewed here. Elevated intracranial pressure in children and specific causes and complications of elevated ICP (eg, ischemic stroke, intracerebral hemorrhage, traumatic brain injury) are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44633?source=see_link\">",
"     \"Elevated intracranial pressure in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/2/35882?source=see_link&amp;anchor=H15#H15\">",
"     \"Management of acute severe traumatic brain injury\", section on 'Intracranial pressure'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/29/33242?source=see_link\">",
"     \"Initial assessment and management of acute stroke\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/56/32650?source=see_link&amp;anchor=H16#H16\">",
"     \"Spontaneous intracerebral hemorrhage: Prognosis and treatment\", section on 'Intracranial pressure control'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/54/37738?source=see_link&amp;anchor=H24#H24\">",
"     \"Treatment of aneurysmal subarachnoid hemorrhage\", section on 'Management of complications'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intracranial pressure is normally &le;15 mmHg in adults, and pathologic intracranial hypertension (ICH) is present at pressures &ge;20 mmHg. ICP is normally lower in children than adults, and may be subatmospheric in newborns [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/2\">",
"     2",
"    </a>",
"    ]. Homeostatic mechanisms stabilize ICP, with occasional transient elevations associated with physiologic events, including sneezing, coughing, or Valsalva maneuvers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Intracranial components",
"    </span>",
"    &nbsp;&mdash;&nbsp;In adults, the intracranial compartment is protected by the skull, a rigid structure with a fixed internal volume of 1400 to 1700 mL. Under physiologic conditions, the intracranial contents include (by volume) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Brain parenchyma &mdash; 80 percent",
"     </li>",
"     <li>",
"      Cerebrospinal fluid &mdash; 10 percent",
"     </li>",
"     <li>",
"      Blood &mdash; 10 percent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pathologic structures, including mass lesions, abscesses, and hematomas also may be present within the intracranial compartment. Since the overall volume of the cranial vault cannot change, an increase in the volume of one component, or the presence of pathologic components, necessitates the displacement of other structures, an increase in ICP, or both. Thus, ICP is a function of the volume and compliance of each component of the intracranial compartment, an interrelationship known as the Monro-Kellie doctrine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/4,5\">",
"     4,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The volume of brain parenchyma is relatively constant in adults, although it can be altered by mass lesions or in the setting of cerebral edema (",
"    <a class=\"graphic graphic_figure graphicRef65853 \" href=\"mobipreview.htm?25/36/26190\">",
"     figure 1",
"    </a>",
"    ). The volumes of CSF and blood in the intracranial space vary to a greater degree. Abnormal increases in the volume of any component may lead to elevations in ICP.",
"   </p>",
"   <p>",
"    CSF is produced by the choroid plexus and elsewhere in the central nervous system (CNS) at a rate of approximately 20",
"    <span class=\"nowrap\">",
"     mL/h",
"    </span>",
"    (500",
"    <span class=\"nowrap\">",
"     mL/day)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/6\">",
"     6",
"    </a>",
"    ]. CSF is normally resorbed via the arachnoid granulations into the venous system. Problems with CSF regulation generally result from impaired outflow caused by ventricular obstruction or venous congestion; the latter can occur in patients with sagittal (or other) venous sinus thrombosis. Much less frequently, CSF production can become pathologically increased; this may be seen in the setting of choroid plexus papilloma. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/10/17576?source=see_link\">",
"     \"Cerebrospinal fluid: Physiology and utility of an examination in disease states\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Cerebral blood flow (CBF) determines the volume of blood in the intracranial space. CBF increases with hypercapnia and hypoxia. Other determinants of CBF are discussed below. Autoregulation of CBF may be impaired in the setting of neurologic injury, and may result in rapid and severe brain swelling, especially in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/7-9\">",
"     7-9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In summary, the major causes of increased intracranial pressure include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Intracranial mass lesions (eg, tumor, hematoma)",
"     </li>",
"     <li>",
"      Cerebral edema (such as in acute hypoxic ischemic encephalopathy, large cerebral infarction, severe traumatic brain injury)",
"     </li>",
"     <li>",
"      Increased cerebrospinal fluid (CSF) production, eg, choroid plexus papilloma",
"     </li>",
"     <li>",
"      Decreased CSF absorption, eg, arachnoid granulation adhesions after bacterial meningitis",
"     </li>",
"     <li>",
"      Obstructive hydrocephalus",
"     </li>",
"     <li>",
"      Obstruction of venous outflow, eg, venous sinus thrombosis, jugular vein compression, neck surgery",
"     </li>",
"     <li>",
"      Idiopathic intracranial hypertension (pseudotumor cerebri)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Intracranial compliance",
"    </span>",
"    &nbsp;&mdash;&nbsp;The interrelationship between changes in the volume of intracranial contents and changes in ICP defines the compliance characteristics of the intracranial compartment. Intracranial compliance can be modeled mathematically (as in other physiologic and mechanical systems) as the change in volume over the change in pressure",
"    <span class=\"nowrap\">",
"     (dV/dP).",
"    </span>",
"   </p>",
"   <p>",
"    The",
"    compliance relationship is nonlinear, and compliance decreases as the combined volume of the intracranial contents increases. Initially, compensatory mechanisms allow volume to increase with minimal elevation in ICP. These mechanisms include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Displacement of CSF into the thecal sac",
"     </li>",
"     <li>",
"      Decrease in the volume of the cerebral venous blood via venoconstriction and extracranial drainage",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, when these compensatory mechanisms have been exhausted, significant increases in pressure develop with small increases in volume, leading to abnormally elevated ICP (",
"    <a class=\"graphic graphic_figure graphicRef54602 \" href=\"mobipreview.htm?35/62/36844\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Thus, the magnitude of the change in volume of an individual structure determines its effect on ICP. In addition, the rate of change in the volume of the intracranial contents influences ICP. Changes that occur slowly produce less of an effect than those that are rapid. This can be recognized clinically in some patients who present with large meningiomas and minimally elevated or normal ICP. Conversely, other patients may experience symptomatic elevations in ICP from small hematomas that develop acutely.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Cerebral blood flow",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following a significant increase in ICP, brain injury can result from brainstem compression",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a reduction in cerebral blood flow (CBF). CBF is a function of the pressure drop across the cerebral circulation divided by the cerebrovascular resistance, as predicted by Ohm's law [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/10\">",
"     10",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    &nbsp;CBF = (CAP - JVP) &divide; CVR",
"   </p>",
"   <p>",
"    where CAP is carotid arterial pressure, JVP is jugular venous pressure, and CVR is cerebrovascular resistance.",
"   </p>",
"   <p>",
"    Cerebral perfusion pressure (CPP) is a clinical surrogate for the adequacy of cerebral perfusion. CPP is defined as mean arterial pressure (MAP) minus ICP.",
"   </p>",
"   <p>",
"    &nbsp;CPP = MAP - ICP",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Autoregulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;CBF is normally maintained at a relatively constant level by cerebrovascular autoregulation of CVR over a wide range of CPP (50 to 100 mmHg) (",
"    <a class=\"graphic graphic_figure graphicRef57676 \" href=\"mobipreview.htm?33/13/34013\">",
"     figure 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. However, autoregulation of CVR can become dysfunctional in certain pathologic states, most notably stroke or trauma. In this setting, the brain becomes exquisitely sensitive to even minor changes in CPP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/11-13\">",
"     11-13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Another important consideration is that the set-point of autoregulation is also changed in patients with chronic hypertension. With mild to moderate elevations in blood pressure, the initial response is arterial and arteriolar vasoconstriction. This autoregulatory process both maintains tissue perfusion at a relatively constant level and prevents the increase in pressure from being transmitted to the smaller, more distal vessels [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/11\">",
"     11",
"    </a>",
"    ]. As a result, acute reductions in blood pressure, even if the final value remains within the normal range, can produce ischemic symptoms in patients with chronic hypertension (",
"    <a class=\"graphic graphic_figure graphicRef57676 \" href=\"mobipreview.htm?33/13/34013\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Cerebral perfusion pressure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conditions associated with elevated ICP, including mass lesions and hydrocephalus, can be associated with a reduction in CPP. This can result in devastating focal or global ischemia. On the other hand, excessive elevation of CPP can lead to hypertensive encephalopathy and cerebral edema due to the eventual breakdown of autoregulation, particularly if the CPP is &gt;120 mmHg [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/11,14,15\">",
"     11,14,15",
"    </a>",
"    ]. A higher level of CPP is tolerated in patients with chronic hypertension because the autoregulatory curve has shifted to the right (",
"    <a class=\"graphic graphic_figure graphicRef57676 \" href=\"mobipreview.htm?33/13/34013\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/11,15\">",
"     11,15",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/27/41398?source=see_link&amp;anchor=H2#H2\">",
"     \"Malignant hypertension and hypertensive encephalopathy in adults\", section on 'Mechanisms of vascular injury'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Ultimately, global or local reductions in CBF are responsible for the clinical manifestations of elevated ICP. These manifestations can be further divided into generalized responses to elevated ICP and herniation syndromes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Global symptoms of elevated ICP include headache, which is probably mediated via the pain fibers of cranial nerve (CN) V in the dura and blood vessels, depressed global consciousness due to either the local effect of mass lesions or pressure on the midbrain reticular formation, and vomiting.",
"   </p>",
"   <p>",
"    Signs include CN VI palsies, papilledema secondary to impaired axonal transport and congestion (",
"    <a class=\"graphic graphic_picture graphicRef50378 \" href=\"mobipreview.htm?30/30/31215\">",
"     picture 1",
"    </a>",
"    ), spontaneous periorbital bruising [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/16\">",
"     16",
"    </a>",
"    ] and a triad of bradycardia, respiratory depression, and hypertension (Cushing's triad, sometimes called Cushing's reflex or Cushing's response) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/3\">",
"     3",
"    </a>",
"    ]. While the mechanism of Cushing's triad remains controversial, many believe that it relates to brainstem compression. The presence of this response is an ominous finding that requires urgent intervention.",
"   </p>",
"   <p>",
"    Focal symptoms of elevated ICP may be caused by local effects in patients with mass lesions or by herniation syndromes. Herniation results when pressure gradients develop between two regions of the cranial vault. The most common anatomical locations affected by herniation syndromes include subfalcine, central transtentorial, uncal transtentorial, upward cerebellar, cerebellar",
"    <span class=\"nowrap\">",
"     tonsillar/foramen",
"    </span>",
"    magnum, and transcalvarial (",
"    <a class=\"graphic graphic_figure graphicRef76974 \" href=\"mobipreview.htm?5/13/5335\">",
"     figure 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/3,17\">",
"     3,17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/9/28825?source=see_link&amp;anchor=H5#H5\">",
"     \"Stupor and coma in adults\", section on 'Neurologic examination'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?28/9/28825?source=see_link&amp;anchor=H12#H12\">",
"     \"Stupor and coma in adults\", section on 'Coma syndromes'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One notable false localizing syndrome seen following neurologic injury, referred to as Kernohan's notch phenomenon, consists of the combination of contralateral pupillary dilatation and ipsilateral weakness [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. Because the diagnostic accuracy of signs and symptoms is limited, the findings described above may be inconstant or unreliable in any given case. Use of radiologic studies may support the diagnosis; however, the most reliable method of diagnosing elevated ICP is to measure it directly.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     ICP MONITORING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Empiric therapy for presumed elevated ICP is unsatisfactory because CPP cannot be monitored reliably without measurement of ICP. Furthermore, most therapies directed at lowering ICP are effective for limited and variable periods of time. In addition, these treatments may have serious side effects. Therefore, while initial steps to control ICP may, by necessity, be performed without the benefit of ICP monitoring, an important early goal in management of the patient with presumed elevated ICP is placement of an ICP monitoring device.",
"   </p>",
"   <p>",
"    The purpose of monitoring ICP is to improve the clinician's ability to maintain adequate CPP and oxygenation. The only way to reliably determine CPP (defined as the difference between MAP and ICP) is to continuously monitor both ICP and blood pressure (BP). In general, these patients are managed in intensive care units (ICUs) with an ICP monitor and arterial line. The combination of ICP monitoring and concomitant management of CPP may improve patient outcomes, particularly in patients with closed head trauma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/20-23\">",
"     20-23",
"    </a>",
"    ]. The specific therapeutic targets for CPP in patients with traumatic brain injury are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/2/35882?source=see_link&amp;anchor=H20#H20\">",
"     \"Management of acute severe traumatic brain injury\", section on 'Cerebral perfusion pressure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of elevated ICP generally is based on clinical findings, and corroborated by imaging studies and the patient's medical history. Closed head injury is one of the most frequent and best-studied indications for ICP monitoring. Much of the current practice of ICP monitoring has been derived from clinical experience with closed head trauma patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/24\">",
"     24",
"    </a>",
"    ]. Indications for ICP monitoring in this indication is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/2/35882?source=see_link&amp;anchor=H15#H15\">",
"     \"Management of acute severe traumatic brain injury\", section on 'Intracranial pressure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Role of computed tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although CT scans may suggest elevated ICP based on the presence of mass lesions, midline shift, or effacement of the basilar cisterns (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef67017 \" href=\"mobipreview.htm?25/36/26176\">",
"     image 1",
"    </a>",
"    ), patients without these findings on initial CT may have elevated ICP. This was demonstrated in a prospective study of 753 patients treated at four major head injury research centers in the United States, which found patients whose initial CT scan did not show a mass lesion, midline shift, or abnormal cisterns had a 10 to 15 percent chance of developing elevated ICP during their hospitalization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other studies have shown that up to one-third of patients with initially normal scans developed CT scan abnormalities within the first few days after closed head injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. Together, these findings demonstrate that ICP can be elevated even in the setting of a normal initial CT, demonstrating the importance of invasive monitoring in high-risk patients and the role of follow-up imaging in patients who develop clinical evidence of increased ICP during hospitalization.",
"   </p>",
"   <p>",
"    Since ICP monitoring is associated with a small risk of serious complications, including CNS infection and intracranial hemorrhage, it is reasonable to try to limit its use to patients most at risk of elevated ICP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/28\">",
"     28",
"    </a>",
"    ]. In general, invasive monitoring of ICP is indicated in patients who are [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/29\">",
"     29",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Suspected to be at risk for elevated ICP",
"     </li>",
"     <li>",
"      Comatose (Glasgow Coma Scale &lt;8) (",
"      <a class=\"graphic graphic_table graphicRef81854 \" href=\"mobipreview.htm?28/62/29676\">",
"       table 2",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Diagnosed with a process that merits aggressive medical care",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Types of monitors",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are four main anatomical sites used in the clinical measurement of ICP: intraventricular, intraparenchymal, subarachnoid, and epidural (",
"    <a class=\"graphic graphic_figure graphicRef78630 \" href=\"mobipreview.htm?2/49/2838\">",
"     figure 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/30\">",
"     30",
"    </a>",
"    ]. Noninvasive and metabolic monitoring of ICP has also been studied, but the clinical value of these methods is unclear at present. Each technique requires a unique monitoring system, and has associated advantages and disadvantages.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Intraventricular",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intraventricular monitors are considered the \"gold standard\" of ICP monitoring catheters. They are surgically placed into the ventricular system and affixed to a drainage bag and pressure transducer with a three-way stopcock. Intraventricular monitoring has the advantage of accuracy, simplicity of measurement, and the unique characteristic of allowing for treatment of some causes of elevated ICP via drainage of CSF.",
"   </p>",
"   <p>",
"    The primary disadvantage is infection, which may occur in up to 20 percent of patients. This risk increases the longer a device is in place [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. Prophylactic catheter changes did not appear to reduce the risk of infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/32\">",
"     32",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/32/44552?source=see_link\">",
"     \"Infections of central nervous system shunts and other devices\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A further disadvantage of intraventricular systems includes a small (approximately 2 percent) risk of hemorrhage during placement; this risk is greater in coagulopathic patients. In addition, it may be technically difficult to place an intraventricular drain into a small ventricle, particularly in the setting of trauma and cerebral edema complicated by ventricular compression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Intraparenchymal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intraparenchymal devices consist of a thin cable with an electronic or fiberoptic transducer at the tip. The most widely used device is the fiberoptic Camino system. These monitors can be inserted directly into the brain parenchyma via a small hole drilled in the skull. Advantages include ease of placement, and a lower risk of infection and hemorrhage (&lt;1 percent) than with intraventricular devices [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/34-36\">",
"     34-36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Disadvantages include the inability to drain CSF for diagnostic or therapeutic purposes and the potential to lose accuracy (or \"drift\") over several days, since the transducer cannot be recalibrated following initial placement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/30\">",
"     30",
"    </a>",
"    ]. In addition, there is a greater risk of mechanical failure due to the complex design of these monitors. The reliability of intraparenchymal devices has been debated. One group found only a small (1 mmHg) drift in a group of 163 patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/37\">",
"     37",
"    </a>",
"    ]; however, a second report found that readings varied by &gt;3 mmHg in more than half of the 50 patients studied [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Subarachnoid",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subarachnoid bolts are fluid-coupled systems within a hollow screw that can be placed through the skull adjacent to the dura. The dura is then punctured, which allows the CSF to communicate with the fluid column and transducer. The most commonly used subarachnoid monitor is the Richmond (or Becker) bolt; other types include the Philly bolt, the Leeds screw, and the Landy screw. These devices have low risk of infection and hemorrhage, but often clog with debris and are unreliable; therefore, they are rarely used. Additionally, they are believed to be less accurate than ventricular ICP devices [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Epidural",
"    </span>",
"    &nbsp;&mdash;&nbsp;Epidural monitors contain optical transducers that rest against the dura after passing through the skull. They often are inaccurate, as the dura damps the pressure transmitted to the epidural space, and thus are of limited clinical utility [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/30,39\">",
"     30,39",
"    </a>",
"    ]. They are used in the management of coagulopathic patients with hepatic encephalopathy complicated by cerebral edema. In this setting, use of these catheters is associated with a significantly lower risk of intracerebral hemorrhage (4 versus 20 and 22 percent for intraparenchymal and intraventricular devices) and fatal hemorrhage (1 versus 5 and 4 percent, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/40\">",
"     40",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/40/38538?source=see_link\">",
"     \"Acute liver failure in adults: Management and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2314865\">",
"    <span class=\"h2\">",
"     Waveform analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;ICP is not a static value; it exhibits cyclic variation based on the superimposed effects of cardiac contraction, respiration, and intracranial compliance. Under normal physiologic conditions, the amplitude of the waveform is often small, with B waves related to respiration and smaller C waves (or Traube-Hering-Mayer waves) related to the cardiac cycle [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pathological A waves (also called plateau waves) are abrupt, marked elevations in ICP of 50 to 100 mmHg, which usually last for minutes to hours (",
"    <a class=\"graphic graphic_waveform graphicRef61774 \" href=\"mobipreview.htm?21/44/22223\">",
"     waveform 1",
"    </a>",
"    ). The presence of A waves signifies a loss of intracranial compliance, and heralds imminent decompensation of autoregulatory mechanisms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/10,41,42\">",
"     10,41,42",
"    </a>",
"    ]. Thus, the presence of A waves should suggest the need for urgent intervention to help control ICP.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Noninvasive systems",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of devices designed to record ICP noninvasively have been studied, but most have not demonstrated reproducible clinical success or have been studied in large clinical trials. We do not use these in clinical practice.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Tissue resonance analysis (TRA), an ultrasound-based method, has shown some promise. In one trial 40 patients underwent both invasive and TRA ICP monitoring, with good correlation between concomitant invasive and TRA measurements [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/43\">",
"       43",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Ocular sonography can provide a noninvasive measure of optic nerve sheath diameter, which has been found to correlate with intracranial pressure. A number of studies have found that diameters of 5 to 6 mm have the ability to discriminate between normal and elevated ICP in patients with intracranial hemorrhage and traumatic brain injury [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/44-50\">",
"       44-50",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Transcranial Doppler (TCD) measures the velocity of blood flow in the proximal cerebral circulation. TCD can be used to estimate ICP based on characteristic changes in waveforms that occur in response to increased resistance to cerebral blood flow [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/51,52\">",
"       51,52",
"      </a>",
"      ]. Generally, TCD is a poor predictor of ICP, although in trauma patients TCD findings may correlate with outcome at six months [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/53-55\">",
"       53-55",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Intraocular pressure can be assessed noninvasively using an ultrasonic handheld optic tonometer. While some evidence suggests that intraocular pressure correlates with ICP in the absence of oculofacial trauma or glaucoma [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/56\">",
"       56",
"      </a>",
"      ], most other studies' findings disagree [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/57-59\">",
"       57-59",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Tympanic membrane displacement (measured using an impedance audiometer) has been compared to direct monitoring, based on the hypothesis that increased ICP will transmit a pressure wave to the tympanic membrane via the perilymph [",
"      <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/60,61\">",
"       60,61",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2314798\">",
"    <span class=\"h2\">",
"     Advanced neuromonitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;In order to supplement ICP monitoring, several technologies have recently been developed for the treatment of severe TBI. These techniques allow for the measurement of cerebral physiologic and metabolic parameters related to oxygen delivery, cerebral blood flow, and metabolism with the goal of improving the detection and management of secondary brain injury. These are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/2/35882?source=see_link&amp;anchor=H27#H27\">",
"     \"Management of acute severe traumatic brain injury\", section on 'Advanced neuromonitoring'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     GENERAL MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The best therapy for intracranial hypertension (ICH) is resolution of the proximate cause of elevated ICP. Examples include: evacuation of a blood clot, resection of a tumor, CSF diversion in the setting of hydrocephalus, or treatment of an underlying metabolic disorder.",
"   </p>",
"   <p>",
"    Regardless of the cause, ICH is a medical emergency, and treatment should be undertaken as expeditiously as possible. In addition to definitive therapy, there are maneuvers that can be employed to reduce ICP acutely. Some of these techniques are generally applicable to all patients with suspected ICH; others (particularly glucocorticoids) are reserved for specific causes of ICH.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Resuscitation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The urgent assessment and support of oxygenation, blood pressure, and end-organ perfusion are particularly important in trauma, but applicable to all patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/62-64\">",
"     62-64",
"    </a>",
"    ]. If elevated ICP is suspected, care should be taken to minimize further elevations in ICP during intubation through careful positioning, appropriate choice of paralytic agents (if required), and adequate sedation. Pretreatment with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/34/35360?source=see_link\">",
"     lidocaine",
"    </a>",
"    has been suggested as a useful intervention to decrease the rise in ICP associated with intubation; however, good clinical evidence supporting this approach is limited [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/65\">",
"     65",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/21/31066?source=see_link\">",
"     \"Overview of inpatient management in the adult trauma patient\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/33/13850?source=see_link\">",
"     \"Advanced cardiac life support (ACLS) in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/25/36248?source=see_link\">",
"     \"Basic life support (BLS) in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Large shifts in blood pressure should be minimized, with particular care taken to avoid hypotension. Although it might seem that lower BP would result in lower ICP, this is not the case. Hypotension, especially in conjunction with hypoxemia, can induce reactive vasodilation and elevations in ICP. As noted above, pressors have been shown to be safe for use in most patients with intracranial hypertension, and may be required to maintain CPP &gt;60 mmHg [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/20\">",
"     20",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/35/40505?source=see_link\">",
"     \"Use of vasopressors and inotropes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Urgent situations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Life-saving measures may need to be instituted prior to a more detailed workup (eg, imaging or ICP monitoring) in a patient who presents acutely with history or examination findings suggestive of elevated ICP. Many of these situations will rely upon clinical judgment, but the following combination of findings suggests the need for urgent intervention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/66,67\">",
"     66,67",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A history that suggests elevated ICP (eg, head trauma, sudden severe headache typical of subarachnoid hemorrhage)",
"     </li>",
"     <li>",
"      An examination that suggests elevated ICP (unilateral or bilaterally fixed and dilated pupil(s), decorticate or decerebrate posturing, bradycardia, hypertension",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      respiratory depression)",
"     </li>",
"     <li>",
"      A Glasgow coma scale (GCS) &le;8",
"     </li>",
"     <li>",
"      Potentially confounding, reversible causes of depressed mental status, hypotension (SBP &lt;60 mmHg in adults), hypoxemia (PaO2 &lt;60 mmHg), hypothermia (&lt;36&ordm;C), or obvious intoxication are absent",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In such patients osmotic diuretics may be used urgently (see",
"    <a class=\"local\" href=\"#H30\">",
"     'Mannitol'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    In addition, standard resuscitation techniques should be instituted as soon as possible:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Head elevation",
"     </li>",
"     <li>",
"      Hyperventilation to a PCO2 of 26 to 30 mmHg",
"     </li>",
"     <li>",
"      Intravenous",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?3/42/3752?source=see_link\">",
"       mannitol",
"      </a>",
"      (1 to 1.5",
"      <span class=\"nowrap\">",
"       g/kg)",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Concomitant with these measures should be aggressive evaluation of the underlying diagnosis, including neuroimaging, detailed neurologic examination, and history gathering. Hyperventilation may be contraindicated in the setting of traumatic brain injury and acute stroke, and is discussed separately (see",
"    <a class=\"local\" href=\"#H34\">",
"     'Hyperventilation'",
"    </a>",
"    below). If appropriate, ventriculostomy is a rapid means of simultaneously diagnosing and treating elevated ICP.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Monitoring and the decision to treat",
"    </span>",
"    &nbsp;&mdash;&nbsp;If a diagnosis of elevated ICP is suspected and an immediately treatable proximate cause is not present, then ICP monitoring should be instituted. The use of ICP monitoring is associated with decreased mortality in patients with traumatic brain injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/2/35882?source=see_link&amp;anchor=H15#H15\">",
"     \"Management of acute severe traumatic brain injury\", section on 'Intracranial pressure'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The type of monitoring device employed should be based on an assessment of the advantages and disadvantages discussed previously (",
"    <a class=\"graphic graphic_figure graphicRef78630 \" href=\"mobipreview.htm?2/49/2838\">",
"     figure 5",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H9\">",
"     'ICP monitoring'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The goal of ICP monitoring and treatment should be to keep ICP &lt;20 mmHg [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/68\">",
"     68",
"    </a>",
"    ]. Interventions should be utilized only when ICP is elevated above 20 mmHg for &gt;5 to 10 minutes. As discussed above, brief physiologic elevations in ICP may occur in the setting of coughing, movement, suctioning, or ventilator asynchrony.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Fluid management",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, patients with elevated ICP do not need to be severely fluid restricted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/69\">",
"     69",
"    </a>",
"    ]. Patients should be kept euvolemic and normo- to hyperosmolar. This can be achieved by avoiding all free water (including D5W, 0.45 percent (half normal) saline, and enteral free water) and employing only isotonic fluids (such as 0.9 percent (normal) saline). Serum osmolality should be kept &gt;280",
"    <span class=\"nowrap\">",
"     mOsm/L,",
"    </span>",
"    and often is kept in the 295 to 305",
"    <span class=\"nowrap\">",
"     mOsm/L",
"    </span>",
"    range. Hyponatremia is common in the setting of elevated ICP, particularly in conjunction with subarachnoid hemorrhage. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/30/3562?source=see_link\">",
"     \"Causes of hyponatremia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/57/17306?source=see_link&amp;anchor=H6#H6\">",
"     \"Treatment of hyponatremia: Syndrome of inappropriate antidiuretic hormone secretion (SIADH) and reset osmostat\", section on 'Subarachnoid hemorrhage'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Similarly, the value of colloid compared to crystalloid fluid resuscitation in patients with elevated ICP has been studied, but findings have been inconclusive with respect to the superior approach [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/70\">",
"     70",
"    </a>",
"    ]. A subgroup analysis in one large study, however, suggested that in patients with traumatic brain injury, fluid resuscitation with albumin was associated with a higher mortality as compared with normal saline [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/71\">",
"     71",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/2/35882?source=see_link\">",
"     \"Management of acute severe traumatic brain injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Hypertonic saline in bolus doses may acutely lower ICP, but further investigations are required to define a role, if any, for this approach in the management of elevated intracranial pressure. (See",
"    <a class=\"local\" href=\"#H32\">",
"     'Hypertonic saline bolus'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Sedation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Keeping patients appropriately sedated can decrease ICP by reducing metabolic demand, ventilator asynchrony, venous congestion, and the sympathetic responses of hypertension and tachycardia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/72\">",
"     72",
"    </a>",
"    ]. Establishing a secure airway and close attention to blood pressure allow the clinician to identify and treat apnea and hypotension quickly.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?17/25/17816?source=see_link\">",
"     Propofol",
"    </a>",
"    has been utilized to good effect in this setting, as it is easily titrated and has a short half-life, thus permitting frequent neurologic reassessment. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/29/15833?source=see_link\">",
"     \"Sedative-analgesic medications in critically ill patients: Selection, initiation, maintenance, and withdrawal\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Blood pressure control",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, BP should be sufficient to maintain CPP &gt;60 mmHg. As discussed above, pressors can be used safely without further increasing ICP. This is particularly relevant in the setting of sedation, when iatrogenic hypotension can occur. Hypertension should generally only be treated when CPP &gt;120 mmHg and ICP &gt;20 mmHg.",
"   </p>",
"   <p>",
"    Caution should be taken to avoid CPP &lt;50 mmHg or, as noted above, normalization of blood pressure in patients with chronic hypertension in whom the autoregulatory curve has shifted to the right (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Autoregulation'",
"    </a>",
"    above). General issues regarding blood pressure management following stroke are presented elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/57/17305?source=see_link\">",
"     \"Antihypertensive therapy to prevent recurrent stroke or transient ischemic attack\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Position",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with elevated ICP should be positioned to maximize venous outflow from the head. Important maneuvers include reducing excessive flexion or rotation of the neck, avoiding restrictive neck taping, and minimizing stimuli that could induce Valsalva responses, such as endotracheal suctioning.",
"   </p>",
"   <p>",
"    Patients with elevated ICP have historically been positioned with the head elevated above the heart (usually 30 degrees) to increase venous outflow. It should be noted that head elevation may lower CPP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/20,73\">",
"     20,73",
"    </a>",
"    ]; however, given the proven efficacy of head elevation in lowering ICP, most experts recommend raising the patient's head as long as the CPP remains at an appropriate level [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Fever",
"    </span>",
"    &nbsp;&mdash;&nbsp;Elevated metabolic demand in the brain results in increased cerebral blood flow (CBF), and can elevate ICP by increasing the volume of blood in the cranial vault. Conversely, decreasing metabolic demand can lower ICP by reducing blood flow.",
"   </p>",
"   <p>",
"    Fever increases brain metabolism, and has been demonstrated to increase brain injury in animal models [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/75\">",
"     75",
"    </a>",
"    ]. Therefore, aggressive treatment of fever, including",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    and mechanical cooling, is recommended in patients with increased ICP. Intracranial hypertension is a recognized indication for neuromuscular paralysis in selected patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/76\">",
"     76",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/44/43720?source=see_link\">",
"     \"Use of neuromuscular blocking medications in critically ill patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Antiepileptic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seizures can both complicate and contribute to elevated ICP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/77,78\">",
"     77,78",
"    </a>",
"    ]. Anticonvulsant therapy should be instituted if seizures are suspected; prophylactic treatment may be warranted in some cases. There are no clear guidelines for the latter, but examples include high-risk mass lesions, such as those within supratentorial cortical locations, or lesions adjacent to the cortex, such as subdural hematomas or subarachnoid hemorrhage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     SPECIFIC THERAPIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;As mentioned previously, the best treatment of elevated ICP is to address its underlying cause. If this is not possible, a series of steps should be instituted to reduce ICP in an attempt to improve outcome. In all cases, the clinician should bear in mind the themes of resuscitation, reduction of intracranial volume, and frequent reevaluation discussed above.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h2\">",
"     Mannitol",
"    </span>",
"    &nbsp;&mdash;&nbsp;Osmotic diuretics reduce brain volume by drawing free water out of the tissue and into the circulation, where it is excreted by the kidneys, thus dehydrating brain parenchyma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/79-82\">",
"     79-82",
"    </a>",
"    ]. The most commonly used agent is",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/42/3752?source=see_link\">",
"     mannitol",
"    </a>",
"    . It is prepared as a 20 percent solution, and given as a bolus of 1",
"    <span class=\"nowrap\">",
"     g/kg.",
"    </span>",
"    Repeat dosing can be given at 0.25 to 0.5",
"    <span class=\"nowrap\">",
"     g/kg",
"    </span>",
"    as needed, generally every six to eight hours. Use of any osmotic agent should be carefully evaluated in patients with renal insufficiency.",
"   </p>",
"   <p>",
"    The effects are usually present within minutes, peak at about one hour, and last 4 to 24 hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/29,83\">",
"     29,83",
"    </a>",
"    ]. Some have reported a \"rebound\" increase in ICP; this probably occurs when",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/42/3752?source=see_link\">",
"     mannitol",
"    </a>",
"    , after repeated use, enters the brain though a damaged blood-brain barrier and reverses the osmotic gradient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/84,85\">",
"     84,85",
"    </a>",
"    ]. Useful parameters to monitor in the setting of mannitol therapy include serum sodium, serum osmolality, and renal function.",
"   </p>",
"   <p>",
"    Concerning findings associated with the use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/42/3752?source=see_link\">",
"     mannitol",
"    </a>",
"    include serum sodium &gt;150 meq, serum osmolality &gt;320 mOsm, or evidence of evolving acute tubular necrosis (ATN). In addition, mannitol can lower systemic BP, necessitating careful use if associated with a fall in CPP. Patients with known renal disease may be poor candidates for osmotic diuresis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/44/32451?source=see_link\">",
"     \"Complications of mannitol therapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h3\">",
"     Other diuretics",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/52/28488?source=see_link\">",
"     Furosemide",
"    </a>",
"    , 0.5 to 1.0",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    intravenously, may be given with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/42/3752?source=see_link\">",
"     mannitol",
"    </a>",
"    to potentiate its effect. However, this effect can also exacerbate dehydration and hypokalemia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/86-88\">",
"     86-88",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Glycerol and urea were used historically to control ICP via osmoregulation; however, use of these agents has decreased because equilibration between brain and plasma levels occurs more quickly than with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/42/3752?source=see_link\">",
"     mannitol",
"    </a>",
"    . Furthermore, glycerol has been shown to have a significant rebound effect and to be less effective in ICP control [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/89,90\">",
"     89,90",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Hypertonic saline bolus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypertonic saline in bolus doses may acutely lower ICP; however, the effect of this early intervention on long-term clinical outcomes remains unclear [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/91-98\">",
"     91-98",
"    </a>",
"    ]. The volume and tonicity of saline (7.2 to 23.4 percent) used in these reports have varied widely. As an example, one controlled trial randomly assigned 226 patients with traumatic brain injury to prehospital resuscitation with 250 mL hypertonic saline (7.5 percent) or the same volume of Ringer's lactate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/91\">",
"     91",
"    </a>",
"    ]. Survival until hospital discharge, six-month survival, and neurologic function six months after injury were similar in both groups.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/42/3752?source=see_link\">",
"     Mannitol",
"    </a>",
"    and hypertonic saline have been compared in at least five randomized trials of patients with elevated ICP from a variety of causes (traumatic brain injury, stroke, tumors) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/98-102\">",
"     98-102",
"    </a>",
"    ]. A meta-analysis of these trials found that hypertonic saline appeared to have greater efficacy in managing elevated ICP, but clinical outcomes were not examined [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/103\">",
"     103",
"    </a>",
"    ]. Further clinical trials are required to clarify the appropriate role of hypertonic saline infusion versus mannitol in the management of elevated ICP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/104\">",
"     104",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/2/35882?source=see_link&amp;anchor=H17#H17\">",
"     \"Management of acute severe traumatic brain injury\", section on 'Osmotic therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucocorticoids were associated with a worse outcome in a large randomized clinical trial of their use in moderate to severe head injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/105,106\">",
"     105,106",
"    </a>",
"    ]. They should not be used in this setting. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/2/35882?source=see_link\">",
"     \"Management of acute severe traumatic brain injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition, glucocorticoids are not considered to be useful in the management of cerebral infarction or intracranial hemorrhage. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/56/32650?source=see_link\">",
"     \"Spontaneous intracerebral hemorrhage: Prognosis and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast, glucocorticoids may have a role in the setting of intracranial hypertension caused by brain tumors and CNS infections. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/26/39335?source=see_link\">",
"     \"Management of vasogenic edema in patients with primary and metastatic brain tumors\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/43/32438?source=see_link\">",
"     \"Treatment and prognosis of brain abscess\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/34/23080?source=see_link\">",
"     \"Dexamethasone to prevent neurologic complications of bacterial meningitis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Hyperventilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of mechanical ventilation to lower PaCO2 to 26 to 30 mmHg has been shown to rapidly reduce ICP through vasoconstriction and a decrease in the volume of intracranial blood; a 1 mmHg change in PaCO2 is associated with a 3 percent change in CBF [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/107\">",
"     107",
"    </a>",
"    ]. Hyperventilation also results in respiratory alkalosis, which may buffer post-injury acidosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/107\">",
"     107",
"    </a>",
"    ]. The effect of hyperventilation on ICP is short-lived (1 to 24 hours) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/108-110\">",
"     108-110",
"    </a>",
"    ]. Following therapeutic hyperventilation, the patient's respiratory rate should be tapered back to normal over several hours to avoid a rebound effect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/111\">",
"     111",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Therapeutic hyperventilation should be considered as an urgent intervention when elevated ICP complicates cerebral edema, intracranial hemorrhage, and tumor. Hyperventilation should not be used on a chronic basis, regardless of the cause of increased ICP.",
"   </p>",
"   <p>",
"    Hyperventilation should be minimized in patients with traumatic brain injury or acute stroke. In these settings, vasoconstriction may cause a critical decrease in local cerebral perfusion and worsen neurologic injury, particularly in the first 24 to 48 hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/24,108,110,112-115\">",
"     24,108,110,112-115",
"    </a>",
"    ]. Thus, the need for hyperventilation should be carefully considered, and prophylactic hyperventilation in the absence of elevated ICP should be avoided. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/2/35882?source=see_link&amp;anchor=H18#H18\">",
"     \"Management of acute severe traumatic brain injury\", section on 'Hyperventilation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Barbiturates",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of barbiturates is predicated on their ability to reduce brain metabolism and cerebral blood flow, thus lowering ICP and exerting a neuroprotective effect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/116-119\">",
"     116-119",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/31/4601?source=see_link\">",
"     Pentobarbital",
"    </a>",
"    is generally used, with a loading dose of 5 to 20",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    as a bolus, followed by 1 to 4",
"    <span class=\"nowrap\">",
"     mg/kg",
"    </span>",
"    per hr [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/120,121\">",
"     120,121",
"    </a>",
"    ]. Treatment should be assessed based on ICP, CPP, and the presence of unacceptable side effects. Continuous EEG monitoring is generally used; EEG burst suppression is an indication of maximal dosing.",
"   </p>",
"   <p>",
"    The therapeutic value of this maneuver is somewhat unclear. In a randomized trial of 73 patients with elevations in ICP refractory to standard therapy, patients treated with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?4/31/4601?source=see_link\">",
"     pentobarbital",
"    </a>",
"    were 50 percent more likely to have their ICP controlled. However, there was no difference in clinical outcomes between groups [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/122\">",
"     122",
"    </a>",
"    ]. In general, the use of barbiturates is a \"last-ditch\" effort, as several studies show that their ability to lower ICP does not appear to affect outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/107,123\">",
"     107,123",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Barbiturate therapy can be complicated by hypotension, possibly requiring vasopressor support. The use of barbiturates is also associated with a loss of the neurologic examination, requiring accurate ICP, hemodynamic, and often EEG monitoring to guide therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Therapeutic hypothermia",
"    </span>",
"    &nbsp;&mdash;&nbsp;First reported as a treatment for brain injury in the 1950s, induced or therapeutic hypothermia has remained a controversial issue in the debate concerning the management of elevated ICP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/107,124,125\">",
"     107,124,125",
"    </a>",
"    ]. It is not currently recommended as a standard treatment for increased intracranial pressure in any clinical setting.",
"   </p>",
"   <p>",
"    Hypothermia decreases cerebral metabolism and may reduce CBF and ICP. Initial studies of hypothermia were limited by systemic side effects, including cardiac arrhythmias and severe coagulopathy. However, later work suggested that hypothermia can lower ICP and may improve patient outcomes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/126\">",
"     126",
"    </a>",
"    ]. Hypothermia also appeared to be effective in lowering ICP after other therapies have failed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/127,128\">",
"     127,128",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hypothermia can be achieved using whole body cooling, including lavage and cooling blankets, to a goal core temperature of 32 to 34&ordm;C. The best method of cooling (local versus systemic), the optimal target core temperature, and the appropriate duration of treatment are not known [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/129\">",
"     129",
"    </a>",
"    ]. It appears that rewarming should be accomplished over a period of less than 24 hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/130\">",
"     130",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The value of therapeutic hypothermia has been best assessed in patients after traumatic brain injury (TBI), but it&rsquo;s role has not been well established in that setting. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/2/35882?source=see_link&amp;anchor=H23#H23\">",
"     \"Management of acute severe traumatic brain injury\", section on 'Induced hypothermia'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44633?source=see_link&amp;anchor=H30#H30\">",
"     \"Elevated intracranial pressure in children\", section on 'Hypothermia'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Given the uncertainties surrounding the appropriate use of therapeutic hypothermia in patients with elevated ICP, this treatment should be limited to clinical trials, or to patients with intracranial hypertension refractory to other therapies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Removal of CSF",
"    </span>",
"    &nbsp;&mdash;&nbsp;When hydrocephalus is identified, a ventriculostomy should be inserted (",
"    <a class=\"graphic graphic_figure graphicRef56391 \" href=\"mobipreview.htm?27/61/28625\">",
"     figure 6",
"    </a>",
"    ). Rapid aspiration of CSF should be avoided because it may lead to obstruction of the catheter opening by brain tissue. Also, in patients with aneurysmal subarachnoid hemorrhage, abrupt lowering of the pressure differential across the aneurysm dome can precipitate recurrent hemorrhage.",
"   </p>",
"   <p>",
"    CSF should be removed at a rate of approximately 1 to 2",
"    <span class=\"nowrap\">",
"     mL/minute,",
"    </span>",
"    for two to three minutes at a time, with intervals of two to three minutes in between until a satisfactory ICP has been achieved (ICP &lt;20 mmHg) or until CSF is no longer easily obtained. Slow removal can also be accomplished by passive gravitational drainage through the ventriculostomy. A lumbar drain is generally contraindicated in the setting of high ICP due to the risk of transtentorial herniation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H38\">",
"    <span class=\"h2\">",
"     Decompressive craniectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Decompressive craniectomy removes the rigid confines of the bony skull, increasing the potential volume of the intracranial contents and circumventing the Monroe-Kellie doctrine. There is a growing body of literature supporting the efficacy of decompressive craniectomy in certain clinical situations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/131-140\">",
"     131-140",
"    </a>",
"    ]. Importantly, it has been demonstrated that in patients with elevated ICP, craniectomy alone lowered ICP 15 percent, but opening the dura in addition to the bony skull resulted in an average decrease in ICP of 70 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/141\">",
"     141",
"    </a>",
"    ]. Decompressive craniectomy also appears to improve brain tissue oxygenation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/142\">",
"     142",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Observational data suggest that rapid and sustained control of ICP, including the use of decompressive craniectomy, improves outcomes in trauma, stroke, and subarachnoid hemorrhage in carefully selected cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/143-150\">",
"     143-150",
"    </a>",
"    ]. The indications for decompressive craniectomy in these settings are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/35/569?source=see_link\">",
"     \"Decompressive hemicraniectomy for malignant middle cerebral artery territory infarction\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/2/35882?source=see_link&amp;anchor=H12#H12\">",
"     \"Management of acute severe traumatic brain injury\", section on 'Decompressive craniectomy'",
"    </a>",
"    .) Obvious mass lesions associated with an elevated ICP should be removed, if possible.",
"   </p>",
"   <p>",
"    Potential complications of surgery include herniation through the skull defect, spinal fluid leak, wound infection, and epidural and subdural hematoma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/151\">",
"     151",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Paradoxical transtentorial herniation is an uncommon but potentially lethal complication in patients with hemicraniectomy and a large skull defect who subsequently undergo lumbar puncture (LP) or CSF drainage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/152,153\">",
"     152,153",
"    </a>",
"    ]. This results from the combined effects of atmospheric pressure with the negative pressure of the LP or ventriculostomy. It has also been described as a delayed complication three to five months after decompressive craniectomy for cerebral infarction in the absence of LP or ventriculostomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/154\">",
"     154",
"    </a>",
"    ]. Marked decompression of the skin and dura over the skull defect accompany and may precede neurologic signs of herniation. Standard treatments to lower ICP can hasten herniation. Instead, the patient should be placed supine or in the Trendelenburg position, CSF drains should be clamped, crystalloid fluid should be administered intravenously, and an epidural blood patch placed for patients with dural leak.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H39\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The best therapy for intracranial hypertension is resolution of the proximate cause of elevated ICP. Regardless of the cause, treatment should be undertaken as expeditiously as possible, and should be based on the principles of resuscitation, reduction of the volume of the intracranial contents, and reassessment. The role of evidence-based guidelines in the clinical management of elevated ICP is evolving [",
"    <a class=\"abstract\" href=\"mobipreview.htm?32/39/33402/abstract/155\">",
"     155",
"    </a>",
"    ]. However, it is important to remember that individual patients respond differently to different therapies; therefore, interventions should be based on careful assessment of the individual clinical scenario rather than on strict protocols.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Adams RA, Ropper AH.. Principles of neurology, 6th, McGraw Hill, New York 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/2\">",
"      Welch K. The intracranial pressure in infants. J Neurosurg 1980; 52:693.",
"     </a>",
"    </li>",
"    <li>",
"     Kaye AH. Brain Tumors: An Encyclopedic Approach, 2nd, Churchill Livingstone, New York 2001. p.205.",
"    </li>",
"    <li>",
"     Monro A. Observations in the structure and functions of the nervous system, Creech and Johnson, Edinburgh 1783.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/5\">",
"      Kellie G. An account of the appearence observed in the dissection of two of the individuals presumed to have perished in the storm of the third, and whose bodies were discovered in the vicinity of Leith on the morning of the 24th, November 1821; with some reflections on the pathology of the brain. Trans Med Chir Soc (Edinburgh) 1821- 1832; 1:84.",
"     </a>",
"    </li>",
"    <li>",
"     Fishman R. Cerebrospinal fluid in diseases of the nervous system, WB Saunders, Philadelphia 1980.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/7\">",
"      Bruce DA, Alavi A, Bilaniuk L, et al. Diffuse cerebral swelling following head injuries in children: the syndrome of \"malignant brain edema\". J Neurosurg 1981; 54:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/8\">",
"      Aldrich EF, Eisenberg HM, Saydjari C, et al. Diffuse brain swelling in severely head-injured children. A report from the NIH Traumatic Coma Data Bank. J Neurosurg 1992; 76:450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/9\">",
"      Levin HS, Aldrich EF, Saydjari C, et al. Severe head injury in children: experience of the Traumatic Coma Data Bank. Neurosurgery 1992; 31:435.",
"     </a>",
"    </li>",
"    <li>",
"     Wilkins RS. Neurosurgery, 2nd, McGraw-Hill, New York 1996. Vol 1, p.347.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/11\">",
"      Strandgaard S, Paulson OB. Cerebral blood flow and its pathophysiology in hypertension. Am J Hypertens 1989; 2:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/12\">",
"      Strandgaard S, Andersen GS, Ahlgreen P, Nielsen PE. Visual disturbances and occipital brain infarct following acute, transient hypotension in hypertensive patients. Acta Med Scand 1984; 216:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/13\">",
"      Enevoldsen EM, Jensen FT. Autoregulation and CO2 responses of cerebral blood flow in patients with acute severe head injury. J Neurosurg 1978; 48:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/14\">",
"      Lassen NA, Agnoli A. The upper limit of autoregulation of cerebral blood flow--on the pathogenesis of hypertensive encepholopathy. Scand J Clin Lab Invest 1972; 30:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/15\">",
"      Kaplan NM. Management of hypertensive emergencies. Lancet 1994; 344:1335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/16\">",
"      Hadjikoutis S, Carroll C, Plant GT. Raised intracranial pressure presenting with spontaneous periorbital bruising: two case reports. J Neurol Neurosurg Psychiatry 2004; 75:1192.",
"     </a>",
"    </li>",
"    <li>",
"     Plum F Posner J. The Diagnosis of Stupor and Coma, 3rd, FA Davis, Philadelphia 1980.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/18\">",
"      Kernohan JW. Incisura of the crus due to contralateral brain tumor. Arch Neurol Psychiatry 1929; 21:274.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/19\">",
"      Binder DK, Lyon R, Manley GT. Transcranial motor evoked potential recording in a case of Kernohan's notch syndrome: case report. Neurosurgery 2004; 54:999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/20\">",
"      Rosner MJ, Rosner SD, Johnson AH. Cerebral perfusion pressure: management protocol and clinical results. J Neurosurg 1995; 83:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/21\">",
"      Lane PL, Skoretz TG, Doig G, Girotti MJ. Intracranial pressure monitoring and outcomes after traumatic brain injury. Can J Surg 2000; 43:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/22\">",
"      Bulger EM, Nathens AB, Rivara FP, et al. Management of severe head injury: institutional variations in care and effect on outcome. Crit Care Med 2002; 30:1870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/23\">",
"      Mauritz W, Steltzer H, Bauer P, et al. Monitoring of intracranial pressure in patients with severe traumatic brain injury: an Austrian prospective multicenter study. Intensive Care Med 2008; 34:1208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/24\">",
"      Marik PE, Varon J, Trask T. Management of head trauma. Chest 2002; 122:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/25\">",
"      Eisenberg HM, Gary HE Jr, Aldrich EF, et al. Initial CT findings in 753 patients with severe head injury. A report from the NIH Traumatic Coma Data Bank. J Neurosurg 1990; 73:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/26\">",
"      O'Sullivan MG, Statham PF, Jones PA, et al. Role of intracranial pressure monitoring in severely head-injured patients without signs of intracranial hypertension on initial computerized tomography. J Neurosurg 1994; 80:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/27\">",
"      Lobato RD, Sarabia R, Rivas JJ, et al. Normal computerized tomography scans in severe head injury. Prognostic and clinical management implications. J Neurosurg 1986; 65:784.",
"     </a>",
"    </li>",
"    <li>",
"     Bullock R, Chesnut RM, Clifton G.. Guidelines for the Management of Severe Brain Injury New York: Brain trauma foundation/American Association of Neurologic Surgeons, 1995.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/29\">",
"      Dennis LJ, Mayer SA. Diagnosis and management of increased intracranial pressure. Neurol India 2001; 49 Suppl 1:S37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/30\">",
"      Brain Trauma Foundation, American Association of Neurological Surgeons, Congress of Neurological Surgeons, et al. Guidelines for the management of severe traumatic brain injury. VII. Intracranial pressure monitoring technology. J Neurotrauma 2007; 24 Suppl 1:S45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/31\">",
"      Mayhall CG, Archer NH, Lamb VA, et al. Ventriculostomy-related infections. A prospective epidemiologic study. N Engl J Med 1984; 310:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/32\">",
"      Holloway KL, Barnes T, Choi S, et al. Ventriculostomy infections: the effect of monitoring duration and catheter exchange in 584 patients. J Neurosurg 1996; 85:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/33\">",
"      Ghajar J. Intracranial pressure monitoring techniques. New Horiz 1995; 3:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/34\">",
"      Ostrup RC, Luerssen TG, Marshall LF, Zornow MH. Continuous monitoring of intracranial pressure with a miniaturized fiberoptic device. J Neurosurg 1987; 67:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/35\">",
"      Gambardella G, d'Avella D, Tomasello F. Monitoring of brain tissue pressure with a fiberoptic device. Neurosurgery 1992; 31:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/36\">",
"      Bochicchio M, Latronico N, Zappa S, et al. Bedside burr hole for intracranial pressure monitoring performed by intensive care physicians. A 5-year experience. Intensive Care Med 1996; 22:1070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/37\">",
"      Poca MA, Sahuquillo J, Arribas M, et al. Fiberoptic intraparenchymal brain pressure monitoring with the Camino V420 monitor: reflections on our experience in 163 severely head-injured patients. J Neurotrauma 2002; 19:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/38\">",
"      Piper I, Barnes A, Smith D, Dunn L. The Camino intracranial pressure sensor: is it optimal technology? An internal audit with a review of current intracranial pressure monitoring technologies. Neurosurgery 2001; 49:1158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/39\">",
"      Miller JD, Bobo H, Kapp JP. Inaccurate pressure readings for subarachnoid bolts. Neurosurgery 1986; 19:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/40\">",
"      Blei AT, Olafsson S, Webster S, Levy R. Complications of intracranial pressure monitoring in fulminant hepatic failure. Lancet 1993; 341:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/41\">",
"      Hayashi M, Handa Y, Kobayashi H, et al. Plateau-wave phenomenon (I). Correlation between the appearance of plateau waves and CSF circulation in patients with intracranial hypertension. Brain 1991; 114 ( Pt 6):2681.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/42\">",
"      Rosner MJ, Becker DP. Origin and evolution of plateau waves. Experimental observations and a theoretical model. J Neurosurg 1984; 60:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/43\">",
"      Michaeli D, Rappaport ZH. Tissue resonance analysis; a novel method for noninvasive monitoring of intracranial pressure. Technical note. J Neurosurg 2002; 96:1132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/44\">",
"      Soldatos T, Karakitsos D, Chatzimichail K, et al. Optic nerve sonography in the diagnostic evaluation of adult brain injury. Crit Care 2008; 12:R67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/45\">",
"      Moretti R, Pizzi B, Cassini F, Vivaldi N. Reliability of optic nerve ultrasound for the evaluation of patients with spontaneous intracranial hemorrhage. Neurocrit Care 2009; 11:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/46\">",
"      Moretti R, Pizzi B. Optic nerve ultrasound for detection of intracranial hypertension in intracranial hemorrhage patients: confirmation of previous findings in a different patient population. J Neurosurg Anesthesiol 2009; 21:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/47\">",
"      Dubourg J, Javouhey E, Geeraerts T, et al. Ultrasonography of optic nerve sheath diameter for detection of raised intracranial pressure: a systematic review and meta-analysis. Intensive Care Med 2011; 37:1059.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/48\">",
"      Geeraerts T, Launey Y, Martin L, et al. Ultrasonography of the optic nerve sheath may be useful for detecting raised intracranial pressure after severe brain injury. Intensive Care Med 2007; 33:1704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/49\">",
"      Geeraerts T, Merceron S, Benhamou D, et al. Non-invasive assessment of intracranial pressure using ocular sonography in neurocritical care patients. Intensive Care Med 2008; 34:2062.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/50\">",
"      Kimberly HH, Shah S, Marill K, Noble V. Correlation of optic nerve sheath diameter with direct measurement of intracranial pressure. Acad Emerg Med 2008; 15:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/51\">",
"      Manno EM. Transcranial Doppler ultrasonography in the neurocritical care unit. Crit Care Clin 1997; 13:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/52\">",
"      Edouard AR, Vanhille E, Le Moigno S, et al. Non-invasive assessment of cerebral perfusion pressure in brain injured patients with moderate intracranial hypertension. Br J Anaesth 2005; 94:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/53\">",
"      Hassler W, Steinmetz H, Gawlowski J. Transcranial Doppler ultrasonography in raised intracranial pressure and in intracranial circulatory arrest. J Neurosurg 1988; 68:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/54\">",
"      Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg 1982; 57:769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/55\">",
"      Tan H, Feng H, Gao L, et al. Outcome prediction in severe traumatic brain injury with transcranial Doppler ultrasonography. Chin J Traumatol 2001; 4:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/56\">",
"      Lashutka MK, Chandra A, Murray HN, et al. The relationship of intraocular pressure to intracranial pressure. Ann Emerg Med 2004; 43:585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/57\">",
"      Sheeran P, Bland JM, Hall GM. Intraocular pressure changes and alterations in intracranial pressure. Lancet 2000; 355:899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/58\">",
"      Han Y, McCulley TJ, Horton JC. No correlation between intraocular pressure and intracranial pressure. Ann Neurol 2008; 64:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/59\">",
"      Kirk T, Jones K, Miller S, Corbett J. Measurement of intraocular and intracranial pressure: is there a relationship? Ann Neurol 2011; 70:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/60\">",
"      Kast R. A new method for noninvasive measurement of short-term cerebrospinal fluid pressure changes in humans. J Neurol 1985; 232:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/61\">",
"      Reid A, Marchbanks RJ, Bateman DE, et al. Mean intracranial pressure monitoring by a non-invasive audiological technique: a pilot study. J Neurol Neurosurg Psychiatry 1989; 52:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/62\">",
"      Procaccio F, Stocchetti N, Citerio G, et al. Guidelines for the treatment of adults with severe head trauma (part I). Initial assessment; evaluation and pre-hospital treatment; current criteria for hospital admission; systemic and cerebral monitoring. J Neurosurg Sci 2000; 44:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/63\">",
"      Procaccio F, Stocchetti N, Citerio G, et al. Guidelines for the treatment of adults with severe head trauma (part II). Criteria for medical treatment. J Neurosurg Sci 2000; 44:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/64\">",
"      Davella D, Brambilla GL, Delfini R, et al. Guidelines for the treatment of adults with severe head trauma (part III). Criteria for surgical treatment. J Neurosurg Sci 2000; 44:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/65\">",
"      Robinson N, Clancy M. In patients with head injury undergoing rapid sequence intubation, does pretreatment with intravenous lignocaine/lidocaine lead to an improved neurological outcome? A review of the literature. Emerg Med J 2001; 18:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/66\">",
"      Smith ER, Madsen JR. Neurosurgical aspects of critical care neurology. Semin Pediatr Neurol 2004; 11:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/67\">",
"      Smith ER, Madsen JR. Cerebral pathophysiology and critical care neurology: basic hemodynamic principles, cerebral perfusion, and intracranial pressure. Semin Pediatr Neurol 2004; 11:89.",
"     </a>",
"    </li>",
"    <li>",
"     Bullock, R, Clifton G. Guidelines for the Management of Severe Brain Injury, Brain trauma foundation/American Association of Neurologic Surgeons, New York 1995.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/69\">",
"      Schmoker JD, Shackford SR, Wald SL, Pietropaoli JA. An analysis of the relationship between fluid and sodium administration and intracranial pressure after head injury. J Trauma 1992; 33:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/70\">",
"      Tranmer BI, Iacobacci RI, Kindt GW. Effects of crystalloid and colloid infusions on intracranial pressure and computerized electroencephalographic data in dogs with vasogenic brain edema. Neurosurgery 1989; 25:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/71\">",
"      SAFE Study Investigators, Australian and New Zealand Intensive Care Society Clinical Trials Group, Australian Red Cross Blood Service, et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007; 357:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/72\">",
"      Lassen NA, Christensen MS. Physiology of cerebral blood flow. Br J Anaesth 1976; 48:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/73\">",
"      Rosner MJ, Coley IB. Cerebral perfusion pressure, intracranial pressure, and head elevation. J Neurosurg 1986; 65:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/74\">",
"      Durward QJ, Amacher AL, Del Maestro RF, Sibbald WJ. Cerebral and cardiovascular responses to changes in head elevation in patients with intracranial hypertension. J Neurosurg 1983; 59:938.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/75\">",
"      Busija DW, Leffler CW, Pourcyrous M. Hyperthermia increases cerebral metabolic rate and blood flow in neonatal pigs. Am J Physiol 1988; 255:H343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/76\">",
"      Murray MJ, Cowen J, DeBlock H, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med 2002; 30:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/77\">",
"      Lassen NA. Control of cerebral circulation in health and disease. Circ Res 1974; 34:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/78\">",
"      Gabor AJ, Brooks AG, Scobey RP, Parsons GH. Intracranial pressure during epileptic seizures. Electroencephalogr Clin Neurophysiol 1984; 57:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/79\">",
"      Bell BA, Smith MA, Kean DM, et al. Brain water measured by magnetic resonance imaging. Correlation with direct estimation and changes after mannitol and dexamethasone. Lancet 1987; 1:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/80\">",
"      Millson C, James HE, Shapiro HM, Laurin R. Intracranial hypertension and brain oedema in albino rabbits. Part 2: Effects of acute therapy with diuretics. Acta Neurochir (Wien) 1981; 56:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/81\">",
"      Nath F, Galbraith S. The effect of mannitol on cerebral white matter water content. J Neurosurg 1986; 65:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/82\">",
"      Paczynski RP. Osmotherapy. Basic concepts and controversies. Crit Care Clin 1997; 13:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/83\">",
"      Jafar JJ, Johns LM, Mullan SF. The effect of mannitol on cerebral blood flow. J Neurosurg 1986; 64:754.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/84\">",
"      Kaufmann AM, Cardoso ER. Aggravation of vasogenic cerebral edema by multiple-dose mannitol. J Neurosurg 1992; 77:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/85\">",
"      Polderman KH, van de Kraats G, Dixon JM, et al. Increases in spinal fluid osmolarity induced by mannitol. Crit Care Med 2003; 31:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/86\">",
"      Pollay M, Fullenwider C, Roberts PA, Stevens FA. Effect of mannitol and furosemide on blood-brain osmotic gradient and intracranial pressure. J Neurosurg 1983; 59:945.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/87\">",
"      Wilkinson HA, Rosenfeld SR. Furosemide and mannitol in the treatment of acute experimental intracranial hypertension. Neurosurgery 1983; 12:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/88\">",
"      Chesnut RM, Marshall LF. Management of head injury. Treatment of abnormal intracranial pressure. Neurosurg Clin N Am 1991; 2:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/89\">",
"      Garc&iacute;a-Sola R, Pulido P, Capilla P. The immediate and long-term effects of mannitol and glycerol. A comparative experimental study. Acta Neurochir (Wien) 1991; 109:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/90\">",
"      Node Y, Nakazawa S. Clinical study of mannitol and glycerol on raised intracranial pressure and on their rebound phenomenon. Adv Neurol 1990; 52:359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/91\">",
"      Cooper DJ, Myles PS, McDermott FT, et al. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA 2004; 291:1350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/92\">",
"      Schwarz S, Georgiadis D, Aschoff A, Schwab S. Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke. Stroke 2002; 33:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/93\">",
"      Munar F, Ferrer AM, de Nadal M, et al. Cerebral hemodynamic effects of 7.2% hypertonic saline in patients with head injury and raised intracranial pressure. J Neurotrauma 2000; 17:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/94\">",
"      Suarez JI, Qureshi AI, Bhardwaj A, et al. Treatment of refractory intracranial hypertension with 23.4% saline. Crit Care Med 1998; 26:1118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/95\">",
"      Shackford SR, Bourguignon PR, Wald SL, et al. Hypertonic saline resuscitation of patients with head injury: a prospective, randomized clinical trial. J Trauma 1998; 44:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/96\">",
"      Lescot T, Degos V, Zouaoui A, et al. Opposed effects of hypertonic saline on contusions and noncontused brain tissue in patients with severe traumatic brain injury. Crit Care Med 2006; 34:3029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/97\">",
"      Koenig MA, Bryan M, Lewin JL 3rd, et al. Reversal of transtentorial herniation with hypertonic saline. Neurology 2008; 70:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/98\">",
"      Francony G, Fauvage B, Falcon D, et al. Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure. Crit Care Med 2008; 36:795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/99\">",
"      Battison C, Andrews PJ, Graham C, Petty T. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med 2005; 33:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/100\">",
"      Vialet R, Alban&egrave;se J, Thomachot L, et al. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med 2003; 31:1683.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/101\">",
"      Schwarz S, Schwab S, Bertram M, et al. Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke. Stroke 1998; 29:1550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/102\">",
"      Ichai C, Armando G, Orban JC, et al. Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients. Intensive Care Med 2009; 35:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/103\">",
"      Kamel H, Navi BB, Nakagawa K, et al. Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: a meta-analysis of randomized clinical trials. Crit Care Med 2011; 39:554.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/104\">",
"      Bhardwaj A, Ulatowski JA. Hypertonic saline solutions in brain injury. Curr Opin Crit Care 2004; 10:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/105\">",
"      Roberts I, Yates D, Sandercock P, et al. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 2004; 364:1321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/106\">",
"      Edwards P, Arango M, Balica L, et al. Final results of MRC CRASH, a randomised placebo-controlled trial of intravenous corticosteroid in adults with head injury-outcomes at 6 months. Lancet 2005; 365:1957.",
"     </a>",
"    </li>",
"    <li>",
"     McLone D. Pediatric Neurosurgery: Surgery of the Developing Nervous System, 4th, W.B. Saunders, Philadelphia 2001. p.626.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/108\">",
"      Muizelaar JP, Marmarou A, Ward JD, et al. Adverse effects of prolonged hyperventilation in patients with severe head injury: a randomized clinical trial. J Neurosurg 1991; 75:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/109\">",
"      Hoff JT. Cerebral protection. J Neurosurg 1986; 65:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/110\">",
"      Laffey JG, Kavanagh BP. Hypocapnia. N Engl J Med 2002; 347:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/111\">",
"      Yundt KD, Diringer MN. The use of hyperventilation and its impact on cerebral ischemia in the treatment of traumatic brain injury. Crit Care Clin 1997; 13:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/112\">",
"      Stocchetti N, Maas AI, Chieregato A, van der Plas AA. Hyperventilation in head injury: a review. Chest 2005; 127:1812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/113\">",
"      Marion DW, Puccio A, Wisniewski SR, et al. Effect of hyperventilation on extracellular concentrations of glutamate, lactate, pyruvate, and local cerebral blood flow in patients with severe traumatic brain injury. Crit Care Med 2002; 30:2619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/114\">",
"      Coles JP, Minhas PS, Fryer TD, et al. Effect of hyperventilation on cerebral blood flow in traumatic head injury: clinical relevance and monitoring correlates. Crit Care Med 2002; 30:1950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/115\">",
"      Imberti R, Bellinzona G, Langer M. Cerebral tissue PO2 and SjvO2 changes during moderate hyperventilation in patients with severe traumatic brain injury. J Neurosurg 2002; 96:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/116\">",
"      Lafferty JJ, Keykhah MM, Shapiro HM, et al. Cerebral hypometabolism obtained with deep pentobarbital anesthesia and hypothermia (30 C). Anesthesiology 1978; 49:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/117\">",
"      Marshall LF, Shapiro HM, Rauscher A, Kaufman NM. Pentobarbital therapy for intracranial hypertension in metabolic coma. Reye's syndrome. Crit Care Med 1978; 6:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/118\">",
"      Messeter K, Nordstr&ouml;m CH, Sundb&auml;rg G, et al. Cerebral hemodynamics in patients with acute severe head trauma. J Neurosurg 1986; 64:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/119\">",
"      Nordstr&ouml;m CH, Messeter K, Sundb&auml;rg G, et al. Cerebral blood flow, vasoreactivity, and oxygen consumption during barbiturate therapy in severe traumatic brain lesions. J Neurosurg 1988; 68:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/120\">",
"      Marshall LF, Smith RW, Shapiro HM. The outcome with aggressive treatment in severe head injuries. Part II: acute and chronic barbiturate administration in the management of head injury. J Neurosurg 1979; 50:26.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/121\">",
"      Rea GL, Rockswold GL. Barbiturate therapy in uncontrolled intracranial hypertension. Neurosurgery 1983; 12:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/122\">",
"      Eisenberg HM, Frankowski RF, Contant CF, et al. High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury. J Neurosurg 1988; 69:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/123\">",
"      Ward JD, Becker DP, Miller JD, et al. Failure of prophylactic barbiturate coma in the treatment of severe head injury. J Neurosurg 1985; 62:383.",
"     </a>",
"    </li>",
"    <li>",
"     Wilkins RH RS. Neurosurgery, 2nd, McGraw-Hill, New York 1996. Vol 1, p.347.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/125\">",
"      James HE, Langfitt TW, Kumar VS, Ghostine SY. Treatment of intracranial hypertension. Analysis of 105 consecutive, continuous recordings of intracranial pressure. Acta Neurochir (Wien) 1977; 36:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/126\">",
"      Marion DW, Obrist WD, Carlier PM, et al. The use of moderate therapeutic hypothermia for patients with severe head injuries: a preliminary report. J Neurosurg 1993; 79:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/127\">",
"      Shiozaki T, Sugimoto H, Taneda M, et al. Effect of mild hypothermia on uncontrollable intracranial hypertension after severe head injury. J Neurosurg 1993; 79:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/128\">",
"      Shiozaki T, Sugimoto H, Taneda M, et al. Selection of severely head injured patients for mild hypothermia therapy. J Neurosurg 1998; 89:206.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/129\">",
"      Mellerg&aring;rd P. Changes in human intracerebral temperature in response to different methods of brain cooling. Neurosurgery 1992; 31:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/130\">",
"      McIntyre LA, Fergusson DA, H&eacute;bert PC, et al. Prolonged therapeutic hypothermia after traumatic brain injury in adults: a systematic review. JAMA 2003; 289:2992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/131\">",
"      Burkert W, Paver HD. [Decompressive trepanation in therapy refractory brain edema]. Zentralbl Neurochir 1988; 49:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/132\">",
"      Burkert W, Plaumann H. [The value of large pressure-relieving trepanation in treatment of refractory brain edema. Animal experiment studies, initial clinical results]. Zentralbl Neurochir 1989; 50:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/133\">",
"      Hatashita S, Hoff JT. The effect of craniectomy on the biomechanics of normal brain. J Neurosurg 1987; 67:573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/134\">",
"      Hatashita S, Hoff JT. Biomechanics of brain edema in acute cerebral ischemia in cats. Stroke 1988; 19:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/135\">",
"      Rinaldi A, Mangiola A, Anile C, et al. Hemodynamic effects of decompressive craniectomy in cold induced brain oedema. Acta Neurochir Suppl (Wien) 1990; 51:394.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/136\">",
"      Moody RA, Ruamsuke S, Mullan SF. An evaluation of decompression in experimental head injury. J Neurosurg 1968; 29:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/137\">",
"      Gaab M, Knoblich OE, Fuhrmeister U, et al. Comparison of the effects of surgical decompression and resection of local edema in the therapy of experimental brain trauma. Investigation of ICP, EEG and cerebral metabolism in cats. Childs Brain 1979; 5:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/138\">",
"      Dam Hieu P, Sizun J, Person H, Besson G. The place of decompressive surgery in the treatment of uncontrollable post-traumatic intracranial hypertension in children. Childs Nerv Syst 1996; 12:270.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/139\">",
"      Gower DJ, Lee KS, McWhorter JM. Role of subtemporal decompression in severe closed head injury. Neurosurgery 1988; 23:417.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/140\">",
"      Guerra WK, Gaab MR, Dietz H, et al. Surgical decompression for traumatic brain swelling: indications and results. J Neurosurg 1999; 90:187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/141\">",
"      Jourdan C, Convert J, Mottolese C, et al. [Evaluation of the clinical benefit of decompression hemicraniectomy in intracranial hypertension not controlled by medical treatment]. Neurochirurgie 1993; 39:304.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/142\">",
"      Jaeger M, Soehle M, Meixensberger J. Effects of decompressive craniectomy on brain tissue oxygen in patients with intracranial hypertension. J Neurol Neurosurg Psychiatry 2003; 74:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/143\">",
"      Carter BS, Ogilvy CS, Candia GJ, et al. One-year outcome after decompressive surgery for massive nondominant hemispheric infarction. Neurosurgery 1997; 40:1168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/144\">",
"      Polin RS, Shaffrey ME, Bogaev CA, et al. Decompressive bifrontal craniectomy in the treatment of severe refractory posttraumatic cerebral edema. Neurosurgery 1997; 41:84.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/145\">",
"      Delashaw JB, Broaddus WC, Kassell NF, et al. Treatment of right hemispheric cerebral infarction by hemicraniectomy. Stroke 1990; 21:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/146\">",
"      Kondziolka D, Fazl M. Functional recovery after decompressive craniectomy for cerebral infarction. Neurosurgery 1988; 23:143.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/147\">",
"      Schwab S, Steiner T, Aschoff A, et al. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke 1998; 29:1888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/148\">",
"      Hofmeijer J, van der Worp HB, Kappelle LJ. Treatment of space-occupying cerebral infarction. Crit Care Med 2003; 31:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/149\">",
"      Pranesh MB, Dinesh Nayak S, Mathew V, et al. Hemicraniectomy for large middle cerebral artery territory infarction: outcome in 19 patients. J Neurol Neurosurg Psychiatry 2003; 74:800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/150\">",
"      Alban&egrave;se J, Leone M, Alliez JR, et al. Decompressive craniectomy for severe traumatic brain injury: Evaluation of the effects at one year. Crit Care Med 2003; 31:2535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/151\">",
"      Diedler J, Sykora M, Blatow M, et al. Decompressive surgery for severe brain edema. J Intensive Care Med 2009; 24:168.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/152\">",
"      Fields JD, Lansberg MG, Skirboll SL, et al. \"Paradoxical\" transtentorial herniation due to CSF drainage in the presence of a hemicraniectomy. Neurology 2006; 67:1513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/153\">",
"      Oyelese AA, Steinberg GK, Huhn SL, Wijman CA. Paradoxical cerebral herniation secondary to lumbar puncture after decompressive craniectomy for a large space-occupying hemispheric stroke: case report. Neurosurgery 2005; 57:E594; discussion E594.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/154\">",
"      Sarov M, Guichard JP, Chibarro S, et al. Sinking skin flap syndrome and paradoxical herniation after hemicraniectomy for malignant hemispheric infarction. Stroke 2010; 41:560.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?32/39/33402/abstract/155\">",
"      Marion DW, Spiegel TP. Changes in the management of severe traumatic brain injury: 1991-1997. Crit Care Med 2000; 28:16.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1659 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-200.215.4.194-8300F9CC1D-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_39_33402=[""].join("\n");
var outline_f32_39_33402=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H39\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Intracranial components",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Intracranial compliance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Cerebral blood flow",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Autoregulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Cerebral perfusion pressure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      ICP MONITORING",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Role of computed tomography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Types of monitors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Intraventricular",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Intraparenchymal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Subarachnoid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Epidural",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2314865\">",
"      Waveform analysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Noninvasive systems",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2314798\">",
"      Advanced neuromonitoring",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      GENERAL MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Resuscitation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Urgent situations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Monitoring and the decision to treat",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Fluid management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Sedation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Blood pressure control",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Position",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Fever",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Antiepileptic therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      SPECIFIC THERAPIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Mannitol",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      - Other diuretics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Hypertonic saline bolus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Hyperventilation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Barbiturates",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Therapeutic hypothermia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Removal of CSF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H38\">",
"      Decompressive craniectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H39\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/1659\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1659|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?25/36/26176\" title=\"diagnostic image 1\">",
"      CT findings in elevated ICP",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1659|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?25/36/26190\" title=\"figure 1\">",
"      Intracranial compensation for mass",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?35/62/36844\" title=\"figure 2\">",
"      Intracranial pressure volume and ICP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?33/13/34013\" title=\"figure 3\">",
"      Cerebral autoregulation in hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?5/13/5335\" title=\"figure 4\">",
"      Transtentorial herniation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?2/49/2838\" title=\"figure 5\">",
"      Intracranial pressure monitors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?27/61/28625\" title=\"figure 6\">",
"      External ventricular device",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1659|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"mobipreview.htm?30/30/31215\" title=\"picture 1\">",
"      Papilledema",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1659|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?8/25/8603\" title=\"table 1\">",
"      Causes of elevated ICP",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/62/29676\" title=\"table 2\">",
"      Glasgow coma scale",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/1659|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"mobipreview.htm?21/44/22223\" title=\"waveform 1\">",
"      ICP waveforms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/40/38538?source=related_link\">",
"      Acute liver failure in adults: Management and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/33/13850?source=related_link\">",
"      Advanced cardiac life support (ACLS) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/57/17305?source=related_link\">",
"      Antihypertensive therapy to prevent recurrent stroke or transient ischemic attack",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/25/36248?source=related_link\">",
"      Basic life support (BLS) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/30/3562?source=related_link\">",
"      Causes of hyponatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/10/17576?source=related_link\">",
"      Cerebrospinal fluid: Physiology and utility of an examination in disease states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/44/32451?source=related_link\">",
"      Complications of mannitol therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/35/569?source=related_link\">",
"      Decompressive hemicraniectomy for malignant middle cerebral artery territory infarction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/34/23080?source=related_link\">",
"      Dexamethasone to prevent neurologic complications of bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/37/44633?source=related_link\">",
"      Elevated intracranial pressure in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/32/44552?source=related_link\">",
"      Infections of central nervous system shunts and other devices",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/29/33242?source=related_link\">",
"      Initial assessment and management of acute stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/27/41398?source=related_link\">",
"      Malignant hypertension and hypertensive encephalopathy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/2/35882?source=related_link\">",
"      Management of acute severe traumatic brain injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/26/39335?source=related_link\">",
"      Management of vasogenic edema in patients with primary and metastatic brain tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/21/31066?source=related_link\">",
"      Overview of inpatient management in the adult trauma patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/29/15833?source=related_link\">",
"      Sedative-analgesic medications in critically ill patients: Selection, initiation, maintenance, and withdrawal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/56/32650?source=related_link\">",
"      Spontaneous intracerebral hemorrhage: Prognosis and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/9/28825?source=related_link\">",
"      Stupor and coma in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/43/32438?source=related_link\">",
"      Treatment and prognosis of brain abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/54/37738?source=related_link\">",
"      Treatment of aneurysmal subarachnoid hemorrhage",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/57/17306?source=related_link\">",
"      Treatment of hyponatremia: Syndrome of inappropriate antidiuretic hormone secretion (SIADH) and reset osmostat",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/44/43720?source=related_link\">",
"      Use of neuromuscular blocking medications in critically ill patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/35/40505?source=related_link\">",
"      Use of vasopressors and inotropes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f32_39_33403="Hx abnl uterine bleeding teen";
var content_f32_39_33403=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F70444&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F70444&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Questions to aid in the diagnosis of abnormal uterine bleeding in adolescents",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Menstrual history",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Age of menarche",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Frequency, duration, severity, regularity of menses",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronicity of current bleeding problem",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Associated symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pain",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fever",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vaginal odor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Bladder/bowel dysfunction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Symptoms of systemic illness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Medical history",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Chronic medical illness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Medicines",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Use of contraceptives or other chronic medications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Family history",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Personal/family history of coagulopathies or gynecologic disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Social factors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Recent stressors (eating disorders, recent move), excessive exercise, sexual activity",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_39_33403=[""].join("\n");
var outline_f32_39_33403=null;
var title_f32_39_33404="Patch test units";
var content_f32_39_33404=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F68134&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F68134&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Available patch test units/devices",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Chamber name",
"       </td>",
"       <td class=\"subtitle1\">",
"        Description",
"       </td>",
"       <td class=\"subtitle1\">",
"        Advantages/disadvantages",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         <strong>",
"          Finn Chamber",
"         </strong>",
"        </p>",
"        <p>",
"         Manufactured and distributed by SmartPractice Finland",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         8 mm round aluminum discs",
"        </p>",
"        <p>",
"         Strips of 10",
"        </p>",
"        <p>",
"         Trays are stackable",
"        </p>",
"       </td>",
"       <td>",
"        <ol>",
"         <li>",
"          Rare reactions to aluminum",
"         </li>",
"         <li>",
"          Rare corrosion by some aqueous solutions",
"         </li>",
"         <li>",
"          Need to add filter paper for liquids",
"         </li>",
"         <li>",
"          Easy to see disc imprints",
"         </li>",
"        </ol>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         <strong>",
"          IQ Square Chamber/IQ Ultra Chamber",
"         </strong>",
"        </p>",
"        <p>",
"         Marketed by Chemotechnique Diagnostics, distributed by Dormer Labs Inc., Toronto, Ontario",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         9x9 mm square chambers",
"        </p>",
"        <p>",
"         Strips of 10",
"        </p>",
"        <p>",
"         Polyethylene plastic chambers",
"        </p>",
"        <p>",
"         Filter paper incorporated",
"        </p>",
"       </td>",
"       <td>",
"        <ol>",
"         <li>",
"          Thin soft chambers for comfort",
"         </li>",
"         <li>",
"          Adhesive rim to each chamber minimizes leakage",
"         </li>",
"         <li>",
"          Can reattach protective tape after filling chambers",
"         </li>",
"        </ol>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         <strong>",
"          Allergeaze Chamber",
"         </strong>",
"        </p>",
"        <p>",
"         Marketed by SmartPractice Canada",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         8x8 mm square chambers",
"        </p>",
"        <p>",
"         Acetal copolymer chambers",
"        </p>",
"        <p>",
"         Strips of 10 chambers mounted on nonwoven polyester",
"        </p>",
"       </td>",
"       <td>",
"        Nonwoven panel flexes and allows ease of movement",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         <strong>",
"          van der Bend Chamber",
"         </strong>",
"        </p>",
"        <p>",
"         Marketed by van der Bend B.V., The Netherlands",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         10x10 mm square chamber",
"        </p>",
"        <p>",
"         Whatman filter paper fixed in each chamber",
"        </p>",
"       </td>",
"       <td>",
"        Chambers can be fixed on tape and joined in a row without tape",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         <strong>",
"          Haye's Test Chamber",
"         </strong>",
"        </p>",
"        <p>",
"         Marketed by HAL Allergenen Lab. B.V., The Netherlands",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         8x8 mm square chambers",
"        </p>",
"        <p>",
"         Strips of 10 square chambers",
"        </p>",
"        <p>",
"         Hydrophilic unbleached nonwoven polyester chambers",
"        </p>",
"       </td>",
"       <td>",
"        Notches in chambers allow them to be filled without removing the cover liner",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_39_33404=[""].join("\n");
var outline_f32_39_33404=null;
var title_f32_39_33405="Mental status exam terms";
var content_f32_39_33405=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F65883&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F65883&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Mental status examination terminology",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td>",
"       <strong>",
"        abulia:",
"       </strong>",
"       loss of initiative, willpower, or drive",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        acalculia:",
"       </strong>",
"       inability to calculate",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        agnosia:",
"       </strong>",
"       inability to recognize one or more classes of environmental stimuli, even though the necessary intellectual and perceptual functions are intact",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        agraphia:",
"       </strong>",
"       inability to write",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        alexia:",
"       </strong>",
"       inability to read for comprehension",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        amnesia:",
"       </strong>",
"       inability to retain new information",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        anomia:",
"       </strong>",
"       inability to name objects or think of words; in practice, often used as a synonym for dysnomia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        anosognosia:",
"       </strong>",
"       inability to recognize one's own impairment",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        anterior aphasia:",
"       </strong>",
"       acquired language disorder in which verbal output is nonfluent",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        aphasia:",
"       </strong>",
"       literally, a complete loss of language function, but in practice, used as a synonym for dysphasia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        aphemia:",
"       </strong>",
"       complete loss of the ability to speak, but retained comprehension and writing ability",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        apraxia:",
"       </strong>",
"       inability to perform a previously learned set of coordinated movements even though the necessary component skills (including intellect, language function, strength, coordination, and sensation) remain intact",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Broca's aphasia:",
"       </strong>",
"       acquired language disorder characterized by nonfluent verbal output with omission of relational words (prepositions, conjunctions, articles, and minor modifiers) and abnormal prosody, impaired repetition, and relatively intact comprehension",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        conduction aphasia:",
"       </strong>",
"       acquired language disorder characterized by prominent impairment of repetition, relatively intact comprehension, and verbal output that is fluent but contains literal paraphasias",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        delirium:",
"       </strong>",
"       an acute confusional state characterized by clouded, reduced, or shifting attention, often associated with sensory misperception or disturbed thinking",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        dementia:",
"       </strong>",
"       acquired impairment of memory and at least one other cognitive function, without clouding of the sensorium or underlying psychiatric disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        dysnomia:",
"       </strong>",
"       difficulty naming objects or finding the desired words",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        dysphasia:",
"       </strong>",
"       acquired disorder of language not due to generalized intellectual impairment or psychiatric disturbance",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        expressive aphasia:",
"       </strong>",
"       acquired language disorder in which verbal output is nonfluent",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        fluent:",
"       </strong>",
"       an adjective used to describe verbal output that is normal to excessive, easily produced, with normal phrase length (five or more words) and normal prosody",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        fluent aphasia:",
"       </strong>",
"       acquired language disorder in which verbal output is fluent",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Gerstmann's syndrome:",
"       </strong>",
"       the constellation of (1) agraphia, (2) acalculia, (3) right-left confusion, and (4) finger agnosia; classically associated with lesions in the angular gyrus of the dominant hemisphere (but the subject of endless debate)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        jargon:",
"       </strong>",
"       verbal output that contains so many literal paraphasias that the words are unrecognizable",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        nonfluent:",
"       </strong>",
"       an adjective used to describe verbal output that is sparse, with only one to four words per phrase",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        nonfluent aphasia:",
"       </strong>",
"       acquired language disorder in which verbal output is nonfluent",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        paraphasia:",
"       </strong>",
"       a substitution error in which the word produced is similar in sound or meaning to the intended word. A literal or phonemic paraphasia is a sound substitution error resulting in production of a word that is phonemically related to the intended word (eg, \"greed\" or \"greeb\" instead of \"green\"). A semantic or verbal paraphasia is a word substitution error in which the word produced is semantically related to the intended word (eg, \"blue\" instead of \"green\")",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        posterior aphasia:",
"       </strong>",
"       acquired language disorder in which comprehension is impaired",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        prosody:",
"       </strong>",
"       the rhythm and tempo of speech",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        prosopagnosia:",
"       </strong>",
"       inability to recognize faces",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        receptive aphasia:",
"       </strong>",
"       acquired language disorder in which comprehension is impaired",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        transcortical aphasia:",
"       </strong>",
"       acquired language disorder in which the ability to repeat is intact",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <strong>",
"        Wernicke's aphasia:",
"       </strong>",
"       acquired language disorder characterized by markedly impaired comprehension and repetition, with verbal output that is fluent but contaminated by numerous paraphasias or, in severe cases, jargon",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_39_33405=[""].join("\n");
var outline_f32_39_33405=null;
var title_f32_39_33406="Barretts esophagus with high grade dysplasia CPC Endosc";
var content_f32_39_33406=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F61537&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F61537&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Barrett's esophagus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 252px; height: 222px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Endoscopic view of the distal esophagus shows a single, 3 cm long linear area of salmon-colored mucosa above the esophagogastric junction suggestive of Barrett's esophagus.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Myron Falchuk, MD, and Andres Gelrud, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f32_39_33406=[""].join("\n");
var outline_f32_39_33406=null;
var title_f32_39_33407="Contents: Breast surgery";
var content_f32_39_33407=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"mobipreview.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"mobipreview.htm?5/48/5902\">",
"       General Surgery",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Breast surgery",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"mobipreview.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"mobipreview.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Breast surgery",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Anatomy and morphology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/10/20649\">",
"           Breast development and morphology",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Diagnosis and evaluation",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?16/51/17207\">",
"           Breast cancer during pregnancy and lactation: Epidemiology and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/60/4040\">",
"           Breast cysts: Clinical manifestations, diagnosis, and management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/33/6680\">",
"           Breast ductal carcinoma in situ: Epidemiology, clinical manifestations, and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/35/39482\">",
"           Breast imaging: Mammography and ultrasonography",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/15/24825\">",
"           Breast masses and other common breast problems",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/33/8728\">",
"           Breast pain",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?26/47/27384\">",
"           Causes and evaluation of gynecomastia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/49/10009\">",
"           Clinical features, diagnosis, and staging of newly diagnosed breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/9/6294\">",
"           Epidemiology and pathogenesis of gynecomastia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/53/857\">",
"           Erythematous disorders of the breast",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/17/28954\">",
"           Factors that modify breast cancer risk in women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?22/29/23002\">",
"           MRI of the breast and emerging technologies",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/47/760\">",
"           Management of gynecomastia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?3/23/3449\">",
"           Nipple discharge",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/6/40039\">",
"           Nipple inversion",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?10/52/11081\">",
"           Overview of benign breast disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/49/41754\">",
"           Screening for breast cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         High risk screening and management",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/14/44265\">",
"           Atypia and lobular carcinoma in situ: High risk lesions of the breast",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/63/44025\">",
"           Characteristics of hereditary breast and ovarian cancer syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/60/5064\">",
"           Genetic risk assessment for individuals at risk for hereditary breast and ovarian cancer syndromes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?31/31/32249\">",
"           Genetic testing for hereditary breast and ovarian cancer syndrome",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/0/17418\">",
"           Management of hereditary breast and ovarian cancer syndrome and patients with BRCA mutations",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/2/7210\">",
"           Mechanisms of action of selective estrogen receptor modulators",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/11/11449\">",
"           Postmenopausal hormone therapy and the risk of breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/51/2872\">",
"           Risk prediction models for breast cancer screening",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/13/44246\">",
"           Selective estrogen receptor modulators and aromatase inhibitors for breast cancer prevention",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Infection",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/17/9495\">",
"           Breast abscess",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/61/43991\">",
"           Breast cellulitis: Clinical manifestations, diagnosis, and management",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/28/454\">",
"           Lactational mastitis",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Pathology",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/47/19194\">",
"           Hormone receptors in breast cancer: Clinical utility and guideline recommendations to improve test accuracy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?9/55/10103\">",
"           Inflammatory breast cancer: Pathology and molecular pathogenesis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/28/43465\">",
"           Measurement of prognostic factors in breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/21/41302\">",
"           Molecular intrinsic subtypes of breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?15/42/16040\">",
"           Pathology of breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?6/22/6503\">",
"           Prognostic molecular profiles of breast cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Primary nonepithelial breast malignancies",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/19/36150\">",
"           Breast lymphoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?28/3/28729\">",
"           Breast sarcoma: Epidemiology, risk factors, clinical presentation, diagnosis, and staging",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?27/2/27689\">",
"           Breast sarcoma: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/63/18424\">",
"           Phyllodes tumors of the breast",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Staging",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/45/24278\">",
"           Tumor node metastasis (TNM) staging classification for breast cancer",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Surgery",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/59/24504\">",
"           Breast biopsy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/42/31402\">",
"           Breast conserving therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/29/39386\">",
"           Breast reconstruction in women with breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?23/36/24138\">",
"           Diagnostic evaluation of women with suspected breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/52/42825\">",
"           Management of the regional lymph nodes in breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/18/12586\">",
"           Mastectomy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/30/1512\">",
"           Oncoplastic techniques in breast conserving surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/20/33095\">",
"           Postmastectomy pain syndrome: Clinical manifestations and diagnosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?4/12/4292\">",
"           Role of breast surgery for stage IV breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/52/20296\">",
"           Sentinel lymph node biopsy in breast cancer: Techniques",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?35/47/36602\">",
"           Sentinel lymph node dissection for breast cancer: Indications and outcomes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?20/23/20856\">",
"           Technique of axillary lymph node dissection",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Survivorship",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/52/1866\">",
"           Clinical manifestations and diagnosis of lymphedema",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?43/45/44761\">",
"           Clinical manifestations and diagnosis of menopause",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?17/61/18392\">",
"           Fertility preserving options for women of advancing age",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/53/25434\">",
"           Menopausal hot flashes",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?8/0/8202\">",
"           Patterns of relapse and long-term complications of therapy in breast cancer survivors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/1/33817\">",
"           Prevention and treatment of lymphedema",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?24/42/25258\">",
"           Sexual dysfunction in women: Epidemiology, risk factors, and evaluation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/57/42904\">",
"           The sexual history and approach to the patient with sexual dysfunction",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Treatment",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/27/12728\">",
"           Accelerated partial breast irradiation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?19/40/20106\">",
"           Adjuvant endocrine therapy for hormone receptor-positive breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/21/43352\">",
"           Axillary node metastases with occult primary breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?13/18/13608\">",
"           Bisphosphonates and denosumab in patients with metastatic cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?2/34/2602\">",
"           Breast cancer during pregnancy and lactation: Treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?25/36/26186\">",
"           Breast cancer in men",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/21/34137\">",
"           Cardiotoxicity of radiation therapy for malignancy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/15/42232\">",
"           Cardiotoxicity of trastuzumab",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/41/30359\">",
"           Complications of breast and chest wall irradiation for early stage breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?36/43/37561\">",
"           Ductal carcinoma in situ: Treatment and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/40/34441\">",
"           Epidemiology, risk factors and the clinical approach to ER/PR negative, HER2-negative (Triple-negative) breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?12/58/13226\">",
"           General principles on the treatment of early stage and locally advanced breast cancer in older women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/22/30058\">",
"           HER2 and predicting response to therapy in breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?30/20/31048\">",
"           Inflammatory breast cancer: Clinical features and treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?33/53/34650\">",
"           Management of locoregional recurrence of breast cancer after breast conserving therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?29/45/30426\">",
"           Management of locoregional recurrence of breast cancer after mastectomy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/38/41576\">",
"           Managing the side effects of tamoxifen",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/28/43465\">",
"           Measurement of prognostic factors in breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?7/2/7210\">",
"           Mechanisms of action of selective estrogen receptor modulators",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?34/63/35831\">",
"           Metastatic breast cancer: Local treatment",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?14/41/14998\">",
"           Microinvasive breast carcinoma",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?1/31/1529\">",
"           Neoadjuvant systemic therapy for breast cancer: Response, subsequent treatment, and prognosis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?18/46/19177\">",
"           Overview of the treatment of newly diagnosed, non-metastatic breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?32/35/33336\">",
"           Overview of the use of osteoclast inhibitors in early breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?0/0/14\">",
"           Paget disease of the breast",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?40/3/41017\">",
"           Postmastectomy chest wall irradiation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?41/55/42873\">",
"           Radiation techniques for locally advanced breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?11/7/11385\">",
"           Role of radiation therapy in breast conservation therapy",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?38/46/39657\">",
"           Techniques of breast and chest wall irradiation for early stage breast cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?42/19/43321\">",
"           The roles of diet, physical activity, and body weight in cancer survivorship",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"mobipreview.htm?39/60/40903\">",
"           Treatment of metastatic breast cancer in older women",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-A61100E0E3-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f32_39_33407=[""].join("\n");
var outline_f32_39_33407=null;
